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ABSTRACT 
The aim of the present study was to investigate the pharmacology of three inwardly 
rectifying K+-channels in neonatal rat cardiac myocytes, IKAch, IKI, IK; \TP- using 
whole cell voltage clamp techniques. Cells were held at -50mV. 
A previous study has shown that clotrimazole, an antimycotic agent, and cetiedil, 
an antisickling agent are potent against the IKACh in atrial myocytes. Structural 
analogues of these compounds were tested on the three inward rectifiers. 
UCL1880, an analogue of clotrimazole was found to be potent on the G-protein 
gated channel, IKACh (with an 
IC50 of 0.18µM. Concentrations which caused an 
almost maximum block of this current were relatively ineffective on the IK1 and 
IKATP. UCL1495, an analogue of cetiedil, had an IC50 of 0.46µM against the G- 
protein gated current. It was ineffective on the IK1 and the IKATP current. Both of the 
compounds exhibited use-dependence but not voltage dependence. 
Glibenclamide, a sulphonylurea, was tested on IKATP and IKAChas it has been 
suggested that the adenosine activation of IKACh includes the activation of IK ATP. 
Glibenclamide was found to be far more effective on the IKATP The concentrations 
which were effective on IK kTp 
did not block the IKACh or the IK1. 
Barium was also tested on these three channels to see if there was any selectivity in 
its action. It had IC50 values of 34.9µM on IKACh, 16.8µM on IK1 and 164.5µM on 
IK. 
\TP. 
The block on IK. \Ch was voltage 
dependent, increasing at negative potentials, 
with an IC 5o of 3.8µM at -120mV. 
UCL 1880 and UCL 1495 are selective for IKACh_ and may be used as 
pharmacological tools to compare and contrast other G-protein gated currents to the 
native atrial channel. 
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CHAPTER ONE: INTRODUCTION 
The surface membranes of cells contain proteins that facilitate the 
movement - be it exit or entry - of charged particles, ions, between the cell and 
its environment. Among the most important of these proteins are ion channels. 
In 1902, Bernstein suggested a selective potassium permeability in excitable 
cells and so can be credited with discovering potassium channels, at least in a 
general sense. Subsequently the majority of cells were shown to have some 
permeability to Na', Ca2+ and Cl- as well as to K+. 
K+ channels stabilize the membrane potential by maintaining it closer to 
the reversal potential for K+ and away from the firing threshold of electrically 
excitable cells. Thus they set the resting membrane potential and tend to inhibit 
the initiation of action potentials - their opening reduces the effectiveness of 
excitatory inputs on a cell. K+ channels can also play a part in the 'spacing' of 
trains of action potentials and this helps some excitable cells to generate 
rhythmic activity. These are not the only roles of K+ channels as they are also 
involved in net transport for example in epithelia where they play a part in the 
movement of salt and water in and out of body compartments. 
The main types of K+ channels, their classification and their roles in 
various tissues are discussed in the following section. Most emphasis has been 
placed on the types of K+ channels that are present in cardiac tissue. 
1.1: VOLTAGE-ACTIVATED K+ CHANNELS 
1.1.1: DELAYED RECTIFIERS (IK) 
Hodgkin and Huxley (1952) discovered the existence of the delayed 
rectifier in squid giant axons. The delayed rectifier K+ channels open in 
response to depolarisation after a delay and contribute to the repolarization 
phase of the action potential in many excitable cells. The current is activated at 
potentials positive to approximately -50mV and activation is complete between 
0 and +20mV. In cardiac muscle the current flows mainly during the late 
plateau phase of the action potential to initiate rapid and final repolarisation of 
L\"TRODCCTION 
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the action potential. This channel is widely distributed in excitable and non- 
excitable cells. 
Peptide toxins have been used extensively in the classification of K+ 
channels. Dendrotoxin (Dendroaspis angusticeps) from the venom of African 
mambas blocks IK in rat nodose ganglia (Stansfeld et al., 1986) and dorsal root 
ganglion neurons of the guinea-pig (Penner et al., 1986). The delayed rectifier 
in the frog node of Ranvier can be blocked by TEA applied either intracellularly 
with an IC50 of -20mM or extracellularly with an IC50 of - 0.4mM (Armstrong 
and Hille 1972). The IC50 for TEA in Myxicola giant axons is 24mM whereas 
even 250mM externally applied TEA has no effect in squid giant axon 
(Armstrong, 1971). 
In guinea-pig atrial cells there are thought to be two types of delayed 
rectifier channel with single channel conductances of 10 and 3pS in symmetrical 
K+ (Horie et al., 1989). Several other studies have demonstrated the presence of 
two components - fast and slow- of this current for example in sheep cardiac 
Purkinje fibres (Noble and Tsien, 1969), bullfrog atrial myocardium (Goto et 
al., 1985), and rabbit sino-atrial node (Noma and Irisawa 1976, DiFrancesco et 
al., 1979). In guinea-pig ventricular myocytes the rapid component can be 
blocked by a class III antiarrhythmic (E4031,5µM) and the slow component by 
the anaesthetics propofol (100µM) and thiopentone (100µM). The contributions 
of these two components to the total current were comparable (Heath and 
Terrar, 1996a). Two components of the delayed rectifier current have also been 
described in frog short skeletal muscle fibres (Lynch, 1985) and in frog oocytes 
expressing the human delayed rectifier K+ channel (h-DRK1) (Bendorff et al., 
1994). The human K+ channel gene, HERG, which has been linked to long-QT 
syndrome, is thought to encode the fast component of the delayed rectifier 
current found in the heart (Wymore et al., 1997). A channel protein known as 
minK associates with another channel protein called KvLQT 1 to produce a 
current which resembles the slow cardiac repolarisation current (IKS) 
(Sanguinetti et al., 1996). MinK forms a stable complex with HERG and 
regulate the rapidly activating cardiac delayed rectifier activity (McDonald et 
at, 1997). 
INTRODUCTION 
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1.1.2: THE TRANSIENT (EARLY) OUTWARD CURRENT (IA). 
This current is referred to both as the transient (early) outward current and 
as the rapidly inactivating current. It was first described by Connor and Stevens 
(1971) in molluscan neurons. By holding the membrane potential at -40mV and 
then stepping to -5mV, the delayed rectifier and Cat+-activated currents were 
observed. By holding at -80mV and stepping to -5mV IA was also activated - 
subtraction of these two currents gave the rapidly activating and inactivating IA 
(Connor and Stevens, 1971). The current is active at the subthreshold stage of 
the membrane potential - during depolarisation after a period of 
hyperpolarisation. In Tritonia neurons the activation threshold is about -65mV 
and the channel conducts at potentials between -65 and -40mV (Thompson, 
1977, Smith, 1978). At the resting potential of -45mV in these neurons the 
channels will be inactivated. 
What is their role? In Anisodoris neurons after an action potential KA 
channels are inactivated but delayed rectifier channels are active so that the cell 
hyperpolarises. This removes the inactivation of KA channels and shuts down 
the IK channels so the membrane begins to depolarize. This reactivates the KA 
channels which open and the resulting outward current tends to keep the cell 
membrane potential negative for a period. Soon, however, the KA channels 
inactivate and depolarisation increases until the firing threshold is again reached 
leading to the generation of another action potential. In this way these channels 
space successive action potentials. Such currents have been observed in 
arthropod muscle and neurons and in vertebrate neurons and the heart (for 
reviews see Rudy, 1988; Llinas, 1988). 
The cardiac IA is found specifically in Purkinje fibres and the atrium and 
makes up the Ito current. In human atria (Escande et al., 1987) and in sheep 
Purkinje fibres (Coraboeuf and Carmeliet, 1982) two components of the current 
can be distinguished. One is long lasting (I,., I= long) and has a slow decay and 
is blocked by 4-AP and Ba 2+ - the IA component. The other is brief (Ibo, b= 
brief) and has a short rise time and decay. This component can be blocked by 
Co2+ and thus may be a Cat+-activated K+ current. 
4-AP blocks I: x with an IC50 of about 2mM in many different tissue types 
L\-TROD UCTIO. V 
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(Rogawski, 1985). Since it is more potent on IA than on IK(Ca) currents, 4-AP can 
be used to distinguish between them in some cells (Rudy, 1988). IK and IA can 
also be distinguished pharmacologically because IA is not as sensitive to TEA 
and more sensitive to 4-AP than IK (Connor and Stevens, 1971, Thompson, 
1977). 
1.1.3: THEM CURRENT (IM) 
This current was first discovered in frog sympathetic neurons (Brown and 
Adams, 1980). It was termed the M-current due to its inhibition by acetylcholine 
acting at muscarinic receptors. It displays time- and voltage- dependent 
characteristics. The current is activated slowly upon depolarisation, in 10- 
100ms, and inactivates slowly when the membrane is hyperpolarised. This 
channel regulates cell excitability in that it is inhibited by neurotransmitters 
such as acetylcholine, Substance P and luteinizing hormone releasing hormone 
(LHRH) which leads to an increase in excitability. These channels are found in 
both the periphery, for example in sympathetic neurons, and in many central 
neurons including human neocortical cells (Halliwell, 1986). 
The neurotransmitters affecting the channel act via a G-protein which is 
pertussis toxin insensitive. The phospholipase C and the phosphoinositol 
pathway may be involved (Dutar and Nicoll, 1988a, b). Protein kinase C may be 
phosphorylating the channel as it inhibits some M current in certain tissues 
(Brown, 1988). The current is blocked by 1 mM Ba 2+ and by TEA (Constanti 
and Sim, 1987, Storm, 1989). 
1.1.4: CALCIUM-ACTIVATED K+ CHANNELS 
These currents are activated by an increase in cytoplasmic free [Ca 2+] and 
are variously termed IK(ca), IK, Ca, Ic, or IMP. With the introduction of patch 
clamp techniques, large conductance K(Ca) channels were discovered in nearly 
every vertebrate excitable cell. In addition to these large conductance channels, 
[(BK) or maxi-channels], intermediate conductance (I x(ca)) and small 
conductance channels (SK(Ca)) also exist. These channels differ in their voltage- 
dependence, Cat- sensitivity, pharmacology and conductance. 
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BK channels were first discovered in chromaffin cells (Marty, 1981) and 
in rat myotubes (Pallotta et al., 1981). They were observed to have large 
conductances - in equal external and internal K+ (150mM) single channel studies 
show a conductance of between 150 and 250pS (Pallotta et al., 1981). The 
channels are voltage-dependent and activate with depolarisation (Pallotta ei al., 
1981; Moczydlowski and Latorre, 1983). The gating is also dependent upon the 
intracellular Ca2+ concentration (Barrett et al., 1982). The activation by Ca2+ can 
occur with concentrations of between 0.2-10µM (Barrett et al, 1982, Latorre et 
al, 1982). These channels are responsible for rapid after-hyperpolarisations for 
example in frog spinal motorneurons (Barrett and Barrett 1976) and in superior 
cervical ganglion cells (Freschi, 1983, Kawai and Watanabe, 1986). 
The BK channels are blocked by TEA at between 0.2 and 5mM. External 
TEA is more effective (IC50 = 0.29mM) than internal TEA (IC50 = 0.45mM) 
(Latorre, 1986). Charybdotoxin blocks the channels in the nanomolar range 
(IC50 -l OnM) (Miller et al., 1985) as does noxiustoxin (IC50 -450nM) and 
iberiotoxin. 
SK channels have a smaller conductance of between 2 and l4pS. They 
display little voltage-dependence, and the gating is determined only by 
intracellular Ca 2+ levels. Half maximal activation occurs at Ca 2+ concentrations 
of 200-500nM (Blatz and Magleby, 1986). They are responsible for slow AHPs 
after an action potential in many neurons. During an action potential the internal 
Ca 2+ concentration increases and this results in the activation of the slow AHP. 
This may slow the firing rate or even hyperpolarise the cell to the extent that the 
threshold potential cannot be reached so that action potentials stop - this is 
referred to as spike frequency adaptation. 
Apamin is a potent blocker of many SK channels (Hugues et al., 1982) 
and has been used to identify the current in e. g. rat superior cervical ganglion 
neurons (Kawai and Watanabe 1986) and guinea-pig hepatocytes (Burgess et 
al., 1981). The channels are relatively insensitive to block by TEA (see Sah, 
1996, for a review). The SK channel in cultured rat skeletal muscles is blocked 
by apamin but is insensitive to block by external TEA (Blatz and Magleby 
1986). 
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A calcium-activated potassium conductance which produces prolonged 
AHPs in some tissues and is insensitive to apamin has also been discovered. 
These channels have been detected in rat hippocampal neurons (Lancaster and 
Nicoll 1987) and in peripheral neurons for example guinea-pig myenteric 
neurons (Kunze et al., 1994). Both the apamin-sensitive and the apamin- 
insensitive SK channels have now been cloned (Kohler et al, 1996). 
The intermediate K(Ca) (Ixca) was the first Cat+-activated K+ conductance 
shown to exist and was discovered by Gardos in the 1950s. Activation occurs 
with [Ca2+]i concentrations of 0.1-10µM (Hamill, 1983, Grygorczyk and 
Schwarz, 1983) as may occur as a result of depletion of intracellular ATP in red 
cells- the 'Gardos effect' (see the review by Gardos and Sarkadi, 1985). It is 
voltage-insensitive with a single channel conductance between the SK value and 
the BK value. In frog erythrocytes the conductance is 50pS in symmetrical K+ 
(Hamill, 1983). Charybdotoxin blocks the erythrocyte channel as well as the BK 
channels (Wolff et al., 1988). Quinine and quinidine block in submillimolar 
concentrations and cetiedil and oligomycin A are also effective (Armando- 
Hardy et al., 1975, Berkowitz and Orringer, 1981, Riordan and Passow, 1971). 
These channels have now been cloned (Ishii et al., 1997). 
1.2: THE INWARDLY RECTIFYING POTASSIUM CHANNEL FAMILY. 
The inward rectifier K+ channels are so called because of reduced outward 
current flow at potentials positive to the reversal potential for K+, EK, in 
comparison to the substantial inward current flow at potentials negative to EK. 
Such behaviour was first described by Katz (1949) who referred to it as 
`anomalous rectification' because it was in the reverse direction to the normal 
outward rectification seen with delayed rectifier currents. 
These channels exhibit different degrees of rectification. Strong inward 
rectifiers such as the background inward IK1 in cardiac tissue pass very little 
current at potentials positive to -40mV. This is relevant to their functions in 
maintaining a stable membrane potential during diastole and a long plateau in 
the action potential that are a common feature of the cardiac action potential in 
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many species. This current is also found in frog skeletal muscle, glial cells, and 
some CNS neurons. 
Weak inward rectifiers also exist such as the KATP channel in the 
pancreatic ß cells, some CNS neurons, the heart and all muscle cell types. These 
are termed weak rectifiers as there is substantial outward current flow at positive 
potentials. These channels can be modulated by somatostatin and galanin via a 
G-protein, for example in insulin secreting cell lines. 
'Intermediate' inward rectifiers are present in various CNS neurons and in 
the heart. These channels are dependent on activation by receptor ligands, often 
through G-proteins. In cardiac tissue acetylcholine and adenosine modulate this 
K+ channel, as is discussed in detail in a later section. 
Figure 1.1 shows a cartoon representation of the current-voltage 
relationships for the three different inward rectifiers. 
W 
V 
S 
Figure 1.1: A schematic representation of the current-voltage relationships 
of the three main kinds of inward rectifer. In this hypothetical case EK is set to 
OmV. Plots for strong (S), intermediate (I) and weak (W) inward rectifiers are 
illustrated. 
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The following sections deal with general aspects of the inwardly 
rectifying K+ channel family including their molecular biology, expression and 
the mechanism of rectification. 
1.2.1: THE MOLECULAR BIOLOGY OF THE KIR FAMILY. 
The cloning of the Drosophila Shaker locus led to the isolation and 
expression of a large family of voltage-dependent potassium channels, Kv 
(Papazian et al., 1987, Tempel et al., 1988). The Kv channel subunits are 
grouped into four subfamilies named after the Drosophila genes. In flies 
displaying the Shaker phenomenon of abnormal leg shaking in response to 
diethyl ether exposure, a transient outward-like K+ current was found to be 
missing from their leg and flight muscles (Salkoff 1985). Identification of the 
defective gene responsible for this led to the cloning of the first K+ channel 
(Tempel et al., 1987,1988). Using the Shaker gene as a probe allowed three 
related Drosophila K+ channels to be isolated (Butler et al., 1989; 1990). 
Together these are the Shaker, Shab, Shaw and Shal groups and are referred to 
as the KvI, Kv2, Kv 3 and Kv4 subfamilies, respectively, according to the 
nomenclature of Chandy (1991) 
The a-subunit of the Kv channel consists of 6 transmembrane domains 
(TM), a cytoplasmic carboxy and amino terminal and a hydrophobic `P' or H5 
loop between TM5 and TM6 which is thought to line the pore of the channel. 
Evidence suggests that the Shaker K+ channels are composed of four subunits so 
that the overall structure resembles the voltage-gated Na+ and Ca+ channels. 
The tetramer can be either homo- or heteromeric (MacKinnon, 1991) 
though heteromeric Kv channels can be formed with subunits belonging to the 
same family only; subunits from different families fail to assemble. The 
assembly is thought to occur due to a specific interaction between the 
cytoplasmic N-terminal domains of the channel subunits (Shen et al., 1995; Xu 
et al.., 1995). Heteromeric association between subunits may permit a large 
number of functionally similar Kv channel types to exist. A CNS Kv channel 
has been identified which comprises Kvl. 2, Kv1.3, Kv1.4, Kvl. 6 and Kvß2 
subunits and it is possible that Kv02, Kvl. 2 and Kv1.4 may exist as 
homomultimers (Shamotienko et al., 1997). 
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Homology screening of the Kv subunits did not lead to the identification 
of genes encoding inwardly rectifying K+ channels. In 1993 expression cloning 
of the cDNA and subsequent homology screening of two inwardly rectifying 
channels led to the discovery of a novel family of mammalian K+ channel genes. 
The two Kir channels were an ATP -dependent channel (Kin. 1 a/ROMK 1; Ho 
et al., 1993) from the outer medulla of the mouse kidney and a classical Ki, 
channel (Kir2.1 /IRK 1; Kubo et al., 1993) from a mouse macrophage cell line. 
These genes code for channel proteins distinct from the Kv family. 
Kir channel cDNA was found to encode proteins of between 372 and 501 
amino acids in length. The amino terminal is on the intracellular side and 
hydrophobicity plots reveal the presence of 2 transmembrane regions (TM 1 and 
TM2). The TM1 and TM2 regions flank a highly conserved `P' region which is 
similar to the region in Kv channels and may line part of the K+ selective 
channel pore (Jan and Jan, 1992; Brown, 1993; Pongs, 1993). These structures 
are all encoded for within the first half of the coding region. The carboxy end of 
the channel protein is also intracellular and there are thought to be a number of 
putative binding domains at the carboxy end as well as membrane associated 
domains. The Kir channel amino acid sequences diverge at the distal amino and 
carboxy termini and an extracellular loop linking TM1 and the P-region is also 
not very well conserved (Salkoff et al., 1992). 
By comparing the remaining `core' sequences the presence of 6 Kir 
subfamilies was identified and these are designated Kir 1.0 to Kir 6.0 (Chandy 
and Gutman 1993). There is 40% sequence homology between subfamilies and 
60% within a subfamily. The highest levels of sequence identity are found in the 
P-region and in the proximal carboxy end. 
The subunit stoichiometry was examined for a background inward 
rectifier member, Kir2. I(IRK 1) and it was shown that the channel is composed 
of four Kir2.1 subunits (Yang et al., 1995) and a similar stoichiometry has been 
suggested for the G-protein-gated channels composed of members from Kira 
(GIRK) subunits (Inanobe et al., 1995). The diversity of the channels is 
increased by subunits being able to form homomeric or heteromeric channels. 
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The G-protein gated channels in atrial cells of the heart are composed of 
Kir3.1(GIRK I) and Kir3.4(GIRK4) subunits and the channels in some of the 
brain neurons are composed of Kir3.1(GIRK 1) and Kir3.2(GIRK2) 
(Krapivinsky et al., 1995; Pessia et al., 1996). The classical background inward 
rectifier is thought to be composed of homomeric Kir2.1 subunits (Kondo et al., 
1995). 
The distribution of the different inward rectifiers and their roles are 
discussed in the following section. 
1.2.2: SIX SUB-FAMILIES OF THE INWARDLY RECTIFYING POTASSIUM 
CHANNEL FAMILY: MOLECULAR AND FUNCTIONAL ASPECTS. 
The naming of these channels is based on either the name given to the 
channel clone or the more uniform terminology proposed by Chandy and 
Gutman (1995) in which the subgroups are referred to as Kirl. x to Kir6. x. In 
this thesis the nomenclature of Chandy and Gutman will be adopted although 
sometimes the channel clone name is also given in parenthesis. 
KIR 1: 
Kir 1.1(ROMK 1) is found mainly in the kidney and is a weak rectifier. It 
is both constitutively active and modulated by ATP for which there is a putative 
phosphate binding loop in the C-terminal end (Ho et al., 1993). Its weak 
rectification is advantageous for a role in the export of K+ into the collecting 
tubules of the distal nephron via the apical membrane of the renal epithelial 
cells. 
The expression of Kin l .1 
in the central nervous system remains unclear. 
Ho et al., (1993) found it to be weakly expressed in the thalamus, hypothalamus 
and the pituitary. Others have found it to be expressed in the rat cortex and 
hippocampal neurons (Kenna et al., 1994). In the human brain Kirl. 1 mRNA 
has not been detected (Yano et al., 1994; Shuck et al., 1994). 
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KIR 2: 
These channel types are all strongly inwardly rectifying and are important 
in setting the resting potential, buffering external K+ , and modulating action 
potential waveforms without excessive K+ loss during depolarisation. Three 
members have been cloned to date 
The first channel of this type, Kir2.1, was cloned from a mouse 
macrophage cell line (Kubo et al., 1993) and is expressed in heart ventricle and 
skeletal muscle. Kir2.1 is believed to be expressed throughout the brain, either 
in the glia or the vasculature (see review, Doupnik et al., 1995). The channel has 
a single channel conductance of - 20pS in 140mM [K+]. 
Kir 2.2 is found in the cerebellum in both mouse and rat brain and it is 
also present in rat kidney, heart and skeletal muscle (Takahashi et al., 1994; 
Koyama et al., 1994). The single channel conductance is -35pS (140mM 
external [K+]). 
Kir2.3 was cloned from human brain tissue (Perier et al., 1994; Tang et 
al., 1994; Makhina et al., 1994) and from mouse and rat brain (Morishigue et 
al., 1994; Lesage et al., 1994; Bond et al., 1994) and is expressed in the 
forebrain of all three species. It is also expressed in human and rat, but not 
mouse, heart. The single channel conductance is ---lOpS (140mM external [K+]). 
The channel protein has a larger extracellular loop than the Kir2.1 and 2.2 being 
15 amino acids longer between TM1 and the P-region (Bond et al., 1994). The 
larger loop may be involved in membrane targeting or interaction with other 
membrane molecules. 
The channels differ not only in their single channel conductance but also 
in their sensitivity to phosphorylation and other second messengers (Fakler et 
al., 1994; Chang et al., 1996; Henry et al., 1996). 
KIR 3: 
These channels are regulated by G-proteins and are intermediate in 
rectification. Most work has been done on the channel expressed in the heart 
which was found to be composed of two Kir3 subunits, Kir3.1 (GIRK1) and 
Kir3.4 (CIR, for Cardiac Inward Rectifier) (Krapivinsky et al., 1995). The 
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cardiac channel is activated by both acetylcholine and adenosine and by the ßy 
subunits of activated G-proteins, as discussed in detail in a later section. 
Kir3. I has been found in some neurons of the mammalian brain and is 
thought to be involved in the suppression of neuronal firing. Two new members, 
Kir3.2 and Kir3.3, have since been cloned from the mouse brain (Lesage et al., 
1994). 
Kir3.4 was cloned from the rat and human heart and is also expressed in 
brain tissue. It was initially thought to be identical to the native KATP channels 
when expressed in mammalian epithelial cell lines (Ashford et al., 1994). It was 
subsequently shown, however, that Kir3.4 co-assembles with Kir3.1 to form the 
atrial G-protein-gated current (Krapivinsky et al., 1995). Although Kir3.4 is not 
expressed in the pancreas, an isoform has been identified (Ashford et al., 1994). 
KIR 4 AND KIR 5: 
These subfamilies are detected in the brain (Takumi et al., 1995; Bond et 
al., 1994) where Kir 4.1 and Kir5.1 have been shown to co-assemble to form 
novel channels. Kir4.1 is also expressed in the kidney (see Section 1.4.3.3). Kir 
5.1 does not form functional channels when expressed in Xenopus oocytes 
(Bond et al., 1994). These channels may co-assemble with other Kir channel 
subunits providing channel diversity (Pessia et al., 1996). 
KIR 6: 
KirI. 1 was thought at first to form a constituent of KATP channels as the 
expressed channels are similar in properties to the endogenous kidney KATP. 
However the evidence for ATP; inhibition of Kirl. la (ROMK1) is inconclusive 
(Ho et al., 1993; Lu and MacKinnon 1994; Nichols et al., 1996). Based on 
sequence homology a novel ubiquitously expressed gene (uKATP or Kir 6.1, 
Inagaki et al., 1995 ) was discovered which led to the discovery of a pancreatic 
isoform, Kir6.2 (BIR, for ß-cell inward rectifier family). These subunits when 
co-expressed with a sulphonylurea receptor (see section 1.4.3.2) led to 
expression of the active KATP channel (Aguilar-Bryan et al., 1995; Ammala et 
al., 1996. ) 
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Kir6.2 has been shown to form the pore of the channel, as with other Kir 
channels, and it is the sulphonylurea receptor which provides some of the 
nucleotide sensitivity (Nichols et al., 1996). Further work has made clear that 
there is no SUR-independent activity of Kir6.2 and a close physical association 
occurs between the SUR and Kir6.2 (McNichols et al., 1996; Schwanstecher et 
al., 1994). Kir6.2 is strongly expressed in pancreatic ß-cells, brain, heart, and 
skeletal muscle (Sakura et al., 1995). 
1.3: THE MODE OF INTRINSIC RECTIFICATION: 
The following sections deal with the role of internal cations, intracellular 
factors and structural determinants which are all involved in inward 
rectification. 
1.3.1: BLOCK BY INTERNAL CATIONS: 
It was originally proposed that rectification may be due to block of the 
channel by a positively charged compound from the cytoplasmic side of the 
membrane in a voltage-dependent manner (Armstrong, 1971). Work done on the 
KATP channels revealed that both Mg2+ and Na'were able to support inward 
rectification (Ciani et al., 1988; Horie et al., 1987). 
Matsuda ei al., (1987) used improved patch clamp techniques and showed 
that in adult guinea-pig ventricular IK1 channels, outward single channel 
currents from cell attached patches were blocked by physiological levels of 
Mgt+. This block was affected by voltage, increasing with depolarization, and 
the results suggested an open channel block by intracellular Mg2+ (Matsuda et 
al., 1987; Shioya et al., 1993; Martin et al., 1995). The importance of Mg2+ in 
inward rectification was also shown for the G protein-gated K+ current in 
guinea-pig atrial cells. Inside-out patches displayed outward current in Mgt+- 
free solution after activation of the channel with 0.1 mM GppNHp applied to the 
inner surface of the membrane. Increasing the Mg 2+ concentration reduced the 
unit amplitude of the outward currents and again the block increased with 
depolarization (Hone & Irisawa, 1987). 
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Vandenberg (1987) independently showed that the excision of inside-out 
ventricular myocyte patches into divalent cation-free internal solution resulted 
in the elimination of rectification of the single channel current. Subsequent 
addition of Mgt+to the internal solution restored rectification. 
Studies have also been carried out on cloned channels. Stanfield et al., 
(1994) expressed the Kir2.1(IRK 1) gene in murine erythroleukaemia cells 
which gave rise to channels which displayed inward rectification. Removal of 
Mg 2+ from the internal solution led to the appearance of outward currents at 
depolarised potentials and the current-voltage relationship no longer displayed 
inward rectification. Expression of Kin. 1(ROMK 1) in oocytes has 
demonstrated how the IC50 value for Mgt' decreases with depolarization 
(Nichols et al., 1994) and it was observed that the block by Mg2+ was rapid and 
weak, resembling that of KATP channels. 
Later work has shown that the Mgt+-dependent inward rectification is 
voltage-dependent, concentration-dependent and reduced by increasing 
extracellular K+ ions, for example IK1 in guinea-pig heart cells (Matsuda et at, 
1987, Taglialatela et al., 1994), KATP channels in oocytes (Nichols et al., 1994) 
and the atrial G-protein gated current (Hone and Irisawa, 1987). It is thought 
that increasing the extracellular [K+] 'knocks-off Mg 2+ from sites inside the pore 
thus decreasing the rectification. Also the repulsive effect of K+ ions in the pore 
decreases the affinity for binding of Mg2+ and relieves the block (Armstrong 
1971, Hille & Schwartz 1978, Horie et al., 1987). 
1.3.2: BLOCK BY INTRACELLULAR POLYAMINES. 
Although the rectification process can be explained by an action of Mgt+, 
there is much evidence to suggest that this is not the only factor. Strongly 
rectifying channels from a cloned inward rectifier displayed substantial 
rectification in the absence of Mg2+ in outside-out patches (Stanfield et al., 
1994). In guinea-pig cardiac myocytes the Mg2+ blocked channels transit to the 
closed state at maintained depolarised potentials, suggesting an intrinsic gating 
mechanism (Ishihara et al., 1989). Excision of inside-out membrane patches 
from Xenopus oocytes containing cloned Kir2.3 (HRK 1) channels resulted in 
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the loss of rectification if moved away from the surface of the cell (Lopatin et 
al., 1994). In Mg2+-free solution rectification was restored by moving the patch 
back towards the surface of the cell. It was concluded that intrinsic factors were 
being released from oocytes and causing rectification. In bovine pulmonary 
artery endothelial cells rectification is observed both in the absence and 
presence of internal Mg2+ (Silver and DeCoursey 1990) and a Kir2.1 channel 
expressed in the mouse fibroblast cell line also displayed both Mg 2+-dependent 
and Mgt+-independent rectification (Ishihara et al., 1995). 
Subsequent biochemical analysis of the cytosol of oocytes and other cells 
revealed that the cytoplasmic factors involved were small positively charged 
molecules - polyamines (Lopatin et al., 1994). Polyamines are naturally 
occurring and are present in cells in mM levels. The naturally occurring 
polyamines such as spermine, spermidine and putrescine restore all the features 
of rectification when applied to inside-out patches containing Kir2 channels 
(Matsuda et al., 1988; Ishihara et al., 1989; Lopatin et al., 1994,995; Fakler et 
al., 1994; Ficker et al., 1994). The voltage dependencies of the block by 
polyamines are steeper than for Mg 2+ (Fakler et al., 1994; Ficker et al., 1994; 
Lopatin et al., 1994,1995). This explains why the rectification seen in situ is 
steeper than predicted for Mg 2+ alone (Hille 1992). 
The degree of rectification is thus due to the extent of block by Mg 2+ and 
polyamines. High affinity polyamine and Mg2+ block is seen with strongly 
rectifying channels. Kin .1 
(ROMK1) channels show mild inward rectification 
and channels expressed in oocyte patches did not strongly rectify when brought 
to the surface of an oocyte. Application of oocyte-conditioned internal medium 
(oocytes were incubated for up to 3 hours in K+;,, t solution, the solution was then 
aspirated and filtered, and stored at 4°C) did not lead to strong rectification, as 
is the case with IRKI (Lopatin et al., 1994). 
Subsequent work has shown that Mg 2+ and polyamines may share the 
same binding site within the channel (see below). Site-directed mutagenesis 
studies also revealed that the structure of the channel plays a part in dictating the 
degree of rectification observed (Pessia et al., 1995; Taglialatela, et al., 1994). 
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The following section discusses the contribution of the channel structure to the 
rectification process. 
1.3.3: STRUCTURAL DETERMINANTS OF INWARD RECTIFICATION. 
Studies have shown that the TM2 region forms part of the lining of the 
pore (Fakler et al., 1994; 1995; Ficker et al., 1994;. Matsuda et al., 1994; 
Taglialatela et al., 1994) and that the different sensitivities of the inward 
rectifiers to block by Mg2+ and polyamines could be attributed to differences in 
their structure at this region. Stanfield et al., (1994) showed that an exchange of 
aspartate at position 172 in the TM2 region for glutamine in murine Kir 
channels resulted in a five-fold reduced affinity for Mg2+ and weaker inward 
rectification. The negative charge carried by aspartate is important for voltage- 
dependent channel gating and may play a part in the binding of Mgt+. 
This has been observed in other inward rectifier channels. In 
Kir2.1(IRK 1) the amino acid at position 172 is aspartate and in Kir 1.1(ROMK 1) 
it is asparagine at position 171. Mutation of the aspartate to asparagine in Kir2.1 
leads to Kirl. 1 like gating and conversely mutating the asparagine in Kirl. 1 to 
aspartate leads to Kir2.1 type gating (Wible et al., 1994). The amino acid at 
position 171 in Kir 1.1 (ROMK 1) is an asparagine and substituition for an 
aspartate - found in Kir2.1 and Kir3.1- converts the weak Kir 1.1 to a strong 
rectifier (Lu an MacKinnon 1994). In Kir6.2, the equivalent amino acid in TM2 
at residue 153 is an asparagine and the channel displays weak rectification 
(Inagaki et al., 1995). Mutation of the asparagine residue in the TM2 region at 
position 160 to aspartate increased the degree of rectification by both Mg2+ and 
polyamines in cloned Kir6.2 KATP channels (Shying et al., 1996). 
It was also shown that the potency of spermine for the different inward 
rectifier channels- Kir2.1(IRK1), Kir4. I(BIR10) and Kirl. 1 (ROMK1)- was 
strongly influenced by the particular amino acid residue at positions analogous 
to 171/172 (Fakler ei al., 1994). The block of an outward current at potentials 
positive to EK by spermine was measured for all three subtypes and fitting the 
Hill equation gave IC50 values of 31 nM, 40nM, and 0.78mM for Kir2.1, Kir4.1 
and Kir 1.1 respectively at a membrane potential of +50mV. A mutation at 
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position 158 in the TM2 region of BIR10 from glutamate to asparagine 
decreased the spermine affinity and the IC50 value increased from 40nM in the 
wild type BIR10 to 3.5mM, a loss of 5 orders of magnitude in sensitivity (Fakler 
et al., 1994). 
The C-terminal domain is also important for inward rectification. A 
chimera was constructed in which the C-terminal domains from Kir3.1(GIRK1) 
and Kir6.2 (BIR) were exchanged. The chimera which had the C-terminal 
domain from Kir3.1(GIRK 1) did not need G-protein activation, displayed 
activation and deactivation kinetics and rectification properties similar to those 
of the Kir3.1(GIRK1) channel. This shows that structural elements in the C- 
terminal can independently control gating and that gating is not solely 
dependent on the residue in the TM2 region as in this chimera the residue in 
TM2 was from BIR10 yet rectification was of the GIRK1 type. (Pessia et al., 
1995). Similarly chimeras between the weakly rectifying Kirl. I(ROMK1) and 
the strongly rectifying Kir2.1(IRK 1) suggests that the C-terminal contains 
structural elements which are needed for strong rectification and high Mg2+ 
affinity, even though the rectification residue in the TM2 region was not 
exchanged (Taglialatela et al., 1994). In the C-terminal domain of Kir2.1 
glutamic acid at position 224 is an important determining factor of Mg2+ and 
polyamine sensitivity as neutralization of this residue and the negative charge in 
TM2 (172) reduces the Mg2+ and polyamine affinity of Kir2.1 to that of 
Kirl. 1(ROMK1) (Yang et al., 1995). 
The off-rates of different polyamines and Mg2+ from the channel are 
influenced by the amino acid residue at position 84 preceding the TM1 region in 
Kir2.1 channels (Ruppersberg et al., 1996). The release of Mg2+ from Kir2.1 is 
reported to occur with a half time (t1,2) of 10.2±0.4 ms and spermine release 
with a t112 of 1.6±0.3 ms at -50mV (Ruppersperg et al., 1996). Kubo et al., 
(1993) observed at] 2for Mg2± release of 0.1±0.05 ms and for spermine release 
of 0.3±0.1 ms in a different Kir2.1 channel. The difference was attributed to the 
presence of threonine at position 84 in the Ruppersberg clone and a methionine 
in the Kubo clone. The residue in Kin l .1 
is lysine and in Kir3.4 it is asparagine 
and mutation of threonine in Kir2.1 to a lysine revealed a fast release of both 
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Mg 2+ and spermine (t112 of less than 0.1 ms) and mutation of the threonine to 
asparagine resulted in a slow release, t1; 2 of -49 ms for Mgt` and -24 ms for 
spermine (Ruppersperg et al., 1996). 
Thus it appears that Mg2+ and polyamines can interact with at least two 
negatively charged amino acid sites one of which is in the TM2 domain at 
positions analogous to 171/172 [receptor site 1 (Rl)] and the other in the C- 
terminus at positions analogous to 224 [receptor site 2 (R2)]. For strong 
rectifiers the amino acids both carry negative charges whilst in the G-protein 
gated channels only one of the sites is negative and for the weak rectifiers they 
are both neutral. 
Chimeras between Kir3.1(GIRK 1) and Kir 1.1 a(ROMK 1) indicate that 
there are residues in TM1 and TM2 regions which affect the strong rectification 
seen in the Kir3.1 channel. The intermediate rectification of the G-protein- 
gated channel was reduced if the acidic aspartate residue at 173 was mutated to 
glutamine (analogous to position 171, Lu and MacKinnon 1994)). Also residues 
in the P region pore-forming domain are important in the Kir3.1 time-dependent 
activation. A phenylalanine at position 137 is unique in Kir3.1 and it seems to 
be important in the time-dependent gating. G-protein activation of the channel is 
not affected by mutations in the TMl and TM2 regions. (Kofuji et al., 1996). 
The amino acids present at R1 and R2 and in the H5/P-region are shown 
in Figure 1.3.3.1. The inward rectifiers have a G-Y-G sequence within the H5 
region which forms the K+-selective pore (MacKinnon, 1991; Yang et al., 
1996). Figure 1.3.3.2 shows a schematic diagram of the channel illustrating the 
important residues involved in rectification as mentioned above. Also shown is 
the evolutionary tree for the inward rectifiers. 
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A: Pore sequences 
133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 
GIRK 1 
AFLFFIETEATIGYGYRY 
ROMK 1 
IRK I 
GIRK2 
S L Q V F F 
S Q T F C 
S E Y V 
B: Mgt' and polyamine binding sites: 
R1 R2 
Ki r l. l (ROMK 1) N G 
Kir2.1-2.3 (IRK l -3) D E 
Kir3.1(GIRK 1) D S 
Kir3.2-3.4(GIRK3-4) N E 
Kir4.1(BIR10) E G 
Kir6. I (uKATP-1) N S 
Kir6.2(BIR) N S 
Figure 1.3.3.1: A, the amino acid residues in the pore sequence of four different 
inward rectifiers (from Koufuji et al., 1996). B, the amino acid residues present 
in the R1 - M2 domain- and the R2 - C-terminal domain. The Kir2 family are 
strong rectifiers and have negative residues at M1 and M2. Kir6 members are 
weak and have the neutral residues at these positions. Kirl. 1 and Kir4.1 have an 
ATP-binding domain within their C-terminals. These two positions are thought 
to be the binding sites for Mg 2+ and polyamines (Isomoto et al., 1997). The 
amino acid key is: A, alanine; C, cysteine; D, aspartic acid; E, glutamic acid; F, 
phenylalanine; G, glycine; I, isoleucine; L, leucine; N, asparagine; Q, 
glutamine; S, serine; T, threonine; V, valine; Y, tyrosine 
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A: 
B' 
Figure 1.3.3.2: A: Cartoon representation of the Kir structure, taken from 
Nichols & Lopatin 1996. The GYG sequence in the pore is conserved in Kv 
channels and is though to form the K+ selective pore. Position 171 in the M2 
region and 224 in the C-terminus are shown. The Mg2+ off rates are thought to be 
controlled by an amino acid around position 84. B: The evolutionary tree of the 
inward rectifier family. Members of the same family are - 50-70% identical, 
whilst members of different families are - 40% identical. (Isomoto el al., 1997). 
Image removed due to third party copyright
Image removed due to third party copyright
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1.4.1: THE ATRIAL G-PROTEIN GATED K+ CHANNEL. 
Parasympathetic stimulation decreases the heart rate by the activation of 
muscarinic receptors and the subsequent opening of K+ channels in the 
sinoatrial node and the atrium in the heart. These channels display intermediate 
inward rectification, and in contrast to IKI, there is substantial outward current 
flowing at depolarized potentials. The single channel conductance is 
approximately 50pS in high external [K+] (Sakmann and Trube 1984; Kurachi et 
al., 1985; Ito et al., 1992). 
Both acetylcholine and adenosine can activate the KACh channel, 
hyperpolarise the myocyte and reduce the action potential duration (Kurachi et 
al., 1986; Belardinelli & Isenberg 1983). The involvement of G-proteins has 
been shown for example in guinea-pig atrial myocytes where the responses to 
both agonists required the presence of GTP on the intracellular side of the 
membrane; also, the conductance and kinetics of the whole cell and single 
channel currents indicated that the two agonists activated the same population of 
K+ channels (Kurachi et al., 1986). Again in ferret ventricular myocytes both 
agonists activated a single population of inwardly rectifying channels which are 
distinct from the background inward rectifier channels (Ito et al., 1995). All the 
evidence indicates that acetylcholine and adenosine activate the same 
population of K+ channels via G-protein activation 
1.4.1.1: G-PROTEIN REGULATION OF THE KACH CHANNEL. 
Much work has gone into defining the involvement of G-proteins with the 
cardiac G-protein gated K+ channels. It has been shown that the activation of the 
KACh channel is mediated by a pertussis toxin-sensitive G-protein via a direct 
membrane delimited pathway with no involvement of second messengers 
(Breitwieser & Szabo 1985; Pfaffinger et al., 1985; Ito et al., 1992). The G- 
protein involved in the activation of IKACh was initially designated GK due to its 
function of activating a K+ conductance (Breitwieser and Szabo 1985) but is 
now generally referred to as Gi. The inactivation of GTPase, and thus the G- 
protein, within chick atrial cells by ADP ribosylation using pertussis toxin 
results in the prevention of any current activation in response to the application 
of acetylcholine (Pfaffinger et al., 1985). In inside-out patches the activation of 
I'N'TRODUCTION 
33 
the current by acetylcholine and adenosine required GTP on the cytoplasmic 
face and the activation was inhibited by the A promoter of pertussis toxin 
providing further evidence for the involvement of a G-protein (Kurachi et al., 
1986). Intracellular dialysis of GTP-y-S into guinea-pig atrial myocytes 
increased the IKACh in the absence of any agonist and pretreatment with pertussis 
toxin prevented the increase (Ito et at, 1991). It has also been observed that in 
cell attached membrane patches the presence of ACh in the pipette but not in the 
bathing solution activates the channel (Soejima and Noma 1984). This evidence 
suggests that the activation of the current is membrane delimited rather than 
indirectly via second messengers. 
Since the discovery of G-protein activation of IKACh many groups have 
speculated about the exact mechanism of activation of the channel by the G- 
protein subunits and it has been debated as to whether it is Ga or Gßß, which 
activates the channel. Clapham and coworkers (Logothetis et al., 1987,1989; 
Clapham and Neer, 1993) postulated that the ßy subunits are responsible. 
Studies done by this group showed that the K+ channel in chick embryonic atrial 
cells could be directly activated by the addition of purified ßy subunits from 
bovine cerebral cortex to the inner surface of an inside-out patch. (Logothotis et 
al., 1987). Another study showed that ßy subunits isolated from rat brain could 
activate the guinea-pig atrial KACh in inside-out patches (Kurachi et al., 1989). 
ßy subunit inhibitors derived from ß-adrenergic receptor kinase 1 decreased 
channel opening probability and increased closed times in inside-out patches 
from rabbit atrial myocytes (Nair et al., 1995) providing further evidence for ßy 
activation of KACK. 
These observations were criticized by Brown, Birnbaumer and their 
coworkers on the grounds that the detergents used to suspend the ßy-subunits 
could themselves activate the channels and that the ßy-subunits prepared from 
the brain might be contaminated by a-subunits (Yatani et al., 1987) which it 
was suggested were responsible for KACh activation. This was effectively ruled 
out by applying the ßy subunits in Mg2+-free solution which would have 
inactivated any Ga present but did not affect the ßy subunit activation of the 
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channel. Also the application of the detergent CHAPS alone did not result in the 
activation of the channel (Kurachi et al, 1989). It was also shown that the 
activation of the channel by recombinant ßy-subunits or GTP-y-S can be 
reversed by a-GDP (Logothetis et al., 1988). This study ruled out any possible 
contamination in the preparations or any artifactual activation by the detergents 
used to solubilize the ßy-subunits. Yamada et al. (1994) also demonstrated the 
activation of the channel by ßy-subunits and inhibition by a-GDP. 
Schreibmayer et al., (1996) observed that GTP-y-S activated Ga actually 
inhibits Gßy activation of KACK in excised membrane patches of Xenopus 
oocytes expressing the channel. Many other studies have also pointed to the 
activation of KACK by ßy subunits (see Kurachi et al., 1989; Ito et al., 1991; 
Reuveny et al., 1994; Yamada et al., 1993; and Kurachi 1995; Muller and Lohse 
1995; Wickman and Clapham 1996 for reviews). 
A contrasting view was proposed by Brown and Birnbaumer's group 
whose results indicated that it was the a subunit which activated the KACh whilst 
ßy did not (Yatani et al., 1987) (Codina et al., 1987). In addition a monoclonal 
antibody against Ga blocked the carbachol induced stimulation of KACh (Yatani 
et al., 1988a) and it was also observed that three recombinant forms of the a- 
subunits of Gi activated the K+ channel (Yatani et al., 1988b). Hence, Brown, 
Birnbaumer and their group concluded that Ga activated the K+ channel. 
However, this work could not be reproduced by Clapham and coworkers 
(Nanavati et al.., 1990). It has also been demonstrated that purified Gßy from 
bovine brain acts through the same molecular mechanism as the endogenous Gi 
in guinea-pig atrial myocytes (Yamada et al., 1993). So it would appear that Ga 
is not responsible for activation of IKACh and the view that Goy activates the 
muscarinic K+ channel has become widely accepted. 
The involvement or otherwise of second messengers in the activation of 
IKACh by Gßy has also been debated. It was reported that inhibitors of 
lipoxygenase or antibodies which block PLA2 activity inhibited the activation of 
KACK by Gßy (Kim et al., 1989a) although it was also observed that some 
inhibitors of lipoxygenases and PLA2 did not block Gßy activation (Ito et al., 
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1992). It was also found that metabolites of arachidonic acid could activate 
IKACh (Kim et al., 1989b, Kurachi et al., 1989) though the activation by the 
arachidonic acid metabolites was shown to be weak compared with the Gßy 
activation (Kim et al., 1989b) 
Recently it has been shown that ßy binds directly to the N-terminal 
hydrophilic domain and the amino acids 273-426 in the C-terminal domain of 
Kir3.1(G1I KI) (Huang et al., 1995; Slesinger et al., 1995). This direct binding 
of the ßy subunit to the C-terminal has also been demonstrated in mouse 
Kir3.1(GIRK1) (Inanobe et al., 1995). It was well established by this stage that 
KACh is a heteromultimer of Kir3.1 (GIRK1) and Kir3.4 (CIR) (Krapivinsky et 
al., 1995a) and further experiments showed that the ßy-subunits bind not only to 
the Kir3.1 subunit but also to Kir3.4 (Krapivinsky et al., 1995b). The binding of 
ßy to immuno - precipitated KACh and recombinant Kir3.1 and Kir3.4 had 
dissociation constants (Kd) of 55,50 and l20nM respectively and it was also 
demonstrated that Ga did not bind to the subunits at a detectable level. 
Chimeric studies replacing the C-terminus of Kir3.1(GIRK1) with that of 
Kir2.1(IRK 1) resulted in persistent activation of the chimera. Conversely, 
replacement of the C-terminal of the Kir2.1 with the C-terminal of Kir3.1 
allowed Gßy to activate Kir2.1 (Takao et al., 1994). Chimeras between Kir3.1 
and Kir3.3 have led to the identification of the important regions in channel 
regulation by G-proteins. There are regions in the N-terminal domain and the C- 
terminal domain of the Kir3.1 which are both capable of binding ßy in a 
chimeric channel (Kunkel and Peralta, 1995). Expression of Kir3.1 and Kir3.4 
in Xenopus oocytes has demonstrated that the N- and the C-termini of both 
subunits have G protein sensitivity and both are needed for maximal stimulation 
by cloned Goly2 (Tucker et al., 1996). 
The physiological characteristics of G-protein activation of KACh have also 
been studied. In inside-out patches from guinea-pig atrial myocytes (Ito et al., 
1991), increasing the concentration of ACh in the pipette resulted in a decrease 
in the threshold concentration of intracellular GTP ([GTP]; ) needed to activate 
the channels. A decrease in the EC50 value of GTP and an increase in the 
maximum response were also observed (seen as an increase in the product of the 
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number of active channels and their open probability). A Hill coefficient of -3 
has been estimated for GTP; activation of the channel; altering the concentration 
of ACh did not affect this value (Ito et al., 1991; Kurachi et al., 1990; Yamada 
et al., 1994). As the functional KACK is composed of 4 channel subunits it is 
possible that Gßy binds to individual subunits resulting in positive cooperativity. 
MOLECULAR BIOLOGY OF THE KACH CHANNEL 
Kir3.1 (GIRK1) mRNA was first isolated from the rat atrium and when 
coexpressed with the muscarinic receptor in Xenopus oocytes results in 
inwardly-rectifying currents in response to the application of acetylcholine 
Kubo et al., 1993; Dascal et al., 1993). Whilst the Kir3.1 expression results in 
currents similar to the native IKACh, there are some differences. For example, 
there is weak stimulation by G-proteins and high agonist-independent activity. It 
was thus thought that the Kir3.1 was not the only subunit needed for the 
expression of the KACh channel. Subsequent work with antibodies specific for 
Kir3.1 showed that immunopurification of the Kir3.1 protein from bovine heart 
resulted in the purification of a second protein (Krapivinsky et al., 1995). 
Sequence analysis showed that this second protein was a previously cloned 
inward rectifier termed CIR (Cardiac Inward Rectifier) or Kir3.4 and this was 
found to be almost identical to the rcKATp-1 cloned by Ashford et al., (1994) 
which was thought to belong to the KATP family. It was concluded that the 
cardiac G-protein gated K+ channel is composed of Kir3.1 and Kir3.4. rcKATP 
therefore did not belong to the KATP family but to the G-protein-gated family of 
inward rectifiers (GIRK). 
A mouse cDNA library was used to identify two additional homologues of 
Kir3.1, Kir3.2 (GIRK2) and Kir3.3 (GIRK3) (Lesage et al., 1994). Alternative 
splicing of the gene encoding mouse Kir3.2 generates three isoforms, termed 
Kir3.2A (GIRK2A), Kir3.2B (GIRK2B) and Kir3.2C (GIRK2C) (Isomoto et al., 
1996). These spliced variants have a common N-terminal and core region 
though they differ at their C-terminal ends. GIKK2B was found to be 
ubiquitously distributed (Isomoto et al., 1996). Channels composed of these 
subunits are important in the CNS. 
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1.4.1.3: THE G PROTEIN-REGULATED K+ CHANNEL IN THE BRAIN. 
G protein coupled channels in the brain suppress neuronal firing. Kir3.1 is 
expressed in some CNS neurons (see Doupnik et al., 1995). Two members 
cloned from mouse brain are Kir3.2 and Kir3.3 (Lesage et al., 1994) and may 
contribute to the diversity in neuronal G protein-activated currents. Kir3.2 when 
expressed in Xenopus oocytes produces receptor-evoked Kir3.1-like currents. 
Kir3.3 subunits do not produce receptor activated currents or constitutively 
active current and are thought to co-assemble with other Kir3. x subunits 
producing diversity within the group (Andrade et al., 1986; North 1989; Chen et 
al., 1993). 
Many neurotransmitters in the brain activate an inwardly rectifying K+ 
conductance via a G-protein, for example GABA acting at GABAB receptors in 
hippocampal pyramidal cells (Bowery, 1980, Duttar and Nicoll, 1988), 
adenosine at Al receptors in CAI pyramidal neurons in rat hippocampal slices 
(Greene and Haas, 1985; Trussel and Jackson, 1987), acetylcholine at M2 
receptors (Egan and North, 1986), dopamine at D2 receptors in rat substantia 
nigra (Lacey et al., 1987), noradrenaline at a2 receptors in hippocampal 
pyramidal cells (Madison et al., 1987), serotonin at 5HT-1A receptors (Andrade 
et al., 1986) and opiates at µ receptors (North et al., 1987). In summary these 
act at the forebrain regions of the hippocampus, thalamus, striatum and the 
neocortex, in the midbrain regions of the raphe nucleus and the substantia nigra 
and in the hindbrain regions of the locus coeruleus, pontine, reticular nucleus 
and the parabrachial nucleus. 
1.4.2: THE BACKGROUND INWARDLY RECTIFYING POTASSIUM 
CHANNEL. 
'Background' inward rectifiers (IK1) were first discovered by Katz in K+ 
depolarised muscle (1949) and they have been investigated particularly in frog 
skeletal muscle (Standen and Stanfield, 1978,1979), starfish eggs (Hagiwara et 
al., 1978) and tunicate eggs (Ohmori et al., 1978). 
The background inward rectifier has been studied in great detail in cardiac 
preparations. The Iß; 1 conductance 
in Purkinje fibres, ventricular and atrial tissue 
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is the dominant component of the resting membrane conductance (Ber-Heler 
and Reuter 1970; Kurachi 1985). More current flows in the inward direction at 
potentials negative to EK than outward current at potentials positive to EK. The 
low conductance at the plateau potential of the action potential helps to maintain 
the plateau and minimizes the loss of K+ from the cell during depolarisation. 
The first inward rectifier, Kir2.1(IRK 1) to be cloned by the use of 
expression cloning techniques was in a mouse macrophage cell line (Kubo et 
al., 1993). Three kinds of IK1 have since been cloned from the mouse brain and 
have been designated MB-IRK 1(Kir2.1), MB-IRK2 (Kir2.2) and MB- 
IRK3(Kir2.3) (MB for mouse brain; Takahashi et al., 1994; Morishige et al., 
1993; 1994). mRNA for Kir2.1(IRK 1) has been found in the heart, the brain and 
skeletal muscle. Expression in Xenopus oocytes leads to a strongly inwardly 
rectifying current which is blocked by extracellular Ba2+ and Cs+ in a voltage- 
and concentration-dependent manner. The decay of the current following 
activation by hyperpolarization is more prominent for Kir2.2 than Kir2.1 and 
Kir2.3 and is thought to be due to block by extracellular cations such as Na+ 
(Ohmori et al., 1978; Biermans et al., 1987; Harvey and Ten Eick, 1989; 
Kelley, 1992; Voets et al., 1996). The single channel conductance of Kir2.1, 
Kir2.2 and Kir2.3 are - 22, -34, and - 13pS respectively in 150mM [K]0. The 
cardiac IK1 has a single channel conductance of - 40pS, with 150mM [K+ ]o. 
There is voltage-dependent inactivation of this current during maintained 
depolarisation in the absence of any blocking cations which is thought to be due 
to intrinsic inactivation (Sakmann & Trube 1984; Kurachi 1985). This is similar 
to the properties of Kir2.2 (Takahashi et al., 1993) and the IK1 channel in heart 
is thus thought to be composed of homotetrameric Kir2.2 subunits. 
1.4.2.1: TWIK-1 
This is a weak inward rectifier of 336 amino acids in length and was the 
first in a group isolated from a human kidney cDNA library (Lesage et al., 
1996). The hydrophobicity plot revealed 4 transmembrane domains and it has 2 
pore motifs in tandem. Assuming that 4 pore domains are needed for a 
functional K+ channel it is expected that TW K-1 channels will prove to be 
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dimers. It does not possess a voltage-sensing domain and it is a weak inward 
rectifier having a single channel conductance of 34pS in symmetrical K' and 
showing Mgt+-dependent rectification. The currents seen on expression in 
Xenopus oocytes are blocked by Ba2+ (IC50 = 100µM) and class I 
antiarrhythmics, such as quinine (IC50 = 50µM) and quinidine (IC50 = 95µM) . 
According to Northern analysis the mRNA is widely distributed in human 
tissues especially in the brain and heart. These channels may be involved in the 
control of the background conductance, the extent of which has yet to be 
determined. 
1.4.3: THE ATP-SENSITIVE K+ -CHANNEL 
KATP channels were first discovered in the heart (Noma 1983) where they 
were observed to be blocked by ATP; above 1 mM and to have a single channel 
conductance of 80pS in 100mM K+. ATP-sensitive channels have since been 
shown to be involved in the shortening of the action potential duration and in 
the cellular loss of K+ observed during metabolic inhibition. They open in 
response to metabolic inhibition or hypoxia and thus couple the metabolic state 
of the heart to the membrane potential. They are found in a wide variety of 
tissues such as pancreatic ß-cells, skeletal muscle, smooth muscle, and some 
neurons of the central nervous system. 
As noted earlier, the rectification of the KATP channel is much weaker than 
with IK1 (in that the conductance in the outward direction is larger) and is due to 
Mg 2+ block of the channels (Findlay 1987a, b, Trube & Hescheler 1984). The 
effects of intracellular polyamines are less marked than for strong rectifiers as 
the sites at which the polyamines bind at in TM1 and the C-terminal domain are 
neutral whereas in strong rectifiers they are negatively charged (Yamada and 
Kurachi, 1995). 
ATP; closes K. ATP channels in the heart with an IC50 of 20-30µM and this 
is independent of whether the ATP is in the free acid form or Mg2+ bound 
(Findlay et al., 1988; Lederer et al., 1989; Terzic et al., 1995). ATP; increases 
the time between bursts of channel activity and decreases the duration of the 
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bursts with no change in the amplitude of the single channel current or in the 
kinetics of the open channel (Kakei et al., 1985; Spruce et al., 1987). This role 
of ATP, is referred to as the `ligand action' as it is thought to require the binding 
of ATP to the channel. 
Binding of ATP to Mg2+ does affect the potency of ATP in other cell 
types and in pancreatic ß-cells the IC50 value for Mg-ATP is 26µM compared 
with 4µM for the block by ATP. This indicates that unbound ATP (ATP 4- ) is 
more potent than Mg-ATP (Ashcroft et al., 1991). In smooth muscle cells Mg- 
ATP is not effective in blocking the channels whereas ATP4" blocks with an 
IC50 of 29µM (Nelson et al., 1995; Kajioka et al., 1991). 
The block by ATP; is reduced in the presence of ADP and the IC50 value 
for block by ATP increases almost fourfold in the presence of 100µM ADP 
(Findlay et al., 1988; Lederer and Nichols 1990; Weiss et al., 1990). ADP also 
increases Po in the 
absence of ATP and this requires Mg2+ (Lederer and Nichols 1990; Weiss et al., 
1990). ATP is thought to bind at two sites at the channel and the binding at one 
increases the affinity of the second site for ATP. The binding of ATP to the 
second site is necessary for channel inhibition. Channel inhibition requires no 
Mg 2+ whereas channel stimulation after rundown does and it has been suggested 
that MgADP and ADP3- have separate binding sites (Findlay, 1988). In the 
absence of Mgt+, mono-, di- and triphosphates compete for the second site and 
inhibit the channel whereas in the presence of Mgt+, ADP binds to the first site 
without increasing the affinity of the second site for ATP (Lederer and Nichols 
1989; see Nelson and Quayle, 1995 for a review). 
KATP channel activity has been observed to decline after the excision of 
inside-out patches into ATP-free solution. This occurs in, for example, isolated 
patches of cardiac membrane where it is thought that the rundown is due to the 
decrease in ATP and a subsequent lack of phosphorylation, as non-hydrolyzable 
analogues of ATP do not stop run-down of the channel (Trube and Hescheler, 
1984). The dependence of channel activity on phosphorylation has also been 
demonstrated in non-cardiac tissue, for example in urinary bladder and 
insulinoma cell lines where KATP channel activity is modulated by protein 
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kinase C (Wang and Giebisch 1991; Bonev et al., 1993). The run-down seen 
after excision of membrane patches into ATP free solution is reversed by 
treatment with Mg-ATP (Ohno-Shosaku et al., 1987, Takano et al., 1990). Thus 
prevention of channel rundown requires Mgt+-dependent hydrolysis of ATP and 
the effect lasts up to ten minutes after removal of ATPi. The need for Mg2+ may 
be due to kinase activity and the maintenance of channel activity may be due to 
an `enzyme dependent' action of ATP (Terzic et al., 1995). 
Hence it can be concluded that the effect of ATPi depends upon the 
channel state. When the channels are open ATP closes them and when they 
close after run- down, treatment with Mg2+-ATP restores channel activity. 
Several drugs which could prove useful in the treatment of hypertension, 
acute and chronic myocardial ischaemia and congestive heart failure have the 
ability to open KATP channels. One such K+-channel opener (KCO) is 
cromakalim, which decreases the action potential duration (as does hypoxia) by 
opening KATP channels in cardiac muscle. The active enantiomer of cromakalim, 
levcromakalim, opens ventricular KATP channels hence decreasing the action 
potential duration and the amplitude and duration of evoked guinea-pig 
ventricular contraction (Sanguinetti et al., 1988; Findlay et al., 1989). The 
channels activated by levcromakalim were thought to be the same as those 
activated during dialysis of the cell or of patches with low concentrations of 
ATPi (Findlay et al., 1989). Levcromakalim has been shown to open the KATP 
channel and inhibit the delayed rectifier current in the rat portal vein, and it was 
initially suggested that the KATP channel activated by levcromakalim is a 
voltage-insensitive state of the delayed rectifier (Ibbotson et al., 1993; Edwards 
and Weston, 1993; Edwards et al., 1995; Heath and Terrar, 1996a). However as 
already discussed in Section 1.2.2 molecular biology has now provided decisive 
structural evidence showing that the KATP channel and the delayed rectifier 
channels are quite different entities. 
KATP channels have different sensitivities to the KCOs depending upon 
cell type. The pancreatic ß-cell K., TP can be activated by diazoxide and weakly 
activated by pinacidil. In contrast the cardiac KATP is activated by pinacidil but 
cannot be activated by diazoxide. The K. ATP in smooth muscle cells can be 
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activated by both of these KCOs (Ashcroft and Ashcroft, 1990; Nichols and 
Lederer, 1991; Terzic et al., 1995; Nelson and Quayle, 1995). As the properties 
of the KATP channels vary between tissues, it may be that the channels are 
composed of heterogeneous subunits. 
The conductance of the channels in cardiac myocytes is between 70 and 
90pS in 140mM symmetrical K+ (Noma 1983, Horie et al., 1987, Ashcroft & 
Ashcroft 1990). The single channel conductance in other tissues varies. In rat 
portal vein two types of KATP channels have been identified (Zhang and Bolton, 
1996). One was termed a LK (larger conductance) channel and had a similar 
conductance (50pS) and other properties to KATP channels described in other 
tissues. The second type was termed MK (smaller conductance) and has a lower 
conductance of 7-22pS. It resembles the type activated by intracellular NDPs 
(nucleoside diphosphates) and is thought to be the target of K+ channel openers 
(Beech et al., 1993). Two types of KATP channel have also been found in many 
smooth muscle cells. For example in portal vein (Beech et al., 1993), cultured 
coronary artery cells (Miyoshi et al., 1992) and urinary bladder (Bonev et al., 
1993) there is a small to intermediate conductance channel of between 15-5OpS. 
Large conductance channels of'130pS are found in the mesenteric arteries 
(Standen et al., 1989), rat tail artery (Furspan and Webb, 1993)and canine aorta 
smooth muscle (Kovacs et al., 1991). 
The channel openings maintained by KCOs are affected by the NDPs and 
can occur spontaneously or after channel rundown (Terzic et al., 1995; and 
Isomoto et al., 1997). For example, pinacidil and levcromakalim are effective 
when applied during spontaneous channel activity and after rundown in the 
presence of NDPs. The mechanism of activation by KCOs is dependent on the 
metabolic conditions of the cell (Terzic et al., 1995; and Isomoto et al., 1997). 
It has thus been proposed that during metabolic inhibition the NDP 
concentration rises and ATP; falls which may result in the activation of the 
channel (Zhang and Bolton 1995). However, it has been noted that NDPs also 
regulate a K+ channel whose activity is similar to the KATP channel in rabbit 
portal veins and rat mesenteric arteries (sometimes referred to as K\DP) (Beech 
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et al., 1993 a, 1993b) and this current is also blocked by ATP; and glibenclamide 
with an IC5 for glibenclamide of 25nM (Beech et al., 1993a). It has been 
suggested that the application of K+ channel openers results in the activation of 
these channels (Beech et al., 1993b, Zhang and Bolton, 1995). The situation in 
smooth muscle cells is thus not clear. The situation in cardiac tissue may be less 
complex, and this is discussed further in Chapter Five. 
1.4.3.1: MOLECULAR BIOLOGY OF KA-rp CHANNELS. 
As already discussed in Section 1.2.2, the ß-cell KATP channel is 
composed of two subunits, a Kir channel subunit - Kir6.2 (BIR) - and a 
sulphonylurea receptor which is discussed in detail in the next section. The 
reconstituted complex was inwardly rectifying, sensitive to ATP;, inhibited by 
sulphonylureas and activated by the KCO diazoxide. Kir6.2 (BIR) was screened 
from the human genomic library using Kir6.1(uKATp-1) as a probe. The amino 
acid sequence showed that Kir6.1 has 70% sequence homology with Kir6.2. It 
has 40-50% homology with other Kir channels. It has two transmembrane 
domains and a H5/P region motif which is Gly-Tyr-Gly in all other inward 
rectifiers but, interestingly, is Gly-Phe-Gly here. 
The mRNA for Kir6.2(BIR) is strongly expressed in pancreatic ß-cells, 
brain, skeletal muscle, cardiac muscle and insulinoma cells, and is weakly 
expressed in lung and kidney, but not found in the spleen, liver or testis (Sakura 
et at, 1995). The second transmembrane domain had an asparagine at position 
160 (analogous to aspartate at positions 171/172 in strong rectifiers) and there is 
a serine at position 212 so that the channel is weakly rectifying. The amino 
acids in analogous positions in strong rectifiers are negatively charged 
(discussed in detail earlier). 
Kir6.1(uKATP-1) also couples to the SUR and displays sulphonylurea 
sensitivity when expressed with the SUR in HEK293 cells (Ammala et al., 
1996). The Kd for binding of glibenclamide was 6.8 ± 1.8nM which is close to 
that for the native ß-cell receptor of 0.3-7nM (Ashcroft and Ashcroft 1992). The 
SUR receptor does not itself act as an ion channel but provides the complex 
with sensitivity to sulphonylureas. In the HEK293 cells it was found to couple 
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to more than one type of Kir channel. However the coupling of the SUR to the 
endogenous Kir channels of the HEK293 cells did not result in ATP sensitivity - 
even though it does regulate the ATP sensitivity of the ß-cell KATP. The 
presence of sulphonylurea sensitivity does not, therefore, necessarily indicate 
the presence of a KATP channel. 
1.4.3.2: THE SULPHONYLUREA RECEPTOR 
The sulphonylurea receptor is a member of the ATP Binding Cassette 
(ABC) superfamily and was first cloned from insulinoma cells (Aguilar-Bryan 
et al., 1995). It has 13 transmembrane domains, 2 nucleotide binding folds with 
Walker A and B consensus motifs and an external NH2 terminus. It also 
contains 2 N-linked glycosylation sites and 20 PKA- and 3 PKC- dependent 
phosphorylation sites. The mRNA for the receptor has been found in the 
pancreas, brain, heart and the kidney. 
Co-expression of a mouse (m)-BIR and a hamster (ha)-SURI in Xenopus 
oocytes results in a K+ conductance which is blocked by ATP with an IC50 of 
10µM and by glibenclamide with an IC50 of 1.8nM and by tolbutamide with an 
IC50 of 32µM. The channel is activated by diazoxide with an EC50 of 60µM. 
These sensitivities to the blockers are similar to those of the ß-cell KATP 
channels (Inagaki et al., 1995). 
The mRNA for the SUR1 has been detected in large amounts in the 
pancreatic ß-cells and in small amounts in the brain (Inagaki et al., 1995. - 
Aguilar-Bryan et al., 1995). An additional homologue - SUR2 - has been 
isolated from the rat brain (Inagaki et al., 1996) and an isoform of SUR2 was 
cloned from a mouse heart cDNA library (Isomoto et al., 1996). Another 
member was found to differ from this mouse SUR2 isoform by 42 amino acids 
in the C-terminal domain. The above mentioned SURs are now termed SUR1, 
SUR2A and SUR2B. The rat rSURI has 65-70% sequence homology with the 
mouse mSUR2A and mSUR2B. 
The co-expression of Kir6.2 with either SUR2A or SUR2B results in a 
K,, rp channel with a single channel conductance of -80pS. The co-expression of 
rSUR2A/mKir6.2 elicits channel activity which is inhibited by ATP; with an 
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IC50 of I OOgM and by I µM glibenclamide. The channel can be activated by 
pinacidil and cromakalim but not diazoxide (Inagaki et al., 1996). These 
characteristics have also been observed in the cardiac and skeletal muscle KATP 
channels. (Fosset et al., 1988; Faivre et al., 1990; Nichols et al., 1991; Terzic et 
al., 1994). The mSUR2B/mKir6.2 complex has features similar to the KATP 
channel in smooth muscle cells (Beech et al., 1993) such as activation by both 
pinacidil and cromakalim. The different SURs have different sensitivities to 
block by sulphonylureas. Tolbutamide is --50 times less potent in the heart than 
in the ß-cells and glibenclamide inhibits the channel in the heart and smooth 
muscle with an IC50 of 5-20µM compared with 4 -50nM in ß-cells (Zunkler et 
al., 1988a, b, Ripoll et al., 1990). 
Distribution studies have shown that the mSUR2A is located in the 
atrium, ventricles, skeletal muscle, cerebellum, eye, and urinary bladder 
whereas mSUR2B is distributed not only in these tissues but also in the 
forebrain, liver, lungs, kidney, spleen, stomach, small intestine, colon, uterus, 
ovary, and fat tissue (Isomoto et al., 1996). This is in keeping with the idea that 
these two SURs expressed with Kir6. x subunits constitute cardiac and smooth 
muscle KATP channels. 
1.4.3.3: ATP-DEPENDENT KIR SUBFAMILY: THE PRESENCE OF A C- 
TERMINAL ATP-BINDING DOMAIN. 
As already mentioned in Section 1.2.2 these Kir family members have a 
putative ATP-binding domain in their C-terminal domain. Kir 1.1(ROMK 1) is 
expressed predominantly in the kidney where it plays a part in electrolyte 
transport. It has been shown that the Kirl. 1 protein is localized in the apical 
membrane of the cortical collecting duct in epithelial cells. Expression in 
oocytes results in a channel with a single channel conductance of 35-45pS in 
90mM [K+]. Mg-ATP; is needed for opening and the channel is inhibited by 
intracellular H'. These properties are similar to those of the channel found in the 
cortical collecting duct cells (Wang et al., 1992; Ho et al., 1993). 
Kir4.1(KAB-2) has 53% sequence homology with Kirl. 1. Expression in 
oocytes leads to strong inwardly rectifying channels which are constitutively 
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active (Bond et al., 1994) whereas Kirl. I is a weak inward rectifier. The charge 
at two sites in the channel structure, R1 in the M2 domain and R2 in the C- 
terminal domain - Mg2+ and polyamine binding sites, as discussed in Section 
1.3.3 and illustrated in Figure 1.3.3.1 - in Kir 1.1 are both neutral. The charge at 
R2 in Kir4.1 is negative (Yang et al., 1995). It is thought that Kir4.1 may 
associate with other Kir channel subunits to form heteromeric channels (see 
Isomoto et al., 1997). 
The mRNA for Kir4.1 is expressed in the kidney where it is found 
specifically in the basolateral membrane of distal tubular epithelial cells (Ito et 
al., 1996). It may provide the K+ for the Na+-K+ pump activity which underlies 
the net movement of univalent cations across these cells. In the brain Kir4.1 
mRNA is expressed in the cerebellum, corpus callosum, hippocampus, 
thalamus, inferior colliculus and the brain stem. It is mainly found in the glial 
cells of the CNS and so may play a role in K+ buffering action. 
1.5: OTHER INWARDLY RECTIFYING POTASSIUM CHANNELS. 
1.5.1: NA+-ACTIVATED CHANNELS. 
These were first identified in cardiac tissue (Kameyama et al., 1984). They 
are activated when intracellular Na+ levels increase to above 20mM. They have 
the highest conductance (more than 200pS) of all the ion channels in the heart. 
Under normal physiological conditions the concentration of Na+ inside the cell 
is about 10mM so these channels are thought to be active only during 
pathophysiological conditions when [Na+]i increases significantly, for example, 
during ischaemia, digitalis intoxication and during perfusion with Ca 2+ and 
Mg2+-free medium. The channel is also present in neuronal tissue where it may 
play a role in repolarisation during the action potential following activation by 
the influx of Na+ ions. A cDNA coding for the channel has not yet been 
isolated. 
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1.6: BLOCK OF K+ CHANNELS BY CLOTRIMAZOLE , 
CETIEDIL AND THEIR 
ANALOGUES. 
Very few compounds have been identified as selective blockers of inward 
rectifier channels. The compounds clotrimazole and cetiedil have recently been 
tested for this action in our laboratory as they are known blockers of other kinds 
of K+ channel. Clotrimazole is an antifungal agent which is now known to block 
Kca channels in red blood cells (Alvarez et al., 1992; Benton 1995). 
Additionally the IK(ca) current in murine erythroleukemia cells and in PC 12 cells 
and the whole cell K+ current in ferret portal vein smooth muscle cells are 
blocked by clotrimazole at concentrations of IOnM to 10µM (Rittenhouse et al., 
1994a, 1997). Clotrimazole is thought to block the K+ channel directly, 
independent of its inhibitory action on the cytochrome p450 epoxygenase 
(Alvarez et al., 1992; Rittenhouse et al., 1994b, Vandorpe et al., 1997). Other 
recent studies have shown the block of K+ currents in many tissue types by 
clotrimazole (Coupry et al., 1996; Brugnara et al., 1993; 1995; 1996). 
Cetiedil is an antisickling agent and can block Kca channels in red blood 
cells (Christophersen and Vestergaard-Bogind, 1985; Benton et al., 1994), 
volume-activated K+ channels in rat hepatocytes (Sandford et al., 1992) and 
levcromakalim-activated K+ channels in smooth and skeletal muscle (Benton 
1995). A previous study in rat atrial myocytes by Dr. A. G. Jones in our 
laboratory has shown that the G-protein gated K+ channel can be blocked by 
clotrimazole and cetiedil, as well as by some of their structural analogues. The 
block by clotrimazole was observed to be use-dependent. Morover, an analogue 
of cetiedil, UCL1495, was found to be very potent with an IC50 of 0.4µM. 
(Jones, 1995). This compound has been shown to be much more effective than 
cetiedil as an IKca blocker in rabbit erythrocytes (Benton et al., 1994) whereas it 
had little effect on levcromaklim-induced current in rat aorta (Benton, 1996). 
1.7: BARIUM BLOCK OF INWARD RECTIFIERS: 
Ba21 is a well characterised blocker of K+ channels. It blocks delayed 
rectifiers from the outside, K(ca) from the inside, and the background inward 
rectifier and KATP from the outside (Hille 1992). The block of the channel 
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occurs with an IC50 of 2.2µM at -120mV in pulmonary artery endothelial cells 
(Voets et al., 1997), 12µM at -65mV in skeletal muscle (Standen and Stanfield, 
1978) and 1.3µM at -120mV in Purkinje fibres (Carmeliet and Mubagwa, 
1986). The block by Ba2+ has been reported to be time and voltage-dependent in 
the IK1 of the SA node (Osterrieder et al., 1982), IK1 in atrial cells (Bechem et 
al., 1983) and in Purkinje fibres (DiFrancesco et al., 1984) as well as in non- 
cardiac tissue (Armstrong and Taylor 1980, Hagiwara et al., 1978, Standen and 
Stanfield 1978). The block by external Ba 2+ is more marked at negative than at 
positive potentials. The voltage-dependence indicates that Ba 2+ penetrates the 
cell membrane. The depth of the binding site within the membrane can be 
indicated by g [which is the fraction of the total electrical potential drop 
between the outside of the channel and the binding site in the channel, and is 
often referred to as the 'electrical distance' (Hille, 1992)] which has a value 
between 0 and 1 (Hagiwara et al., 1978). The value for IK1 is 0.64 - 0.68 in 
starfish egg and 0.64 - 0.74 in skeletal muscle fibres indicating that the binding 
site is close to the inner mouth of the channel. 
IC50 values for block of IKACh by Ba 2+ have been estimated as 125µM at 
OmV and 15.3 pM at -80mV in guinea-pig atrial cells (Zang et al., 1995); 11 µM 
at -70mV in rabbit Purkinje fibres (Carmeliet and Mubagwa, 1986). The block 
of IKACh is described by 1: 1 binding of Ba 2+ to a site within the channel. The 
value of p for IKACh in guinea-pig atrial cells is - 0.3 which indicates that the 
binding site is near the extracellular face of the membrane (Zang et al., 1995). 
Ba 2+ is considered to cause an open channel block, as its action is dependent 
upon the extracellular K+ concentration and is also time- and voltage-dependent. 
The initial peak of current induced by adenosine is not significantly reduced by 
the pre-application of Bat+, indicating that there is no block of closed channels 
(Zang et al., 1995). 
Block by Ba2_ of K. ATP channels is voltage-dependent in frog skeletal 
muscle with an IC50 of 0.1 mM at -62mV (Quayle et al., 1988). In mouse 
pancreatic ß-cells the block is also voltage-dependent and the IC50 value is 
0.18mM at -62mV and 12.5µM at -123mV (Takano and Ashcroft 1996). The 
voltage-dependence is attributed to Ba 
2+ binding at a site within the channel so 
A7RODUCTION 
49 
impeding the flow of K+ ions. Single channel studies by Quayle et al., (1988) 
have shown that Ba2+ decreases the mean channel lifetime compatible with an 
open channel block. However,. Takano and Ashcroft (1996) found that K+ ions 
had no effect and proposed that Ba 2+ binds to a site outside the pore, inducing 
closure of the channel. They also argued that the study in skeletal muscle did 
not fully examine the effects of increasing external K+ on the Ba 2+ block. The 
explanation for these differences remains unclear. 
To summarise, it appears that Ba2+ is most effective on the Iß I channel 
followed by IKACh and finally IATP. The block of IK1 and IKACh is voltage 
dependent and is thought to be due to open channel block whereas the nature of 
the block of IATP remains unclear. The different potencies may be attributed to 
the amino acid residues present at important sites within the channel structure as 
discussed previously in Section 1.3.3. The residues at R1 and R2 in IK1 are 
negative as is R1 in IKACh. As these are important in binding of Mg2+ and 
polyamines, it may be that there are some residues present which are important 
in the binding of Bat+. The corresponding residues in KATP are neutral which 
may decrease the affinity for Ba2+ and possibly reduce the voltage-dependence 
of the blocking action. As of yet no one has thought to correlate 
Mg2+/polyamine block or degree of rectification with sensitivity to Bat+, though 
a relationship seems possible. 
1.8 : OTHER BLOCKERS OF INWARD RECTIFIERS : 
The IK1 channel is blocked from the outer side of the membrane by TEA, 
Cs+, Rb+, Na+ and Sr 2+ and by H+ from the inside (Hille 1991). IK1 in skeletal 
muscle is blocked by TEA with an IC50 of 20mM (Stanfield, 1983). 
KATP channels in pancreatic ß-cells are blocked by 25% by 10mM TEA 
(Cook and Hales, 1984) and in ventricular cells 1 mM causes an almost complete 
block (Kakei et al., 1985). 4-AP at 1mM abolishes KATP channel openings in 
guinea-pig ventricular cells (Kakei et al., 1985) and in pancreatic ß-cells the 
channel is blocked by 10mM (Cook and Hales, 1984). However the channel 
activated by metabolic exhaustion of frog skeletal muscle is insensitive to 
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similar concentrations of 4-AP (Castle and Haylett, 1987). The ATP-current is 
also blocked by glibenclamide, tolbutamide, phentolamine, ciclazindol and 
lidocaine (Edwards and Weston, 1993). Blockers of the atrial IKACh include 
quinidine, having an IC50 of -1 0µM (Nakajima et al., 1989), disopyramide 
(IC50 = 1.7µM) and flecainide (IC50 = 3.6µM (Inomata et al., 1991). The channel 
is also blocked by Cs2+, 4-AP, TEA and quinine. 
1.9: AIMS OF PRESENT STUDY: 
The primary aim of the present work was to examine the effects of 
compounds structurally related to drugs tested previously as potential inhibitors 
of IKACh in neonatal rat cardiac tissue. These compounds were also tested on IK1 
and IATP in order to determine their possible selectivity. Selectivity would not be 
unexpected in view of the structural differences between the three channels, as 
is the case for the rectification due to intracellular block by Mg2+ and 
polyamines, as discussed in Section 1.3.3. 
Bat+was also used as a well characterised inhibitor displaying an open- 
channel block and compared with published results in order to determine its 
selectivity between the three channels in the neonatal rat heart. The block by 
Ba 2+ is also affected by residues in the channel structure (see Section 1.7 and 
Chapter Six) and it was hoped the findings with Ba2+ might be useful in 
interpreting the effects of other inhibitors, including the new compounds to be 
tested. 
The effect of glibenclamide on IKACh and IATP was also studied in some 
detail in the hope that this would provide information as to whether or not the 
current induced by application of adenosine in atrial myocytes included a 
component of IATP as has been suggested by Li et al., (1995). These authors 
observed that the current activated by adenosine in guineepig atrial cells was 
susceptible to inhibition by glibenclamide. As glibenclamide was considered to 
be a specific blocker of KATP channels, it was concluded that the application of 
adenosine resulted in the activation of not only G-protein gated channels but 
also KATP channels. It was also hoped that the present examination of the effect 
of glibenclamide on all three channels would be useful in determining whether 
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the SUR associated with inward rectifier channel subunits other than KA p 
subunits, as has already been described by others (see Section 1.4.3.1. ). 
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CHAPTER Two: METHODS. 
2.1: TISSUE CULTURE 
2.1.1: PREPARATION OF NEONATAL RAT CARDIAC MYOCYTES 
A previous procedure developed in this laboratory, and described by 
Jones (1995) was modified for use in the preparation of both atrial and 
ventricular myocytes. A one day old rat pup (of either sex) was killed by 
cervical dislocation and the thorax opened. The heart was removed into Hanks 
balanced saline solution in a Falcon culture dish. This solution was 
supplemented with Cat+, Mg 2+ and EGTA (see below) as this made cells more 
robust and calcium-tolerant. The Hanks solution used throughout the isolation 
procedure had been pre-heated to 37 °C. 
The atria and ventricular tissues were separated using a dissecting 
microscope and transferred into fresh solution in separate dishes. The atria were 
`nicked' with scissors to increase the surface area for enzyme access and 
ventricles were cut into - lmm3 pieces. After dissection the solution was 
replaced with one containing 2 mg / ml collagenase and 6 mg / ml bovine serum 
albumin. The tissue was then incubated in this solution at 37 °C for 35 minutes. 
It was next place in Hanks containing 2.5 mg / ml trypsin at 37 °C for a further 
10 minutes. A final incubation in this solution, but now enzyme free and 
containing 6 mg / ml bovine serum albumin, at room temperature for 10 
minutes served to arrest further enzyme activity. 
Cells for electrical recording were isolated by dabbing pieces of tissue to 
the bottom of a culture dish containing Hanks solution. Single cells detached 
from the tissue and stuck readily to the base of the dish. The tissue was not 
triturated at any time. Cells were left in this solution for 2 hours before use and 
some were incubated in culture medium (see below) at 37 °C (95%02+5% 
C02) for use the next day. 
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The composition of the isolation medium and of the culture medium are 
given in Section 2.1.2. 
The two different cell types did not appear vastly different. Atrial cells 
were 7-10 µm in diameter and appeared elongated and striated. After 2 hours in 
culture dishes, they became rounded. Ventricular cells were slightly bigger with 
a diameter of 10-14 µm. Cells were less elongated but still striated. These cells 
retained their structure after 2 hours in culture. The next day both cell types had 
become more spherical, the atrial ones more so than those from the ventricles. 
2.1.2: ISOLATION AND CULTURE MEDIUM 
Isolation medium was Hanks balanced salt solution without calcium or 
magnesium, from Gibco. This was supplemented with the following: 
Ca 2+ 20 µM 
Mg 2+ 1L 
EGTA 100 µM 
The free Ca 2+ concentration was estimated to be 20nM. 
Cells were kept overnight in culture medium of the following composition: 
L-15 (Leibovitz) medium with L-glutamine (42.6 ml) 
Penicillin-Streptomycin (1 ml containing 200 IU-200 µg) 
Foetal Calf Serum (5 ml) 
24.9 mM Sodium bicarbonate (1.4 ml of 7.5%) 
2.2: RECORDING TECHNIQUES. 
2.2.1: MEDIUM. 
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During an experiment cells were constantly perfused with a 
physiological solution that was buffered with Hepes. The solution composition 
was as follows: 
NaCl 136 mM 
KC1 4.7 mM 
CaC12 1.0mM 
MgC12 1.2 mM 
N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (Hepes) 10 mM 
Glucose 10 mM 
The pH was adjusted to 7.4 with 1M NaOH. 
This solution flowed under gravity into the 35mm diameter culture dish 
via an inlet tube made of stainless steel. The inlet was positioned to direct the 
inflowing solution directly onto the cell. The solution level was kept constant by 
a similar tube which was attached to a suction pump thus maintaining a constant 
volume in the recording chamber. The solution flowed at -5 ml / min and was 
pre-heated by passage through a water jacket to give a temperature in the culture 
dish of - 31 °C. Drugs were dissolved in the perfusion solution and stored in 
separate reservoirs. The perfusion could be switched from drug-free solution to 
one of 4 drug solutions. The time taken for a new solution to reach the cell was 
5s. 
2.3: WHOLE CELL RECORDING TECHNIQUE. 
2.3.1: PATCH PIPETTES. 
Patch pipettes were pulled from thin walled borosilicate glass tubing 
(GC-150TF Clark Electromedical Instruments) containing an inner filament. 
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This was usually done using a List patch electrode puller (L/M-3P-A; List 
Medical), although in some cases an in-house horizontal puller was employed. 
Pipettes were not fire-polished and had resistance of between 8-14 MSZ. 
However, for experiments with GTP-y-S, pipettes with resistance of between 3- 
6 MSZ were employed. Prior to use pipettes were backfilled with internal 
solution with the aid of a1 ml syringe fitted with a 0.22µm Millipore filter. 
2.3.2: INTERNAL SOLUTION 
The internal solution was of the following composition: 
K-Citrate (K3 C6 H5 07 
. 
H20) 56mM 
KCI 25 mM 
NaC1 lo mm 
MgC12 1 mM 
HEPES 35 mM 
K-EGTA 1 mm 
CaC12 1.01mM 
This gave a free Ca 2+ concentration of 49µM, and a free Mg2+ of 74µM as 
calculated using REACT (G. L. Smith, Department of Physiology, University of 
Glasgow, U. K. ). 
The pH of the solution was adjusted to 7.2 with 1M KOH. 
100µM GTP (Na-salt, Sigma), 3 mM ATP (Na-salt, Sigma) and 10 mm Mg2+ 
(MgC12) were added when activating the G-protein gated current via adenosine 
receptors. When it was desired to activate the channel directly through the G- 
protein, GTP was replaced with GTP-y-S (Na-salt, Sigma). Internal ATP was 
left out when examining the levcromakalim-induced current in ventricular 
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myocytes (see Chapter Five). 
2.3.3: VOLTAGE-CLAMP TECHNIQUES. 
The culture dishes were placed in a hollow in a perspex block which was 
mounted onto the stage of an inverted Nikon TMS phase contrast microscope. 
This in turn was mounted on steel and concrete slabs supported on a Micro-g 
vibration isolation table (Technical Manufacturing Corporation) to minimise 
any external vibration. A Narishige hydraulic micro-manipulator system 
controlled the movement of the pipette. Screening from electrical interference 
was provided by a Faraday cage. 
Whole-cell voltage-clamp recordings were carried out using a patch- 
clamp amplifier made in the Pharmacology Department UCL, by Mr Ted Dyett. 
PCLAMP 6 was used to generate command voltages and to record data. Voltage 
and current outputs from the patch amplifier were amplified five-fold, low-pass 
filtered at 1.5kHz (using an in-house 8 pole Bessel low pass filter) and digitised 
(Instrutech VR-10 digital data recorder). The pipette currents were displayed on 
the computer monitor, on a digital oscilloscope (Gould 20 MHz digital storage 
Type 1424), and on a pen recorder (Gould Easy Graf TA 240, ). Data were 
stored on the hard drive of a PC (Acer) using the Axon TL1 Labmaster digitiser 
and the pCLAMP6 acquisition program and also on tape (Panasonic 
videocassette recorder NV-L20 HQ). The stored data were analysed with the aid 
of the pCLAMP 6 data analysis program Clampfit. 
The patch pipettes were held in a Perspex holder (Clark Electromedical) 
which was attached directly to the head-stage of the patch amplifier mounted on 
the micro manipulator. The pipette and seal resistance were estimated by 
constant voltage pulses ( usually -1 OmV lasting I Oms) by the 'test-seal' program 
provided by pCLAMP 6. The pipette was lowered toward a cell until a 
decrease in the current deflection indicated that the pipette was touching the cell 
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surface. Gentle suction was then applied and a large increase in resistance 
indicated the formation of a seal. The fast capacity transients due to pipette 
capacitance were then compensated. Once the seal resistance had reached at 
least 1 GSZ the holding potential was set to -50mV. A further application of 
suction ruptured the cell membrane underneath the pipette tip, and this was 
indicated by an increase in the capacity transients and in the current pulse. The 
transients due to cell membrane capacitance were compensated for before 
conducting the experiment proper, and the values of the membrane resistance 
and capacitance were noted. 
The differences between the ionic compositions of the bathing solution 
and the cell are likely to lead to a change in the liquid junction potential after 
formation of the whole cell configuration. Junction potentials were estimated 
using the computer program JPCALC (Barry, 1994). This requires the total 
concentrations of internal and external ions to be known. However, citrate was 
not an option within the program. Selecting aspartate as a substitute gave a 
theoretical value of +9.4mV, and using acetate gave a value of +7mV. Using 
these values as guides it is estimated that the junction potential is -+1 OmV in 
the whole cell configuration. Thus in the current-voltage relationships presented 
in this study the reversal potentials are actually IOmV positive to their true 
value. Whilst this has been taken into account when interpreting the results 
obtained, corrections have not been applied to the 'raw' data presented. 
2.4: DATA ANALYSIS. 
Results presented are means ± standard errors, and the number of 
observations are given either in parenthesis or in the figure legends. t-tests were 
used in order to assess statistical significance. Differences were considered 
significant when P was less than 0.05. Further details are given in the text. Log 
concentration-response curves were constructed by fitting the unweighted data 
to the Hill equation shown below using the method of least squares 
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minimisation. This was done using either Origin 4.1 (Microcal software) or 
CVFIT (written by Professor D. Colquhoun). This gave estimates for the IC50 
values and the Hill slopes. 
y=y max IC 50 n+ 
(Equation 
2.4) 
where 
ymax = maximum response 
[B] = concentration of the blocker, B. 
n= Hill coefficient. 
IC50 = half maximum inhibitory concentration of B. 
The maximum responses were normally constrained to 100% since the agents 
tested were capable of completely abolishing the measured current. 
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CHAPTER THREE: INHIBITORS OF THE G-PROTEIN-GATED K+ 
CURRENT IN RAT ATRIAL MYOCYTES. 
3.1: INTRODUCTION. 
The main aim of the present study was to investigate the pharmacology 
of the G-protein-gated K+ channel in atrial myocytes and to compare it with that 
of two other cardiac inward rectifiers, the background inward rectifier, IK1, and 
the ATP-sensitive channel IKATP. This chapter presents results from experiments 
on the G-protein-gated current. 
Some compounds with known blocking actions on K+ channels were 
examined first. Several of these, including clotrimazole and cetiedil, have been 
tested previously in rat atrial myocytes and other tissues in our laboratory 
(Jones, 1995). Novel compounds based on clotrimazole and cetiedil have since 
been developed in the Department of Chemistry at University College London 
and in the present work these have been tested extensively on this channel. They 
include a new analogue of clotrimazole, UCL1880, and an analogue of cetiedil, 
UCL1495, which has been previously tested in a preliminary fashion by Jones 
(1995). 
The G-protein-gated K+ channel in atrial cells can be activated by either 
adenosine or acetylcholine (Belardinelli & Isenberg, 1983, West & Belardinelli 
1985, Kurachi et al 1987). In this study adenosine was employed since earlier 
work (Jones, 1995) had suggested that some of the compounds previously tested 
may block muscarinic receptors. However, a possible difficulty with the use of 
adenosine was that it has been reported that the actions of adenosine on atrial 
cells may include an activation of IKATP. Li et al (1995) have shown that the 
sulphonylurea glibenclamide- generally taken to be highly selective in blocking 
KATP - is capable of blocking the adenosine response in guinea-pig atrial cells 
but not the response to acetylcholine. Also, Wang and Lipsius (1995) showed 
that acetylcholine activated a glibenclamide-sensitive K+ channel in cat atrial 
myocytes suggesting that acetylcholine too activates the KATP channels. Li et 
al., (1995) accordingly proposed that the current activated by adenosine in rat 
atrial myocytes may involve not only the G-protein-gated channel but also 
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activation of the KATP channels. An alternative explanation is that glibenclamide 
is not as selective for the KATP channels as has been thought. In order to address 
this issue glibenclamide was tested in the present work against the adenosine 
response. The concentration range over which glibenclamide blocked the action 
of adenosine was compared with that for its effect on the KATP channel in 
ventricular myocytes and with published values for the glibenclamide effect on 
KATP channels in other studies. 
3.2: Aims: 
The overall aim was to establish the potencies of UCL1880, UCL1495 
and glibenclamide in blocking the adenosine-induced current in rat atrial 
myocytes. The results were to be compared with the effects of the same 
compounds on two other cardiac inward rectifiers, IK1 and IKATP. The effect of 
Ba 2+ on the adenosine-induced current was also investigated in these cells. 
3.3: RESULTS. 
3.3.1: THE ADENOSINE RESPONSE 
Figure 3.3.1.1 A shows the effect of 1 gM bath applied adenosine applied 
for approximately 30 seconds on an atrial myocyte clamped at -50mV. An 
initial outward current developed which reached a peak within 10 seconds and 
then decayed towards a new lower steady state level. The current falls to 
between 60-70% of the peak within the time of application of adenosine. At - 
50mV adenosine activated a peak outward current of 235 ± 40pA and mean 
steady state outward current (measured 25 seconds after initiation of the 
response) of 162 ± 23pA. 
Figure 3.3.1.2A shows the current-voltage relationship of the control and 
adenosine-induced current from an atrial myocyte. The current activated by 
adenosine is inwardly rectifying and reverses at -90mV which is close to the 
calculated EK set for these cells (-94mV). 
The whole cell control adenosine responses shown in Figure 3.3.1.1, 
3.3.1.3 and 3.3.1.4 exhibit a decay in the outward current with time. This decay, 
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Figure 3.3.1.1. The effect of 0.2µM UCL 1880 on the current activated by 1µM 
adenosine. A. Control response ; adenosine was bath applied for approximately 30 
seconds and evoked an outward current. The membrane potential of the atrial cell 
was held at -50mV. B. Response of the same cell in the presence of 0.2µM UCL 1880. 
The compound was applied 4 minutes prior to the adenosine application. The horizontal 
bar above each trace indicate5the application time of adenosine. There is a delay before 
the response due to the time required for the new solution to reach the cell. The vertical 
deflections throughout the response are due to -IOmV voltage steps. The larger 
deflections are in response to short volitge ramps but are not faithfully reproduced by 
the recorder. The arrows on the left of the traces indicate the zero current level. 
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Figure 3.3.1.2. The steady state whole-cell current-voltage (I-V) relationship and the 
response to I pM adenosine in rat atrial myocytes. A. The current was measured in control 
conditions (. ), in the presence of adenosine (. ), and subtracted to give the current due 
to adenosine (A). Each voltage step lasted 1 second and currents were measured near 
the end of the steps. B. The currents elicited by adenosine alone (A) and by adenosine 
in the presence of 2µM UCL1880 ("). Background currents were subtracted. Cells were 
held at a potential of approximately -50mV. The membrane potential was stepped from 
between -120 and +40mV in +lOmV increments relative to the holding potential. 
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which has been analyzed in Section 3.3.2, varied from cell to cell and can be 
attributed to different amounts of desensitization. In atrial cells this is thought to 
involve not only the receptors but also subsequent events as, by-passing the 
receptor using GTP-y-S gives rise to a current that is also subject to 
desensitization (Kurachi et al, 1987, Zang et al, 1993). This component of 
desensitization is thought to involve a phosphorylation / dephosphorylation 
event at the G-protein and/or the channel protein (Kim, 1991 & 1993; Zang et 
al., 1993). 
3.3.2: BLOCK OF THE ADENOSINE RESPONSE BY UCL188O, UCL1495 
AND GLIBENCLAMIDE. 
Selected compounds were tested as inhibitors of the current activated by 
adenosine at the steady state level at a holding potential of -50mV. A control 
adenosine response was obtained and the adenosine was then reapplied 
following a4 minute exposure of the cell to the drug. Preliminary experiments 
and the earlier work of Jones (1995) with similar compounds suggest that this 
period of time is sufficient for any blocking action to reach a steady state. The 
cell was then bathed in Krebs alone and the adenosine application repeated at 5 
minute intervals until the response had recovered. 
Figure 3.3.1.1B shows an adenosine response in the presence of 0.2µM 
UCL1880. It can be seen that the response has been greatly reduced at the 
steady state level whereas the peak response is only slightly diminished. At 
higher concentrations of UCL1880 the peak was reduced to a greater extent (see 
also the results with UCL1495, below). The current-voltage relationships for the 
steady state adenosine response alone and in the presence of a relatively high 
concentration of UCL1880 (2µM) are shown in Figure 3.3.1.2B. 
Figure 3.3.1.3 shows the response of a different cell to adenosine alone 
and to adenosine in the presence of the cetiedil analogue UCL1495. The control 
response shows the characteristic peak and decline to a steady level. In the 
presence of 2µM UCL1495 both the peak and in particular the steady level are 
greatly reduced. 
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Figure 3.3.1.3. Effect of 2µM UCL 1495 on current induced by 1µM adenosine. 
Records from a rat atrial myocyte held at -50mV. A. Control response; adenosine 
was bath applied for 30s and evoked an outward current. The horizontal bar 
indicates the time for which adenosine was applied; the delay is due to the time 
required for it to reach the cell. B. The adenosine response was greatly reduced 
in the presence of 2µM UCL1495, which had been applied 4 minutes beforehand. 
C and D. Recovery of the response at 5 and 10 minutes, respectively, after 
washout of UCL 1495. 
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A different pattern of inhibition was seen when the ability of 
glibenclamide to block the response to adenosine was examined. Figure 3.3.1.4 
illustrates the effect of glibenclamide at 20µM on the adenosine current. It can 
be seen that the peak and the steady state responses have both been reduced, and 
to a comparable extent. 
Following these preliminary experiments a range of concentrations were 
tested and log concentration-response curves were constructed for all three 
inhibitors. The response was taken as the block of the steady state current at - 
50mV. The Hill equation (Equation 3.3.2) was fitted to the data using the 
method of least squares giving estimates of half-maximal inhibitory 
concentrations (IC50) and the Hill coefficient (nH). 
1n 
max 
ymax = maximum inhibition 
IC 
50n 
ý' ýn 
[B] = concentration of blocker 
n= Hill slope 
(Equation 3.3.2) where 
IC50 = half maximum inhibitory concentration of blocker (IC50). 
The maximum inhibition was constrained to 100% as there was no 
indication that any of these drugs were capable of producing more than 100% 
block. (High concentrations of inhibitor did not reveal an inward current in 
response to adenosine). 
Figure 3.3.2 shows the log concentration-response curves for the effect 
of UCL1880, UCL1495 and glibenclamide on the adenosine response. It can be 
seen that all three compounds tested are active in the micromolar range. 
Table 3.3.2 shows the IC50 values and the Hill coefficients obtained from 
the curves for each compound. 
These results indicate that UCL1880 with an IC50 of 0.2µM is the most 
effective of the three in blocking the adenosine-induced current. It is also more 
active than the parent compound clotrimazole which has an IC50 of 0.9µM 
(Jones 1995). 
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Figure 3.3.1.4: Effect of glibenclamide on current induced by 1µM adenosine. 
Records from a rat atrial myocyte cell held at -50mV. (A), Control response, 
adenosine was applied for 30 seconds and evoked an outward current which 
declined to a lower level. The horizontal bar indicated the time of adenosine 
application; delay is due to time required to reach the cell. (B), Preincubation 
of the cells in 20µM glibenclamide for 4 minutes decreased the response with 
little change in its overall shape. (C), Recovery of response after 5 minute 
washout with Krebs solution. 
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Figure 3.3.2: Log-concentration response curves for the effect of UCL 1880 
(. ) 
, 
UCL 1495 (. ) and glibenclamide (&) on the response to 1µM adenosine. 
Block was measured towards the end of an approximately 30 second application 
of adenosine to atrial cells held at -50mV. All inhibitors were applied for 4 
minutes prior to the application of adenosine response. Values in brackets 
indicate the number of cells tested at each concentration of inhibitor. 
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COMPOUND IC50 M nH 
UCL1880 0.18±0.02 0.95±0.07 
UCL1495 0.46±0.04 1.68±0.35 
Glibenclamide 23.5±5.50 0.78±0.18 
Table 3.3.2: IC50 and nH values from the curves shown in Figure 3.3.2. 
3.3.3: POSSIBLE USE-DEPENDENCE OF THE BLOCK BY UCL 1880 AND 
UCL 1495 
Use-dependence has been described previously for UCL 1495 (Jones 
1995). As has been shown in Figure 3.3.1.1B the adenosine response shows a 
marked fade in the presence of 0.2µM UCL1880. This suggests that at low 
concentrations of blocker the current is activated before it is blocked i. e. the 
blocking action is use-dependent. 
The effect of glibenclamide on the adenosine-induced current is quite 
different as already noted. In contrast to the blocking actions of UCL1495 and 
UCL1880 both the peak and the plateau response was reduced in the presence of 
glibenclamide and it would appear, therefore, that the blocking action of 
glibenclamide does not require the current to be activated. To quantify this, the 
effects of the drugs on the peak and steady state current were measured. Figure 
3.3.3.1 illustrates the procedure. 
The peak response and the steady state current level towards the end of 
the adenosine response, i. e. approximately 25 seconds after the initiation of the 
outward current, were measured. The ratio of steady state to peak was then 
calculated for both control adenosine responses and adenosine responses in the 
presence of the blocking drug. Figure 3.3.3.2. shows the results obtained. The 
change in the ratio with increasing concentrations of UCL1880 is illustrated in 
A. In control conditions where there is no UCL1880 present the ratio is 0.7± 0.1 
(n= 21). In increasing concentrations of UCL 1880 the ratio decreases indicating 
that UCL 1880 causes a proportionately greater reduction in the steady state than 
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Figure 3.3.3.1: Measurement of peak and near steady state currents during an 
adenosine response. The steady state was divided by the peak current to obtain 
a ratiofor the adenosine response in the absence and in increasing concentrations 
of blocking compound. If the steady state current is maintained the ratio will 
be close to 1. For a use dependent block, the ratio should get smaller compared 
with the control. 
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Figure 3.3.3.2: Effect of drugs on end/peak ratio of adenosine response. 
The steady state to peak current ratio was calculated in the absence and 
then in the presence of the indicated concentration of drug. Stars indicate 
a significant difference (p < 0.05) between control ratio and the ratio in 
the presence of the drug. The bars represent the standard error of the mean. 
The n number is shown above each bar in parenthesis. 
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in the peak response. However, with concentrations higher than 0.2µM there is 
no further reduction in the ratio as the peak and the steady state currents are now 
both becoming much smaller i. e. the total adenosine current is greatly reduced. 
Figure 3.3.3.2 B shows the effect of UCL1495, and at high concentrations of 
this blocker the ratio becomes small. 
The effect of glibenclamide is illustrated in section C of the Figure. The 
action of this compound displays little or no use-dependence as the ratios 
remain fairly high even at concentrations causing more than 50% inhibition. 
Figure 3.3.3.3 shows an example of a well maintained adenosine 
response before, (A) and during the presence of 0.5µM UCL1880 (B). Whilst 
the peak response is reduced by a small amount, it is clear that the main 
component of the block occurs after the current has been activated. The onset of 
the block can be seen in the decline of the response in the presence of the 
blocker. 
Figure 3.3.3.4 shows log concentration-response curves for the effect of 
the compounds on the peak rather than the steady state adenosine response. If a 
compound displays any use-dependence then it is expected that it will be less 
effective in reducing the peak response as compared with that at the steady state. 
This could be further analyzed by calculating the relative potencies for the peak 
and the steady state response for each compound. Table 3.3.3. displays the IC50 
values for the block of the peak current and also shows the values for the block 
of the steady state response (from Table 3.3.2) for comparison. The IC50's are 
lower in each case for the inhibition of the steady state indicating that the drugs 
have more effect on the maintained phase of the current. The difference is 
greatest between the values for UCL1880 and least for glibenclamide. 
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Figure 3.3.3.3: The use dependent effect of UCL1880 on the adenosine induced current. 
A; A control response to 1 µM adenosine in a rat atrial myocyte. The peak declines to a 
maintained steady state leve. After preincubation in 0.5µM UCL1880, B, the maintained 
current sags away to a much greater extent. The cell was held at -50mV Adenosine was 
applied for 30 seconds. UCL 1880 was preapplied for 4 minutes. Application bars are 
shown above each trace. 
THE G-PROTEIN-GATED CI, RRE, \'T 
75 
100 
80 
60 
Z 
2 
H 
40 
20 
0 
CONCENTRATION (µM) 
Figure 3.3.3.4: Dose response curves showing the effect of UCL1880 (1), UCL1495 
(I ) and glibenclamide (A) on the peak adenosine response in atrial myocytes. The 
Hill equation was fitted to the data. The blockers were applied 4 minutes prior to 
adenosine application. 
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INHIBITION OF INHIBITION OF 
PEAK CURRENT STEADY STATE 
CURRENT 
COMPOUND IC50 nx IC50 nH 
UCL 1880 0.52± 1.16± 0.18± 0.95± 
0.16 0.42 0.02 0.07 
UCL1495 0.76 ± 1.73 ± 0.46± 1.68± 
0.09 0.36 0.04 0.35 
GLIBENCLAM DE 31.3± 0.61± 23.5± 0.78± 
7.9 0.6 5.5 0.18 
Table 3.3.3 : The IC50 and nH values for the block of the peak and steady state 
adenosine current. 
3.3.4: THE EFFECT OF VOLTAGE ON THE BLOCK OF THE ADENOSINE 
CURRENT. 
The effect of voltage on the block of adenosine by UCL1880, UCL1495 
and glibenclamide was next investigated. It was thought that if the compounds 
owed their use-dependence to, for example, a block of the open channels, then 
the block would be expected to be greater at more negative membrane 
potentials. 
The cells were held at -50mV and stepped to -120 mV for 1 second in 
the presence of adenosine. 10 such steps were applied at an interval of 2 seconds 
as this was thought sufficient to measure any block which may develop. The 
currents in the presence of adenosine were measured at the end of the 1 second 
pulse. This was repeated after a4 minute exposure to the drug. In all cases the 
background currents in the absence of adenosine were subtracted from the 
current with adenosine present. 
Figure 3.3.4.1 A shows the current produced by a step to-120mV in the 
presence of adenosine. Adenosine has induced an outward current at the holding 
potential of -50mV and an inward current in response to the step to -120mV. 
Following the very rapid development of the ohmic current due to the unblock 
of Mg2+ from the channels. there is a further increase in inward current which 
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Figure 3.3.4.1. The effect of membrane potential on the block of the adenosine 
current. A. Current activated during a1 second voltage step from -50 to -120mV 
in the presence of I pM adenosine. B. The adenosine response in the presence of 
2µM UCL 1880 applied 4 minutes beforehand. The arrows on the left indicate zero 
current level. Both the outward current at -50mV and the additional current activated 
at -120mV are blocked by the compound. The current traces shown are averages of 
10 such jumps. 
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then remains at a steady state. This slow component is believed to be due to an 
increase in the open probability of the G-protein-gated channels. 
(Sakmann et al 1983, Carmeliet and Mubagwa 1986). Figure 3.3.4.1 B shows the 
current in the presence of 2 µM UCL1880. It can be seen that the outward 
current at -50mV and the current pulse at -120mV have both been reduced. The 
time course of the current at -120mV in the presence of UCL 1880 does not 
display any decay after the initial instantaneous current and both the 
instantaneous and the steady state level have been reduced. Note that on 
stepping back to -50mV in the control step there is an outward current which 
decays. This is probably a consequence of a relief of Mg2+ and polyamine block 
which occurred at -120mV and resulted in an increase in the outward holding 
current on stepping back to -50mV. The transient outward current decays as 
block by Mg2+ and polyamines is re-established. The transient outward current 
could also be partly due to the deactivation of the G-protein-gated channels 
(Carmeliet and Mubagwa 1986). In the presence of UCL1880 this transient 
current was reduced. This tail current was not studied further. 
Figure 3.3.4.2 A shows the response of another cell in the presence of 
adenosine. After the initial inward current in response to stepping to -120mV 
there is a further increase in the inward current which, in this instance, then 
declines a little. This subsequent decline may be due to extracellular block by 
cations such as Na' as is the case for background inward rectifiers (Kelly et al., 
1992, Voets et al., 1996) or to desensitization of the G-protein coupled 
receptors. Figure 3.3.4.2B shows the adenosine response at -120mV in the 
presence of 20µM glibenclamide. Both the outward and inward currents have 
been reduced. 
The results from all three compounds at -120mV are summarized in 
Table 3.3.4 which also shows the percentage inhibitions at -50mV. These results 
indicate that there is little voltage-dependence of the inhibition of the adenosine- 
induced current by any of the compounds. It is also noteworthy that, if there was 
an increase in block at -120mV, then the current would have possibly relaxed at 
this potential. 
A 
1 00r 
B 
Figure 3.3.4.2: A shows the control current in response to a step from 
-50mV to -120mV in the presence of 1pM adenosine. B shows the current 
at -120mV in the presence of adenosine applied after a4 minute incubation 
in 211 glibenclamide. Glibenclamide was bath applied. In both traces there 
is a small inward current activated on returning to the holding 
potential of -50mV. 
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COMPOUND CONCENTRATION 
M 
-120mV -50mV 
UCL1880 2 86±4 78± 5 
UCL1495 2 69± 5 78± 8 
Glibenclamide 20 35± 7 34± 9 
Table 3.3.4 : Effect of voltage on the block of the adenosine current. 
3.3.5: BLOCK BY UCL1880 OF THE ACETYLCHOLINE RESPONSE. 
The block of the adenosine response could in principle occur at any 
point between the activation of the receptor and the subsequent opening of the 
K+ channel. Adenosine and acetylcholine are thought to activate the same 
population of G-proteins and channels (see Chapter 1). Hence, if a compound 
can be shown to block both the adenosine and acetylcholine response then the 
possibility that its action is on the receptor become less likely. Thus UCL 1880, 
the most potent compound in inhibition of the adenosine response, was 
investigated as a potential blocker of the response to acetylcholine. 
Responses to acetylcholine were found difficult to obtain and were seen 
in only 8 out of 21 cells tested with 1µM acetylcholine. Cells which developed 
an outward current to adenosine did not always produce a current to 
acetylcholine. Figure 3.3.5.1 A shows a whole cell current trace from a cell 
bathed in 1 µM acetylcholine which did result in an outward current. It usually 
differed from that to adenosine in that the peak and steady state phases were less 
clearly distinguished. 
Figure 3.3.5.1B shows the effect of prior incubation with 0.2µM 
UCL 1880. The extent of inhibition was calculated in the same way as in the 
experiments with adenosine. In 4 cells the average steady state inhibition caused 
by 0.2µM UCL1880 was 48 ± 7%. This is consistent with the figure of 53±5% 
for inhibition of the adenosine response by the same concentration of UCL1880. 
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Figure 3.3.5.1: A shows a control whole cell current response to l pM 
acetylcholine. B shows the acetylcholine response after a four-minute incubation in 
0.2[iM UCL 1880. The cell was held at -50mV and the drugs were bath applied. 
The downward deflections are due to I OmV voltage steps. The larger deflections 
are due to the application of voltage ramps. The horizontal bars above the response 
indicate the 30-second application of acetylcholine. 
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Figure 3.3.5.2 shows an example of an ACh current which displayed a 
greater degree of desensitization. The response in the presence of UCL1880 
consisted of a peak followed by a decay in the outward current i. e. a use- 
dependent block of the kind seen with adenosine 
3.3.6: THE USE OF GTP-y-S TO VERIFY NON-RECEPTOR BLOCK. 
The non-hydrolyzable analogue of GTP, GTP-y-S, activates the GTP 
binding protein and causes irreversible activation of the muscarinic K+ channel 
whilst by-passing the receptor. It was thus possible to investigate the effects of 
the inhibitors on IKACh independently of receptor activation by using GTP-y-S. 
Cells were loaded with 100µM GTP-y-S by including it in the patch pipette. To 
ensure activation of the current the cells were exposed to adenosine in the 
bathing solution for 1 minute when whole cell recording had been achieved. 
Figure 3.3.6.1 A shows the outward current initiated by adenosine under 
these conditions. It can be seen that at the holding potential of -50mV and prior 
to application of adenosine an outward current is already developing. This is 
probably due to the agonist-independent effect of the GTP-y-S. The additional 
current evoked by adenosine does not display as much fade compared with the 
responses supported by GTP. After the adenosine is washed out the current 
declines a little but not back to the control level (i. e. prior to adenosine 
application). In 37 cells loaded with GTP-y-S an outward current of 106.4 ± 
11 pA was maintained -1 minute after washout of adenosine. The effects of 2 
and 10µM UCL1880 are shown. 2µM UCL1880 produces a rapid and 
substantial decline in the outward current and increasing the concentration of 
UCL 1880 from 2 to 10µM does not produce a significantly greater block. 
The upper trace in Figure 3.3.6.1 B shows the adenosine response from a 
different cell and again a slight outward current develops prior to application of 
adenosine. After adenosine washout the current declines to a lower maintained 
level. The effect of 1 µM glibenclamide was then tested. At this concentration 
there was little block. 
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Figure 3.3.5.2. The effect of UCL 1880 on the response to 1µM acetylcholine 
in a neonatal rat atrial myocyte. The cell was held at -50mV. Acetylcholine, 
1 µM, was bath applied for 30 seconds, as indicated by the horizontal bars 
above each trace. A; A control acetylcholine response. B; the response in the 
presence of 2µM UCL 1880 after a4 minute preincubation period. Note the sag 
of the response in the presence of UCL1880. This is as for adenosine. Downward 
deflections are due to -lOmV voltage steps and bigger deflections across the trace 
are due to voltage ramps. Note that the 'spikes' are not very well reproduced from the 
chart recorder tracing. 
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Figure 3.3.6.1: A shows the outward current due to I µM adenosine and the 
maintenance of this current by 100µM GTP-y-S in the patch pipette. 2 and 10µM 
UCL1880 were applied cumulatively as indicated and reduced the current. B (i): 
The maintenance of an outward current initiated by application of adenosine. 1µM 
glibenclamide has little effect; (ii) shows the effect of 100µM barium and 20µM 
cetiedil. The time and current scales are different for A and B. Some outward 
current develops prior to adenosine application. Cells were held at -50mV, and all 
drugs were bath applied. 
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It has been previously shown that cetiedil and UCL1495 block the 
current maintained by GTP-y-S current in these cells (Jones, 1995). Therefore 
cetiedil was used as a 'positive control' and its effect can be seen in the lower 
trace in Figure 3.3.6.1B. Also shown is the effect of 100µM Ba 2+ which has 
been also used as a positive control. Both compounds caused an inhibition 
which is quick in onset but appears slower in offset. This most likely reflects a 
delay in washout rather than slow dissociation of the drug from the channels. 
Figure 3.3.6.2A shows current-voltage relationships for a cell which has 
been loaded with GTP-y-S prior to, during and after application of 1 µM 
adenosine. The currents are inwardly rectifying although there is substantial 
outward current for the G-protein-gated currents at positive potentials. 
Figure 3.3.6.2B shows the current-voltage relationship of a different cell 
and the effects thereon of 2 and 10µM UCL1880. In this particular example 
2µM UCL1880 - which caused - 90% block of the adenosine response - can be 
seen to produce a block of only -20%. Raising the concentration to 10µM 
increases the block to -50% at -50mV. 100µM Ba 
2+ was also tested and is 
observed to produce almost complete inhibition. 
A log concentration-response curve was constructed for the action of 
UCL1880. The maintained response in the presence of GTP-y-S was measured 
approximately 1 minute after washout of adenosine and the blocked response 
was then measured 4 minutes after application of the drug. The log 
concentration-response curve is shown in Figure 3.3.6.3. The IC50 of 0.25µM is 
close to the value of 0.18µM for the block of the current induced by adenosine. 
However the maximum and the slope are different. On the adenosine-induced 
current 2µM UCL1880 causes an inhibition of 90% (Figure 3.3.2) as compared 
with 55% in GTP-y-S loaded cells. Raising the concentration to 10 gM does not 
further increase the block observed. The reduction in the maximum suggests 
that only a component of the GTP-y-S current is inhibited by UCLI 880. It may 
well be that the inclusion of current carried by another ion which is insensitive 
to UCL1880. One possibility is that the additional activated current is through 
the K: ATP channels. However, the small effect of glibenclamide on this current 
does not support this as 1 pM glibenclamide is very potent on the K. kTP channels 
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Figure 3.3.6.2: Current- voltage relationship of the GTP-y-S current in 
atrial myocytes. A displays the control curve, the current activated by 1 gM 
adenosine, and the current maintained by GTP-y-S. B displays the effect 
of 2 and 10µM UCL 1880 and 100µM barium. Cells were held at -50mV and 
ramped from between -120 and OmV. 100µM GTPy -S was included in 
the patch pipette. 
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Figure 3.3.6.3: UCL 1880 block of the GTP-y-S current in rat atrial myoc} tes. 
1 pM adenosine was applied to activate the current. Data were fitte with the Hill 
equation giving an IC50 value of 0.25µM and a Hill slope of 1.89. The maximum 
\\ as reduced to 55%. Values above each data point indicate the number of cells 
tested with that concentration of inhibitor. 
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as shown in Chapter Five. Figure 3.3.6.4 shows the combined results for the 
effect of glibenclamide, cetiedil and Ba 2+ on the current activated in GTP-y-S 
loaded cells. 
3.3.7: BA2+ BLOCK OF THE G-PROTEIN-GATED K+ CHANNEL 
Figure 3.3.7.1 illustrates the effect of 3µM Ba 2+ on the current flowing 
in response to adenosine. A shows the adenosine current during a voltage step to 
-120mV from a holding potential of -50mV. B shows the adenosine current in 
the presence of 3 µM Bat+; both the outward (at -50mV) and the inward currents 
(at -120mV) were reduced. 
Figure 3.3.7.2 presents current-voltage relationships showing the effect 
of 100µM Ba2+ on the adenosine response. Though Ba2+ reduced the current at 
all potentials, it can be seen that the current at -120mV is blocked to a greater 
degree than that at the holding potential of -50mV. This was investigated further 
by calculating the block at -50mV and the block at -120mV. Log concentration- 
response curves were constructed at both potentials and are shown in Figure 
3.3.7.3. The Hill equation was fitted to the data giving values for the IC50 of 
Ba 2+ of 34.9 ± 2.2µM at -50mV and 3.8 ± 1.8µM at -120mV. It is evident that 
Ba 2+ is a more active blocker of the current at -120mV and this is in keeping 
with its reported voltage-dependent action. 
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Figure 3.3.6.4: A summary of the results from experiments carried out using 
GTP-y-S. The results for the effects of glibenclamide (0 ) at 1 and 10µM, 
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Figure 3.3.7.1: The effect of 3µM barium on the current in the presence of 1µM 
adenosine at -120mV A shows the control current at -120mV. B shows the current 
in the presence of adenosine after the cell was incubated in barium for 4 minutes. 
Both the inward and outward currents have been reduced. The current at -120mV 
has declined by approximately 50%. Cells were held at -50mV and stepped down to 
-l 20mV for 1 second. 
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Figure 3.3.7.2: The current in the presence of 1 pM adenosine (-l-), and 
the effect of 100pIM barium (-"-) thereupon are shown. The cell was held 
at - 0mV and stepped from between approximately -120 and OrnV in +IOmV 
increments. Currents were measured at the steady state in each pulse. 
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Figure 3.3.7.3: Log-concentration response curve for barium block of IK A«. 
Block of the outward current have been measured at -5OmV (") and of the 
inward current at -l20mV ( ). Data points were fitted with the Hill equation. 
The numbers of cells tested for each concentration are given in brackets above 
each point. 
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3.3.8: DISCUSSION: 
3.3.8.1: THE ADENOSINE RESPONSE: 
In neonatal rat atrial myocytes 1 gM adenosine activated an outward 
current at a holding potential of -50mV. Its amplitude was 162±23pA when 
measured at the steady state level The reversal potential shows it to be a K+ 
current and it is likely to be the same as that activated by acetylcholine in 
cardiac cells (Belardinelli and Isenberg, 1983, Kurachi et al., 1983, Ito et al., 
1995). The same population of K+ channels in neonatal rat atrial myocytes has 
also been shown to be activated by somatostatin (Lewis and Clapham, 1989). 
The channel conductance does not vary greatly between species and in human 
atrial myocytes the slope conductance is 46 ± 2pS in 145mM external K+ (Sato 
et al., 1990). Early suggestions that the current activated by ACh and adenosine 
flows through background IK1 channels are not supported by the finding that the 
ACh-activated current increases with time during hyperpolarising steps whereas 
the current through IK1 channels decreases. Furthermore, the Ba 2+ sensitivity is 
weaker for IKACh than for IK1 (Sakmann et al., 1983, Soejima and Noma 1984, 
Heidbüchel et al., 1987). In this study Ba2+ blocked IKACh with an IC50 of 
34.9µM and IK1 (see Chapter 4) with an IC50 of 16.8µM. 
3.3.8.2: THE ACETYLCHOLINE RESPONSE. 
In the same cells acetylcholine, unlike adenosine, did not routinely 
activate an outward current, which was seen in only 8 out of 21 cells tested. In 
guinea-pig atrial cells the EC50 for the ACh response is 0.15µM (Kurachi et al., 
1986) so that the concentration of 1 µM ACh used in this study should have been 
sufficient. The presence of muscarinic receptors in atrial tissue of the rat has 
been demonstrated (Wei and Sulakhe, 1978, Dashwood and Spyer, 1986) and it 
has also been shown that there is a muscarinic current present in fetal and 
neonatal rat hearts (Takano and Noma, 1997). There is no obvious explanation 
for the lack of response observed in the present work. It is possible that not 
enough ACh receptors are activatable under the conditions of my experiments. 
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3.3.8.3: DESENSITIZATION: 
The response to adenosine showed 'fade' in that the outward current 
reached a peak and then declined to a lower maintained level. The process is 
often described as desensitization and has been observed in many studies in 
cardiac tissue (Carmeliet and Mubagwa, 1986, Heidbuchel et al., 1987, Kurachi 
et al., 1987, Kim 1991,1993). Desensitization has been reported to be biphasic 
in that there is an initial phase lasting -20 seconds followed by a slower phase 
lasting several minutes (Zang et al., 1993, Kim, 1993), this was not analyzed in 
the present work. Desensitization is seen both with acetylcholine and 
adenosine. Also an acetylcholine response cannot be elicited after 
desensitization induced by adenosine suggesting a common mechanism 
underlying the desensitization seen with both agonists (Kurachi et al., 1987). 
This heterologous desensitization suggests an effect at the G protein and/or 
channel level. The desensitization is seen on activating the current either with 
agonists or with GTP-y-S and thus by-passing the receptor (Zang et al., 1993). 
With agonist activation both fast and slow phases of desensitization are seen 
whereas with the GTP-y-S the slow phase of desensitization is less obvious. 
Thus the fast phase of desensitization is thought to be due to a decline in the 
activity of the G protein and/or the K+ channel whereas the slow phase may 
represent a reduction in the receptor activity. The early phase of desensitization 
is associated with a shortening of channel open time and increase of mean 
closed time. This is possibly due to the action of a Cat+- calmodulin dependent 
phosphatase, since the addition of [ATP]; increases the mean open time and this 
effect of ATP is reversed by increasing intracellular Ca 2+ (Kim 1991). The 
ACh-activated channel can, therefore, be modulated by phosphorylation and 
dephosphorylation. 
3.3.8.4: BLOCK OF THE ADENOSINE RESPONSE: 
The results presented in this chapter show that UCL1880, UCL1495, 
glibenclamide and Bat' are effective in blocking the G protein-gated K+ current 
activated by adenosine in neonatal rat atrial myocytes. UCL 1880 was the most 
potent inhibitor with an IC50 of 0.18µM. The structural analogue of cetiedil, 
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UCL1495 was also quite active blocking the current in the low µM range. 
Glibenclamide, which is a very potent inhibitor of IKATP, also blocked the 
current though only at higher concentrations than for UCL 1880 and UCL 1495. 
3.3.8.4.1: UCL1880 AND UCL1495 BLOCK OF THE ADENOSINE 
CURRENT. 
It has been reported that the block by clotrimazole of the G-protein- 
gated K+ current activated by acetylcholine and adenosine in atrial myocytes is 
use-dependent (Jones, 1995) in the sense that the adenosine response faded 
more rapidly in the presence of clotrimazole. In the present study the block 
caused by the structural analogue of clotrimazole, UCL1880, showed the same 
feature (see Figure 3.3.1.1 and 3.3.3.3). This has been quantified for UCL1880 
in Figure 3.3.3.2. 
UCL 1880 was effective in blocking the response to acetylcholine as well 
as to adenosine reducing the likelihood that the block involved an interaction 
with the receptor. 
If, as these results suggest, the block occurs at the G-protein and/or K+ 
channel stage and not at the receptor then activation of the current 
independently of receptor activation by GTP-y-S should also be inhibited by 
UCL1880. In such experiments UCL1880 did indeed cause a block, though not 
as much as observed for the action of UCL1880 on the agonist-induced current. 
It might be argued that this was because UCL 1880 has caused some receptor 
block which contributes to the overall inhibition of the adenosine-induced 
current, this component being absent in the GTP-y-S current. An important 
observation , 
however, was that UCL1880 could not produce complete 
inhibition of the GTP-y-S-activated current. As shown in Figure 3.3.6.1 and 
Figure 3.3.3.6, increasing the concentration of UCL 1880 from 2 to 10µM did 
not substantially further increase the amount of block observed. The IC50 value 
for the block by UCL1880 of the GTP-y-S current was estimated at 0.25µM 
which is close to the value of 0.18µM for the block of the adenosine-induced 
current. The maximum block of -S 55% by UCL1880 of the GTP-y-S current is 
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achieved at between 2 and 10µM and there remains a UCL1880 insensitive 
component. This is blocked by 100µM Ba2+ and thus may be a K+ current. In 
the light of these observations it can be speculated that the inclusion of GTP-y-S 
in the patch pipette has resulted in the activation of not only IKACh but also an 
additional current. This current is G-protein linked, susceptible to block by 
cetiedil and Bat' but is insensitive to UCL1880. It is worth bearing in mind that 
there are many G protein-modulated currents in cardiac tissue including an L- 
type Ca 2+ current (Yatani et al., 1987,1988), the fast inward Na+ current (Ono 
et al., 1989, Matsuda et al., 1992) and Cl- currents (Ackerman and Clapham, 
1993). Intracellular dialysis with GTP-y-S could in principle influence any of 
these currents. 
The recovery from block took increasingly longer at higher 
concentrations requiring more than 15 minutes after 2µM UCL1880. This may 
be due to the time taken for the drug to leave the lipid of the cell membrane. In 
keeping with this, it was observed that the adenosine current 5 minutes after 
washout of high concentrations of UCL1880 still displayed increased fade (as 
illustrated for UCL1495 in Figure 3.3.1.3C and D) - use-dependence- 
suggesting that the drug molecules are still within the membrane in close 
proximity to the channel. 
UCL1495 also appears to have a use-dependent action. Lower 
concentrations of UCL 1495 cause an increase in the spontaneous decline in the 
response as compared with the control which is in contrast to the action of the 
parent compound cetiedil which displayed no use-dependence in inhibition of 
the adenosine current (Jones 1995). Interestingly, cetiedil appears to block the 
Cat+-activated-K+ channels in red blood cells in a use-dependent fashion 
(Benton 1995). 
Quantification of the use-dependent action of UCL1880 and UCL1495 
indicated that it was more apparent with low concentrations of the drug. This 
may result from the more rapid onset of block by the higher concentrations 
which masks any use-dependence. It was observed that some of the adenosine 
responses did not show an obvious peak and the application of the blocker did 
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not then result in so large an acceleration in decay as compared with the more 
'peaky' responses. This is probably because of a relatively slow perfusion 
system and the correspondingly slow development of the adenosine current in 
such experiments. UCL1880 and UCL1495 block the steady state phase more so 
than the peak current phase which is reflected in the IC50 values listed in 
Table3.3.3. UCL1880 is more than twice as potent on the maintained phase than 
on the peak current phase. UCL1495 is also more effective on the maintained 
phase but only by - 1.5 times. The block by UCL1880 could in principle 
involve either a direct channel blocking action or an allosteric interaction with 
the channel protein in such a fashion as to favour the formation of an inactivated 
conformation of the channel. This could be further investigated by single 
channel recordings. 
The results show that the structural analogue of clotrimazole, UCL1880, 
is a potent blocker of the G-protein-gated muscarinic K+ channel. There are 
other known potent blockers of this current such as disopyramide which blocks 
the ACh-induced current in guinea-pig atrial cells with an IC50 of 1.5µM (- 
53mV) though this is probably mainly due to muscarinic receptor block since 
this compound was less effective in blocking the adenosine-activated or GTP-y- 
S induced current (Nakajima et al., 1989). In the same study quinidine was just 
as effective in blocking the GTP-y-S supported current as the adenosine-induced 
current having an IC50 Of -1011M, suggesting that it blocks the functions of the 
activated G-proteins and/or the K+ channel itself Since quinidine is a well 
known blocker of other K+ channels it is not surprising that it also blocks the 
KACh channels. An inhibitory action of quinidine was also seen in another study 
which looked at the mechanism by block of various anti-arrhythmic compounds 
(Inomata et al., 1991). SUN 1165 [N-(2,6-dimethylphenyl)-8- 
pyrrolizidinylacetamide hydrochloride hemihydrate)] and disopyramide had 
IC50 values of 29µM and 1.7µM, respectively, against the ACh response in 
guinea-pig atrial cells. However in GTP-y-S loaded cells the IC50 values for both 
of these compounds were greater than 100µM and it was concluded that these 
compounds mainly block the muscarinic receptor (Inomata et al., 1991). In the 
same study flecainide and quinidine had IC50 values of 3.6µM and 1.6µM, 
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against ACh respectively, and against the GTP-y-S the values were 5.3µM for 
flecainide and 4.4µM for quinidine. Thus flecainide and quinidine seem likely 
to act at the G-protein and/or the channel. The Ca2+ channel antagonist, 
verapamil, blocks the ACh current in guinea-pig atrial cells with an IC50 of 1 µM 
and has also been shown to bind to muscarinic receptors. However the GTP-y-S 
current was also blocked with an IC50 of 3 µM, and it was concluded that 
verapamil affects the functions of the muscarinic ACh receptor as well as G 
proteins and/or K+ channel (Ito et al., 1989). 
UCL 1880 is a much more potent inhibitor of the adenosine-induced 
current than any of the above mentioned compounds and clearly merits further 
investigation. 
3.3.8.4.2: GLIBENCLAMIDE BLOCK OF THE ADENOSINE CURRENT. 
Glibenclamide blocked the steady state adenosine current with an IC50 of 
24µM and was not significantly more effective in reducing the peak current 
(Figure 3.3.1.4 and 3.3.3.2C). The evidence from the GTP-y-S experiments 
makes it unlikely that the adenosine receptors are blocked. Hence the action is 
more likely to be at the channels. However the exact mechanism of the block by 
glibenclamide is not clear, though the absence of use-dependence may mean 
that glibenclamide blocks the channels in their closed forms. 
Glibenclamide is, of course, a well characterized blocker of ATP- 
sensitive channels where its action is known to be through the sulphonylurea 
receptor subunit. One possibility is that the glibenclamide sensitivity observed 
in the present work is a consequence of the activation of KATp channels by 
adenosine, as suggested by Li et al, (1995). Glibenclamide is usually considered 
to be highly selective in its actions against KATP channels. However, Li et al., 
(1995) showed that 20µM glibenclamide blocked up to 70% of the adenosine- 
induced current in guinea-pig atrial cells but not the acetylcholine-induced 
current. In the same study adenosine was shown to activate two conductance 
levels in single channel recordings, only one of which was observed on 
application of acetylcholine. It was suggested that the additional openings 
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induced by adenosine were due to KATP channels. The concentration of 
glibenclamide used by Li et al was however much higher than usually needed to 
block KAT? channels. Why adenosine but not ACh should activate KATP is not 
clear but it may be noted that in cat atrial myocytes it was found that ACh was 
able to activate a glibenclamide sensitive current and this was attributed to 
opening of KATP channels (Wang and Lipsius 1995). In ventricular myocytes of 
the neonatal rat the application of adenosine and intracellular GTP had the same 
effect as GTP-y-S in restoring the KATP current blocked by intracellular ATP 
(Kirsch et al., 1990) suggesting that the ATP channels may be coupled to 
adenosine receptors via G-proteins. A recent study in rat ventricular cells has 
shown that adenosine activates KATP channels via protein kinase C activation 
since the adenosine response is reduced in the presence of specific PKC 
inhibitors (Koppel and Standen 1997). 
Although all these studies provide evidence for the activation of KATP 
channels by adenosine in cardiac myocytes, the interpretation of the action of 
glibenclamide still requires caution. Although low concentrations may produce 
a specific block of these channels, high concentrations - possibly even at 1- 
10µM - may exert other actions 
(Beech, 1997). 
In the present work, the response to adenosine was found to be blocked 
by glibenclamide with an IC50 of 24µM. However the results to be described in 
Chapter Five show that the levcromakalim-activated current is 66% blocked by 
glibenclamide at 1 µM, a much lower concentration. It has been reported that the 
block by glibenclamide of the KATP channel in cardiac myocytes occurs with an 
IC50 of between 5-20µM (Nichols and Lederer, 1991). As KATP is also thought 
to be activated by Ga-subunits (Kirsch et al., 1990, Ito et al., 1992) the presence 
of GTP-y-S in the patch pipette in the experiments summarized in Figure 3.3.6.4 
may have activated some KATP current which would have been expected to be 
blocked by 1 pM glibenclamide. Yet 1 pM glibenclamide blocked that current by 
only 12% and raising the concentration to 10µM increased the block to only 
--40%. Thus if there is any activation of IKATP by adenosine in these neonatal rat 
atrial myocytes it is rather small. 
THE G-PROTEIN-GATED CURRE \T 
100 
The actions of glibenclamide and other sulphonylureas result from 
binding at the SUR. Could there be a SUR associating with the KACh channel 
protein? My results show that glibenclamide blocks the adenosine current and 
the GTP-y-S current to the same degree so that receptor block is unlikely. The 
blocks of the peak current and steady state current phases are not significantly 
different and there is no evidence either for a use-dependent action of 
glibenclamide or for any voltage-dependent effect thus effectively arguing 
against a channel block (although it is possible that the lack of voltage- 
dependence may reflect binding of the molecule outside the electrical field of 
the membrane). It can also be speculated that the channels may not be the only 
target for the glibenclamide bound SUR and that this complex may interfere 
with the G- protein or its activation of the channel. The binding of the SUR to 
inward rectifier K+ channels other than the KATP channel is discussed further in 
Chapter Six. 
3.3.8.4.3: BLOCK OF THE ADENOSINE CURRENT BY BA2+. 
The known K+ channel blocker Ba 2+ blocked the adenosine current in a 
voltage- and concentration-dependent manner. The results in Figure 3.3.7.3 
show that Ba 2+ is more effective in blocking the current at -120mV than at - 
50mV; the IC50 value is 3.8µM at -120mV and 34.9µM at -50mV. This has also 
been observed in guinea-pig atrial cells where the block of the adenosine- 
induced current occurs with an IC50 of 125µM at OmV and 15.2µM at -80mV 
(Zang et al., 1995). Other studies have shown that the block of IKACh by Ba 2+ is 
dependent upon the membrane potential and on the K+ concentration bathing the 
cell. This evidence supports the notion that Ba2+ blocks the channel 
preferentially when it is in the open state (Zang et al., 1995). The dependence of 
the IC50 values on the membrane potential is thought to be due to Ba 
2+ binding 
to a site within the pore of the channel and within the electrical field of the 
membrane. The block is described in most studies as 1: 1 binding of Ba 
2+ to a 
binding site in the channel since in most studies the Hill coefficient for the 
inhibition curve is -I (Standen et al., 1978, Zang et al., 1995, Carmeliet and 
Mubagwa, 1996). The Hill coefficients in this study are significantly lower 
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being 0.6±0.14 for the block at -50mV and 0.5±0.13 at -120mV. The reason for 
the difference between the values in this study and published values remains 
unclear. A value of less than 1 may indicate that there are two components of 
the activated current which are blocked with different affinities. This is further 
discussed in Chapter Six. 
The voltage-dependence of the Ba2+ block of the current was compared 
with the effect of voltage on the block produced by the other compounds since 
Ba2+ is a well established open-channel blocker. Table 3.3.4 shows no voltage- 
dependence of the compounds investigated in this study. This does not 
completely rule out a voltage-dependent block as it may be possible that the 
molecules block in their uncharged form, or at the open channel outside the 
voltage field of the membrane. Alternatively this result could be explained by 
the fact that at relatively high concentrations of blocker used to investigate the 
effect of voltage there is already a substantial block and an increased block due 
to the voltage change may not be distinguishable. In retrospect it would have 
been informative to use a lower concentration (such as the IC50 value) to 
compare the block at the different potentials. Nevertheless the evidence from the 
effect of the blockers on the ratio of peak to steady state current does suggest a 
use-dependent effect. UCL1880 and UCL1495 may block the channel in their 
non-ionized form as has been shown in skeletal muscle and Helix neurons for 
the blocking actions of external 4-aminopyridine which increases with alkaline 
pH (Gillespie, 1977, Plant and Standen 1982). This has been explained by the 
increased proportion of the 4-AP in its uncharged lipid-soluble form as the pH 
approaches its pKa of 9.17. The pKa values for UCL 1880 and UCL 1495 have 
not yet been determined but are needed to provide information as to what 
percentage of the drugs are in their ionized or non-ionized forms at the pH 
tested in this study. 
The evidence thus far suggests that the actions of UCL1880 and 
UCL 1495 occur at the channel. To further confirm this the compounds were 
tested on two other inward rectifiers found in cardiac myocytes, IKl and IKATP. It 
would also be interesting to see if any specificity was displayed by any of the 
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compounds. In the following chapter, results of the action of UCL1880, 
UCL1495, glibenclamide and Ba 2+ on IK1 are presented. 
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CHAPTER FOUR: THE BACKGROUND INWARD 
RECTIFIER POTASSIUM CHANNEL IN NEONATAL RAT 
ATRIAL MYOCYTES. 
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CHAPTER FOUR: THE BACKGROUND INWARD RECTIFIER 
POTASSIUM CHANNEL IN NEONATAL RAT ATRIAL MYOCYTES. 
4.1: INTRODUCTION: 
Katz (1949) first described the classical inward rectifier, IK1 , 
in frog 
skeletal muscle. It is a `strong' rectifier with little outward current flow at 
potentials positive to EK. Its electrophysiological properties - such as more 
current flowing in the inward direction and the dependence of the kinetics of the 
channel on the extracellular K+ concentration - are such that IK1 has a role in 
maintaining the resting membrane potential and in regulating the action 
potential duration (in conjunction with voltage-gated K+ channels) thereby 
controlling electrical excitability. 
The IK1 channel has been described in many tissues and has been studied 
extensively in frog skeletal muscle (Standen & Stanfield 1978,1979), starfish 
egg (Hagiwara et al., 1978) and tunicate eggs (Ohmori et al., 1978). These 
channels have several characteristic features such as block by intracellular Mg 2+ 
and polyamines, as well as by extracellular Ba2+ and other cations. Removal of 
intracellular Mg2+ abolishes the rectification leading to ohmic conductance in 
isolated patches (Matsuda et al., 1987; Vandenberg 1987; Martin et al., 1995). 
The block by intracellular Mg 2+ shows the characteristics of open channel block 
such as interruptions of single channel events which increase with high 
concentrations of Mgt+, and voltage-dependence (Vandenberg, 1987). The 
rectification occurring at potentials positive to EK is thought to be due not only 
to Mg2+ but also to the voltage-dependent block by intracellular polyamines 
such as spermine and spermidine (Bechem et al., 1983; Matsuda et al., 1987; 
Shioya et al., 1993; Lopatin et al., 1994; Martin et al., 1995). As already 
discussed in Chapter 1, specific amino acid residues within the channel structure 
are now known to influence the extent of rectification (Faklar et al., 1994; Lu 
and Mackinnon, 1994; Pessia et al., 1995). 
The inwardly rectifying conductance (IK1)in cardiac myocytes is the 
dominant component of the resting conductance in ventricular (Ber Heler & 
Reuter 1970) and atrial tissue (Kurachi 1985). The inward rectifier helps to keep 
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the membrane potential close to EK during diastole and it ensures that at plateau 
potentials there is little outward current so that K+ efflux is reduced during this 
phase of the action potential. The reduction in K+ conductance helps to maintain 
the plateau which is important for Ca 2+ entry and consequently the pumping 
action of the heart. Repolarisation eventually occurs due to activation of the 
delayed rectifier current and inactivation of Ca2+ current. As repolarisation 
proceeds, the current through IK1 increases which accelerates the return to the 
diastolic potential. 
Thus the IK1 channel plays a role in determining the shape of the 
cardiac action potential by: 
(1) setting the diastolic membrane potential 
(2) maintaining the plateau phase 
(3) contributing to rapid repolarisation 
4.2: Aims: 
The aim of the work described in this chapter was to investigate the 
actions of UCL1880, UCL1495, glibenclamide and Ba2+ on the background 
current in rat atrial myocytes for subsequent comparison with their actions on 
the G-protein coupled potassium channel and the levcromakalim-activated 
potassium channel. Ba 2+ was tested for comparative purposes as it is a well- 
characterised blocker of the channel. 
4.3: RESULTS 
4.3.1: THE IK1 CURRENT 
The current through IK1 channels was activated in response to voltage 
steps from a holding potential of -50mV to between -120mV and OmV in 
+IOmV increments. Each voltage step lasted 500ms. Full steady state current- 
voltage relationships were plotted to demonstrate the inwardly rectifying nature 
of these currents. Figure 4.3.1.1. A shows a representative whole cell voltage 
clamp experiment. Depolarising steps positive to -40mV resulted in an inward 
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Figure 4.3.1.1. A shows the current traces in response to voltage steps 
between -12OmV and OmV, in +l OmV increments from a holding potential of 
-50mV. Each step lasted 500ms. The arrow on the left indicates the zero 
current level. The voltage protocol is also shown. B displays the current 
-voltage relationship for the same cell, plotted from the currents observed 
just before the end of the step. 
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calcium current which is reported to be blocked by cadmium, a Ca2+ channel 
blocker, in human atrial cells (Sato et al., 1994). This current has also been seen 
in tricuspid valve cells in rabbit heart where it is blocked by cobalt (Anumonwo 
et al., 1990). Returning to the holding potential of -50mV from potentials 
negative to -70mV resulted in the activation of sodium transients. Such 
transients have been observed in tricuspid valve cells and are sensitive to TTX 
(Anumonwo et al., 1990). Figure 4.3.1.1 B shows the corresponding current- 
voltage relationship from this cell which displays inward rectification though 
this is partially obscured by the activation of the Ca2+ current at increasingly 
positive potentials. 
Figure 4.3.1.2A shows another example of a current trace from a different 
cell. Comparison with the records in Figure 4.3.1.1 reveals a difference between 
the currents activated at -120mV. In Figure 4.3.1.1 A the inward current in 
response to a voltage step to -120mV shows a decay whereas in Figure 4.3.1.2 
A the current increases during the voltage step. The two different types of 
hyperpolarization- activated current have been described in the literature. At 
hyperpolarizing potentials in cardiac tissue IK1 is activated as well as If current 
which is selective for Na' and K+ and is termed the pacemaker current 
(DiFrancesco et al., 1984, Tourneur et al., 1987, Thuringer et al., 1992). IKI 
decreases with time and this is thought to be due to block by extracellular Na+. If 
increases with time after activation and is modulated by a cAMP dependent, 
phosphorylation-independent pathway and possibly directly by intracellular 
Ca 2+ (see DiFrancesco 1993 for a review). If channels open at negative 
potentials , close at positive potentials and are 
blocked by Cs+ and Rb+ ions 
(Hille 1991). 
The current at -120mV in Figure 4.3.1.1 A decreases with time and is 
therefore mainly Ikl whereas the current shown in Figure 4.3.1.2A increases 
with time and is most likely a mixture of IK1 and If.. In the atrial cells used in 
this investigation the majority of currents observed were predominantly lKI. 
Figure 4.3.1.2 B shows the current-voltage relationship for all of the 
current traces displayed in 4.3.1.2. A. A substantial amount of inward current is 
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Figure 4.3.1.2. A shows current traces in response to voltage steps between 
-12OmV and OmV. Steps were 500ms in duration and were applied in +l OmV 
increments. The arrow on the left indicates the zero current level. B illustrates 
the I-V plot for the steady state current in A. The voltage protocol is shown in the 
inset. 
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observed at potentials negative to EK and the current displays rectification. In 
this case there is no inward current switching on at depolarising potentials. 
Figure 4.3.1.3 shows a current-voltage relationship composed of data 
averaged from five cells. The reversal potential is quite close to the calculated 
EK of -94mV and the current-voltage plot displays inward rectification. In this 
averaged response there is an inward current at potentials positive to -40mV, 
thought to be due to a calcium current switching on at depolarising potentials. 
For the main part of the investigation the actions of the drugs were studied 
at a potential of -120mV. Cells were held at -50mV and stepped to -120mV for 
1 second. In the following section the characteristics of the current activated at - 
120mV are considered. 
Figure 4.3.1.4 shows sample traces, recorded from two different cells, of 
the current activated at -120 mV alone. Note that the currents are shown on an 
expanded vertical scale to those in Figures 4.3.1.1 and 4.3.1.2. A shows an 
almost instantaneous increase in inward current which arises due to the change 
in the driving force on stepping to -120mV and to the rapid reversal of block by 
internal Mgt+. The time constant for Mg2+ dissociation from the channel has 
been estimated to be between 0.1 and l Oms in Kir2.1 clones (Kubo et al., 1993, 
Ruppersberg et al., 1996). There is also a very small amount of decay 
throughout the rest of the current pulse. 
In B the initial inward current is seen to decay (the capacity transient does 
not materially affect the initial decay seen) and on returning to the holding 
potential of -50mV there is a small outward current which decays within 10-20 
milliseconds. This may be due to a reduction in the block of the channel by 
intracellular Mg2+ at the hyperpolarised potentials which is then re-established 
on returning to -50mV (Kelly et al., 1992). 
The decay seen in B is typical of the background IK1 current seen at 
potentials negative to EK in many different tissues (Biermens et al., 1987; 
Harvey and Ten Eick 1989; Kelley et al., 1992; Dominique-Ashen et al., 1995) 
and is attributed to external block by monovalent cations, in particular Na'. It 
has been shown that the removal of Na' from the external solution reduces this 
decay and that this Nat-dependent inactivation is voltage-dependent, becoming 
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Figure 4.3.1.3: Current-voltage relatiänship for the background 
inwardly rectifying potassium channel in rat atrial myocytes. Data 
are averages from -5 cells. 
Cells were held at -50mV and stepped 
from between -120 and OmV in +10mV increments. Each step lasted 
1 second. Currents were measured towards the end of the 1 second 
pulse. 
THE BACKGROUND CURRENT 
111 
A 
-lw 
IOOpA 
JJ-_. 
I second 
B 
lOOpA 
Figure 4.3.1.4: Two examples of the current activated at -120mV from a holding 
potential of -50mV. Traces are from different atrial myocytes. Each example is an 
average of 10 traces. The steps were applied when the cell was bathed with Krebs 
solution. The time scale is the same in each example. Each step was 1 second in 
duration. 
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more marked at potentials negative to - -120mV (Ohmori, 1978; Biermans et 
al., 1987; Harvey & Ten Eick, 1989; Kelley et al., 1992; Voets et al., 1996). 
4.3.2: THE EFFECTS OF UCL 1880, UCL 1495, GLIBENCLAMIDE AND 
BA2+ ON THE IK1 CURRENT. 
The possible blocking actions of the drugs were investigated by 
examining their effects on the current at -120mV i. e. at a potential at which a 
measurable amount of current could be observed. Currents were measured 
toward the end of a1 second pulse at the steady state level first under control 
conditions and then after 4 minute exposure of the cell to the drugs. Full dose - 
response curves were not constructed, rather the concentrations that had been 
found effective against the G-protein-gated current were used for comparison. 
Ba2+ was employed as a control as it is a known blocker of IK1 currents in a 
variety of tissues including cardiac tissue (DiFrancesco et al., 1984; Sakmaan & 
Trube, 1984; Tourneur et al., 1987; Imoto et al., 1987). A full dose response 
curve was constructed for Ba 2+ and some further studies were carried out in 
order to investigate the characteristics of Ba 2+ block (see section 4.3.3). 
Initially 2µM UCL1880 was tested against the background current and in 
11 cells tested there was no block (3 ± 8%). This concentration reduced the 
response to adenosine by -90% (Chapter 3). Increasing the concentration of 
UCL 1880 to 10 µM resulted in a block of 22 ± 11 % (n=11). Figure 4.3.2.1 
shows the effect of 10µM UCL1880 and of 10µM Bat+on the background 
current. A shows the control current which displays a small amount of decay 
after the initial inward current. B shows the effect of Bat+. It can be seen that 
Ba2+ had only a small effect on the instantaneous inward current. Subsequently 
the current declines within 50ms to approximately 60% of the control steady 
state level. C shows the effect of 10µM UCL1880. The block observed is 
different from the Ba2+ block in that the total inward current has been reduced 
t+ 
and there is no evidence of a subsequent decay, as observed with Ba. 
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Figure 4.3.2.1: The effect of 10µM Ba 2and 10µM UCL 1880 on the 
background inward rectifier current in a neonatal rat atrial myocyte. 
The current is shown under control condition, A, after 4 minute 
incubation with 10µM barium, B, and after 4 minute incubation with 
10µM UCL 1880, C. Trace C was taken -5 minutes after Trace B. The 
effect of Ba21 was readily reversible. In this experiment the block caused 
by UCLI880 was larger than usual. The cell was stepped down to -120mV 
for I second from a holding potential of -50mV. All drugs were bath 
applied. The scale bars for B and C are as in A. 
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Figure 4.3.2.2 shows the effect of 20µM glibenclamide on the background 
current. This concentration was chosen to be close to the IC50 value determined 
for the block of the G-protein-gated current in Chapter 3. The currents in control 
conditions and in the presence of glibenclamide have been superimposed and 
there was no significant effect on the resting current. In this example any decay 
is so small and fast that the capacity transient masks it. 20µM glibenclamide 
caused a block of 12 ± 13% (n=5). Increasing the concentration of 
glibenclamide to 50gM resulted in a block of 13 ± 8% (n = 4). Figure 4.3.2.2B 
shows the effect of 50µM glibenclamide and again the currents in control 
conditions and in the presence of glibenclamide have been superimposed. Here 
the steady state inward current at -120mV has been blocked by approximately 
30%. In this example there is also an outward current present on returning to the 
holding potential which has been reduced in the presence of glibenclamide. The 
tail currents were not studied in detail. 
2µM UCL1495 was tested on the background current using a different 
protocol. A step down to -120mV was followed by a voltage ramp to OmV, over 
2s. Figure 4.3.2.3 shows the first 750ms of the resulting current in response to 
the initial step down to -120mV. UCL1495 did not cause a significant block (5 
± 13%, n= 5). Figure 4.3.2.4 A shows the full current-voltage relationship for 
the current in the absence and presence of 2µM UCL1495 for the same cell. The 
current in response to the voltage ramp is inwardly rectifying and there is no 
block by UCL 1495. However UCL 1495 is effective against the adenosine 
current in the same cell as shown in Figure 4.3.2.4B: this current is blocked by 
65% at -50mV. This result shows clearly the selective action of UCL1495 
against the G-protein gated current. 
The effect of voltage on the block of the background current was also 
investigated. Figure 4.3.2.5 shows current-voltage relationships in the absence 
and presence of drugs. A shows the lack of effect of 2µM UCL1880 at any 
voltage. B is from a different cell and it can be seen that 2µM UCL1495 and 
20µM glibenclamide did not have a great effect on the current at -120mV or at 
any other voltage. In contrast, it can be seen that I00MM Ba2+ blocked the 
current at potentials both negative and positive to EK. Since these drugs had no 
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Figure 4.3.2.2: A shows the effect of 20µM glibenclamide on the 
background current at -120mV. B shows the effect of 50µM 
glibenclamide on a different cell. Traces are averages of 10. Each 
step is 1 second in duration. Arrows on the leß indicate the zero 
current level. Glibenclamide was bath applied for 4 minutes. Cells 
were held at -50mV. 
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Figure 4.3.2.3: A The current in response to a voltage ramp as 
indicated inset. This is under control conditions. The cell was 
held at -50mV and stepped to -120mV for 250msecs. The whole of 
the trace is not shown here. B The effect of 2pM UCL1495. The cell 
was bathed in UCL1495 for 4 minutes before the voltage protocol 
was applied. 
THE BA CKGRO UND CURRENT 
117 
A 
-1. 
cor 
B. 
0 
-1 
0 
2 jM UC 
0 
0 
Q 
Figure 4.3.2.4: Current-voltage (IV) relationships showing the effect of 
2pM UCL1495 on A, the background current and B, adenosine-induced 
current after subtracting the background current. Data are from the same 
cell which was held at -50mV and ramped from between -120 and 0 mV. 
Cells were incubated in UCL 1495 for 4 minutes prior to ramping. All dnigs 
were bath applied. 
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Figure 4.3.2.5 : A; Current-voltage relationship for the background current 
in rat atrial myocytes. Cells were held at -50mV and stepped from between _ 
-120mV and OmV in +IOmV increments for 1 second duration. This was 
done for control (--  --) and after 4 minutes incubation in 2µM UCL1880 (-" -- ). 
B; data from a different cell showing the I-V plots for control, ( - -) and 
in the presence of 2µM UCL1495, (. ) 20µM glibenclamide (--"-) and 
100µM barium (--"-). 
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effect at -120mV it is not surprising that there was no effect at any other 
voltage. The voltage-dependent effect of Bat- is described in the following 
section. 
The current present at the holding potential of -50mV was measured in control 
conditions and in the presence of drugs. The results from these experiments are 
summarised and compared with the block at -120mV in Table 4.3.1. There is 
hardly any block at either -120mV or -50mV. 
COMPOUND -120mV -50mV 
UCL 1880 
2µM 3±8 -2±11 
10µM 22±11 -18±12 
GLIBENCLAMIDE 
20µM 12±13 10±11 
50µM 13±8 -16±4 
UCL1495 
2µM 5±13 12±24 
Table 4.3.1 The effect of voltage on the blocking action of the compounds on 
the background inward rectifier. Inhibitions were calculated at -120mV and - 
50mV. 
A full dose response curve was constructed only for Ba2+ and is shown in 
Figure 4.3.2.6 together with the results from the above studies. The Ba2+ data 
were fitted with the Hill equation which, on constraining the maximum 
inhibition to 100%, gave an IC50 value of 16.8±13µM and a Hill slope of 0.28 ± 
0.10. 
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Figure 4.3.2.6: Log concentration-response curve for the effect of 
barium ( squares ), UCL 1880 (circles ), glibenclamide (triangles ) 
and UCL1495 (diamonds) on the background current in neonatal 
rat atrial myocytes. A full relationship was constructed for barium 
only giving an ICs0 value of 16.8µM. Inhibitions were calculated 
at -120m V. 
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4.3.3: FURTHER INVESTIGATION OF THE BA 2+ BLOCK OF THE IK1 
CURRENT. 
The action of Ba2+ on the background inward rectifier potassium channel 
has been widely examined in many tissues including the heart (Isenberg et al., 
1976, Hiraoka et al., 1980) starfish egg (Hagiwara et al., 1976,1978) tunicate 
egg (Ohmori et al., 1978) and skeletal muscle (Standen & Stanfield, 1978). Ba 2+ 
has been shown to block the current in a time- and voltage-dependent manner 
(DiFrancesco et al., 1984; Tourneur et al., 1987; Imoto et al., 1987) and at low 
concentrations of Ba 2+ (5 - 50µM) the voltage- and time-dependent block is 
clear. At higher concentrations of Ba 2+ the block is too fast for the time 
dependent nature to be obvious (Ishihara & Hiraoka, 1994). 
Experiments were carried out to investigate the nature of the block of the 
IK1 current in rat atrial myocytes by Bat+. Figure 4.3.3.1 shows the effect of 
3 gM Ba2+ on the background current. The current traces are in response to 10 
hyperpolarising voltage steps to -120mV from a holding potential of -50mV. 
Each step was 1 second in duration and the steps were separated by 1 second. 
The top trace, A, shows control currents and it can be seen that there is decay 
throughout the duration of the pulse. Figure 4.3.3.1B shows the onset of the 
Ba2+ effect. The current traces are in response to 10 steps which were applied on 
immediately switching to the Ba 2+ solution. The effect comes on at the sixth 
step and the current in each step thereafter decays more than in the control. C 
shows the currents after a 4-minute incubation period and it can be observed 
that a steady state has been reached which is at a lower level than in the control 
traces. 
Figure 4.3.3.2 shows the averages of traces taken from Figure 4.3.3.1 A 
and C. In the control there is observed an initial decay which occurs within a 
few milliseconds and subsequently the current remains quite steady for the 
remainder of the pulse duration. In the presence of 3µM Ba2+ the current decays 
to a new lower level and thereafter declines only slightly. Note that the outward 
holding current has also decreased in the presence of Bat+. 
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Figure 4.3.3.1: The effect of barium on the background IKl current in neonatal rat 
atrial myocytes. A shows 10 control steps. B shows the onset of 3µM barium 
block which begins on the sixth pulse; C shows the block after 4 minutes. Cells 
were held at -50mV and stepped down to -120mV for 1 second . 
Steps were 
separated by I second. Barium was bath applied. PA Ck, ý, , v, 
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Figure 4.3.3.2: The effect of 3µM Ba`+. The cell were held at -50mV and 
a voltage step was applied to -120mV. The traces above are the average 
from 10 such steps, under control conditions and in the presence of 3µM 
barium The barium was bath applied and the cell was exposed for 4 minutes. 
The arrow on the left indicates the zero current level. 
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Figure 4.3.3.3 shows the same averaged recordings on an expanded time 
scale. The initial inward current - prior to decay - is at the same level in control 
conditions and in the presence of Bat+. The Ba2+ causes inhibition only after the 
current begins to flow. As most of this current is mainly a consequence of the 
reversal of the blocking action of Mg2+ and polyamines, (since there is 
significant outward current at -50mV so many channels are unblocked and 
contribute immediately to the ohmic current at -120mV) it may be concluded 
that Ba2+ blocks the newly opened, unblocked, channels. 
The increase in decay seen with Ba2+ is observed with low concentrations 
of Ba 2+ whereas at high concentrations the effects of Ba 2+ are so fast as to be 
unresolvable with the techniques used. Figure 4.3.3.4 shows the effect of 
100µM Ba 2+ on the current at -120mV. In this particular cell the control current 
declines slowly to a lower level during the pulse. This may be attributable to 
block by extracellular Na+. 100µM Ba2+ causes the current decay to become very 
fast and to reach a lower level. There is also a reduction in the outward holding 
current. 
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Figure 4.3.3.3: Parts of the current traces shown in Figure 4.3.3.2 but on an 
expanded scale This shows the control current decay and the effect of 3µM 
barium. The traces are averages of 10 and are in response to voltage steps 
to -120mV from a holding potential of -50mV. 
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Figure 4.3.3.4: The effect of a high concentration of barium on the 
background current. The control current shows a decay to a steady 
state level. 100µM barium reduces the steady state level and also seems 
to increase the initial decay. Cells were held at -50mV and 10 voltage 
steps to -120mV applied- of 1 second duration. The averages of these 10 
traces are displayed. The barium was bath applied for 4 minutes. The arrow 
on the left of the trace indicates the zero current level. 
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4.4: DISCUSSION. 
4.4.1: THE IK1 CURRENT. 
The results that have been presented confirm the presence in neonatal rat 
atrial myocytes of a conductance which displays strong inward rectification. It 
is possible, however, that other background currents may be present, such as If, 
TWIK1 or some basal G-protein-activated current (Ito eta!., 1991). The lack of 
effect of UCL1880 suggests that there is little contribution of IKACh. 
IK1 was activated by stepping down to -120mV from a holding potential of 
-50mV for 1 second. The inward current observed arises as a result of the 
change in driving force on K+ at -120mV and the rapid reversal of channel block 
by Mg 2+ and polyamines. The current, once established, decayed to a variable 
extent. The activation of the current and its subsequent decay has been 
discussed in detail in Chapter 1. 
4.4.2.: THE EFFECT OF DRUGS ON IKI. 
4.4.2.1: THE EFFECT OF UCL 1880, UCL1495 AND GLIBENCLAMIDE ON 
II( 
Application of UCL1880, UCL1495 and glibenclamide produced little 
block of IK1 at -120mV. The concentration of UCL1880 used - 2µM - was 
effective in blocking the G-protein gated current as described in Chapter 3. It 
can be seen from Table 4.3.1 that at 2µM UCL1880 produces no significant 
effect at -120mV and even 10µM UCL1880 results in block of only - 20%. For 
the purposes of this study, the main and important point is that at the 
concentrations effective on the G-protein-gated current there is no block of the 
IK, current by UCL1880. 
UCL 1495 was tested at 2µM. This concentration, which caused 
approximately 90% block of the G-protein-gated current, caused little (5%) 
block of IK1at -120mV. Nor was there evidence 
for any significant block of Ihl 
at -120mV by either 
20µM or 50µM glibenclamide. 
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The overall conclusion is that the concentrations of UCL1880, UCL1495 
and glibenclamide which are effective in blocking the G-protein-gated current 
(Chapter 3) did not inhibit the background'K1. 
The effects of the drugs on the holding current were also examined but the 
difficulty here was that the current flowing at -5OmV was no greater than l OpA 
and varied considerably from cell to cell. Any blocking action was therefore 
difficult to evaluate. It is presumed that much of the holding current at -50mV 
flows through IK1 channels though, as noted earlier, their may be some basal 
activity of the G-protein-gated current (Ito et al., 1991). If there was a 
significant portion of the holding current due to basal G-protein activity then 
some block by the drugs at the concentrations tested would have been expected, 
as these were effective in blocking the adenosine-activated current as described 
in Chapter 3. However, the holding current at -50mV was too small and variable 
to allow this to be evaluated with any degree of certainty. 
The effects of glibenclamide are thought to occur by its interaction with 
the sulphonylurea receptor thus if the SUR was to combine with the IK1 
channels then block by glibenclamide might be possible. The lack of effect of 
glibenclamide on the IK1 channels indicated that there is little or no association 
of the SUR with IK, channels. This is discussed further in Chapter 6. 
4.4.2.2: THE BLOCK OF IK1 BY BA2+. 
The block of the current by Bat' was as expected. The decay observed in 
the control currents increased in the presence of Bat+. Ba 2+ is known to block 
the open channels in a voltage-dependent manner, which is in keeping with the 
observed voltage-dependence in the present study. Any block of the current at - 
50mV was difficult to measure as previously explained so that a complete 
concentration-response curve was not determined. 300µM Ba 
2-+ caused a block 
of 60 ± 10% at -50mV and a somewhat greater block of 77 ± 12% at -120mV. 
It has been reported that the block by Ba 2+ is reduced when the external 
[K+] is increased (DiFrancesco el al., 1984). This suggests that Bat- and K~ 
compete for the same site within the channel which is in keeping with the 
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evidence that Ba 2+ blocks the open channels. The potential-dependence of the 
block is a consequence of the blocking site residing within the voltage gradient 
across the cell membrane. The Ba 2+ is attracted by the electrical field of the 
membrane into the channels where it binds. This resembles Hy block of Na+ 
currents in frog nodes of Ranvier (Woodhull et al., 1973). 
The decay occurring during the control hyperpolarising pulse may be a 
result of an intrinsic decay and/or a block by extracellular cations such as Na'. 
The results show that Bat+increases the rate of decay. The block by Ba 2+ is time- 
dependent in rabbit Purkinje fibres and frog skeletal muscle (Carmeliet and 
Mubagwa, 1986, Standen and Stanfield, 1978). Ba 2+ has been shown to cause a 
block of the open channels in guinea-pig heart cells decreasing the mean open 
time (Sakmann and Trube 1984) without an effect on the current amplitude. 
Single channel studies show that the Ba2+ block is voltage-dependent being 
greater at negative potentials (Bechem ei al., 1983). 
The log concentration-response curve for the findings with Ba2+ provided 
an estimate for the IC50 value which at 16% µM, although in the low gM range 
and not at all precise, was not as low as other reported values such as 2.2µM at - 
125mV in bovine pulmonary artery endothelial cells (Voets ei al., 1997), 12µM 
at -65mV in skeletal muscle (Standen and Stanfield, 1978) and 1.3µM at - 
120mV in Purkinje fibres (Carmeliet and Mubagwa, 1986). Also it was noted 
that the log concentration-response curve was flat with a low nH value of 0.28. It 
is possible then that there are two components of the background current, one 
having a greater susceptibility to block by Ba 2} than the other. It is conceivable 
that If contributes to the background current observed. In addition there may be 
some basal G-protein turnover which would also affect the results. However 
UCL 1880, which was observed to be potent (IC50 of 0.18. M)on the G-protein- 
activated current in Chapter 3, at 2µM did not block the background current, 
thus ruling out a significant contribution of this current to the background 
current. Another current which may also contribute to the background current 
investigated is TWIKI, a weak inward rectifier which is blocked by Ba 2+ with an 
IC50 of 100µM (Chapter 1, section 1.5.2). 
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To summarise, this study of the IK1 current has shown that the compounds 
which are effective against the G-protein-gated current have a minimal blocking 
action on the IK1 current and therefore exhibit a considerable degree of 
selectivity in this regard. The results also indicate that the Ba 2+ block of Ixl 
channel is similar to that reported in other cell types and species. This suggests 
that though the background current investigated might be composed of more 
than one component, the major contributor is Ixl. 
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CHAPTER FIVE: THE LEVCROMAKALIM-INDUCED 
POTASSIUM CURRENT IN NEONATAL RAT VENTRICULAR 
MYOCYTES. 
5.1: INTRODUCTION 
A reduction in the action potential duration and the associated increase 
in the whole cell outward current due to metabolic inhibition in cardiac tissue 
has been the focus of much research in the last few years (Sanguinetti et al., 
1988; Findlay, 1989,1993; Wilde et al., 1990; Nakaya et al., 1991; de Lorenzi et 
al., 1994). These characteristics have been attributed to the opening of KATP 
channels which were first investigated at the single channel level in cardiac 
tissue by Noma (1983). The conductance of the channel in cardiac myocytes in 
symmetrical 140mM K+ is 70 -90pS (Noma, 1983, Horie et al., 1987, Terzic et 
al., 1995). This channel has also been found in other tissues including 
pancreatic ß-cells, skeletal muscle, smooth muscle, renal tubule cells, and some 
central nervous system neurons. The single channel conductance shows 
variation, for example in skeletal muscle the conductance is between 40 and 
60pS and in pancreatic ß-cells it is between 50 and 75pS (Davies et al., 1991, 
Terzic et al., 1995, Isomoto et al., 1997). KATP channels are weak inward 
rectifiers (for review and additional references see Nichols and Lopatin 1995, 
Doupnik et al., 1995, and Introduction). 
Subsequent work in cardiac tissue has demonstrated channel opening in 
response to potassium channel openers (KCOs) such as cromakalim, an 
experimental antihypertensive agent which is active in the µM range 
(Sanguinetti et al., 1988; Escande et al., 1988; Osterrieder et al., 1988; Findlay 
et al., 1989) and levcromakalim which is the active enantiomer of cromakalim 
and has an IC50 of 1.9µM in guinea-pig papillary muscles (Findlay et al., 1989). 
The current activated by KCOs can be blocked by sulphonylureas such as 
tolbutamide (Findlay et al., 1989) and glibenclamide which at low 
concentrations are generally considered to be highly selective for IKA&r 
(Sanguinetti et al., 1988). Tolbutamide is - 50 times less potent in the heart than 
in ß-cells with an IC50 for block of whole cell KATP current of 7µM in ß-cells 
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and 400µM in cardiac cells (Belles et al., 1987). Glibenclamide blocks the atrial 
channel with an IC50 of 5-20µM whereas in pancreatic ß-cells the IC50 is 4- 
50nM (Zunkler et al., 1988a, b). 
The exact nature of the KATP in smooth muscle has been complicated by 
the possibility of there being two different types of channel. In some studies on 
smooth muscle cells it was observed that the channels activated by metabolic 
inhibition with cyanide and those activated by KCOs such as pinacidil had 
similar single channel characteristics and were blocked to the same extent by 
glibenclamide (Zhang and Bolton, 1995, Teramoto and Brading, 1996). In 
contrast, however, some studies have suggested that the channels activated by 
KCOs are not the same as those activated by metabolic inhibition. It has been 
suggested that there are two types of channels, one of which is the KATP channel 
recognised in other tissues and the other a channel which is regulated by 
intracellular nucleoside diphosphates and is the target for KCOs (KAP) (Beech 
et al., 1993b, Zhang & Bolton, 1996). This argument stems from the difference 
in sensitivity to sulphonylurea block of the current activated either by KCOs or 
by metabolic inhibition and this has been observed mainly for the KATP in some 
studies on smooth muscle cells (Beech et al., 1993b). 
KNDP is not thought to exist in the heart. However it was observed in rat 
ventricular myocytes that activation of the current by rilmakalim was blocked 
by glibenclamide with an IC50 of 8nM whereas block of the current induced by 
metabolic inhibition with 2-deoxy-D-glucose occurred with an IC50 of 480nM 
(Krause et al.., 1995). It has been proposed that the increase in [ADP]; or the 
decrease in [ATP]; during ischaemia and hypoxia (Venkatesh et al., 1991) 
affects the sensitivity of the current to sulponylurea block (Findlay 1993). 
5.2: Aims 
The KATP channels investigated in cardiac myocytes were activated by 
the KCO levcromakalim. The drugs which had been tested on the G protein- 
gated current (Chapter 3) and the background inwardly rectifying current 
(Chapter 4) were also tested on the current activated by levcromakalim. The 
results were to be compared with those from the other two chapters in order to 
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assess the selectivity of the blocking compounds between the three different 
inward rectifiers. It was also hoped that the results would prove useful in 
determining whether the activation of IKACh by adenosine includes a component 
of IKATP (Kirsch et al.,, 1990 Li et al., 1995, and Chapter 3). 
5.3: RESULTS: 
5.3.1: THE LEVCROMAKALIM-INDUCED CURRENT. 
In all experiments ATP was omitted from the internal pipette solution to 
avoid any inhibition of the current activated by the opener. This proved 
effective in allowing the cells to respond to levcromakalim; channel run down 
was not normally a problem. 
Initialy it was the aim to investigate IKATP in atrial myocytes. However, 
the application of 10µM levcromakalim did not activate an outward current in 
these cells (though one sometimes developed spontaneously - see section 5.3.3). 
It has been observed that the KCOs pinacidil and levcromakalim activate an 
outward current in rabbit ventricular myocytes but have no effect in rabbit atrial 
myocytes whereas in both guinea-pig atrial and ventricular myocytes the KCOs 
were effective (Ogbaghebriel & Shrier, 1995). This would suggest a tissue (and 
species) difference in response to KCOs and possibly also a differential 
distribution of KATP channels. Experiments were accordingly made on 
ventricular cells which were isolated from 1 day old rats adopting the procedure 
used in the isolation of atrial myocytes. 
It has already been found that the KCOs are effective within the µM 
range on cardiac tissue (Sanguinetti et al., 1988, Findlay et al., 1989, Krause et 
al., 1995). Accordingly, 10µM levcromakalim was initially applied in an 
attempt to activate the current. This concentration did not give a consistent 
activation. In 7 out of 20 cells tested, the current activated was 100 ± 23 pA in 
amplitude; the remaining cells did not respond. I µM glibenclamide blocked the 
current activated by 10µM levcromakalim by 81±11% (n=7) and 2µM 
UCL 1880 blocked the current by 40±12%. 
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Increasing the concentration of levcromakalim to 50µM resulted in the 
consistent activation of an outward current of 196 ± 27pA amplitude (n=46). 
Figure 5.3.1.1 shows a representative trace of this response. The current was 
activated after a short delay of approximately 5-10 seconds in this particular 
cell, which is most probably due to the time taken for the drug solution to reach 
the cell. However it should be noted that activation of this current has been 
observed to occur after a delay (Sanguinetti et al., 1988, Krause et al., 1995) 
and in some of the ventricular cells tested the current activation was delayed by 
up to 1 minute. Rarely, it took up to 5 minutes for the current to be activated and 
if current activation was not observed after 5 minutes the cell was discarded. 
For the cell shown in Figure 5.3.1.1 the current rises quickly and reaches 
-70% of the peak current within 10 seconds. It is well maintained throughout 
the levcromakalim application. The subsequent application of 1 pM 
glibenclamide in the continued presence of levcromakalim resulted in an almost 
immediate reduction in the outward current. The recovery from the block also 
began fairly quickly, within 20-30 seconds. The delay is most probaby due to 
slow washout of the rather high concentration of glibenclamide that has been 
applied. In this example the current did not return to the level recorded prior to 
application of levcromakalim and this may be an instance where run down of 
the levcromakalim-induced current occurred. 
Figure 5.3.1.2 shows the current -voltage relationship from the cell 
illustrated in Figure 5.3.1.1. It can be observed that the current in the presence 
of 50µM levcromakalim has increased in both the inward and outward 
directions and the subtracted levcromakalim-induced current is very weakly 
rectifying. The reversal potential is close to the estimated equilibrium potential 
for K+ set in these cells (-94mV) so that it can be concluded that the current is 
carried by K'. 
Because the current activated in the rat ventricular myocytes by 
50µM levcromakalim was K+ selective, displayed weak inward rectification, 
and was blocked by the sulphonylurea glibenclamide, it can be presumed to be 
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v m 
Figure 5.3. l. 2. The current -voltage relationship of a rat ventricular myocyte. The background 
current displaying inward rectification (-"-) is shown with the current in the presence of 50µM 
levcromakalim (-"-). The subtracted current displays weak inward rectification (-A-). The cell 
was held at approximateley -50mV and voltage and stepped from between approximateley 
-120mV and +50mV in +IOmV increments. The levcromakalim was bath applied. 
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5.3.2: THE EFFECTS OF UCL1880, uCL1495, GLIBENCLAMIDE AND 
BARIUM ON IKAIP. 
The effects of the drugs tested on IKACh and IK1 were examined on the 
IKATP. Drugs were bath applied in the presence of levcromakalim and cells were 
bathed in drug solutions for a period of 4 minutes. This is consistent with the 
incubation time used for testing the compounds on the IKACh and the Ixl. 
Initially the drugs were applied at those concentrations that were 
effective in blocking IIACh. Glibenclamide was used as a control blocking agent 
and to confirm that KATP channels were involved in the response. 
UCL 1880 
Figure 5.3.2.1 shows the whole-cell current response from a ventricular 
cell held at -50mV. Application of levcromakalim resulted in the activation of 
an outward current which after reaching a steady state level was shown to be 
reduced in the presence of I iM glibenclamide, the effect of which was 
reversible. The subsequent application of 10µM UCL1880 also resulted in the 
block of the current and this effect was quick in onset. Washout of this 
concentration of UCL 1880 did not result in recovery of the IKATP even after 15 
minutes. 
2µM UCL1880 was also tested and the resulting block was not as great 
as for 10µM UCL1880 (see Table 5.3.1). After washout of the 2µM UCL1880 
the current recovered slowly over a period of 10-15 minutes. In most cases it 
was found that the current did not regain the pre-UCL1880 level. This could be 
due either to run down of the whole cell current or to the slowness of the offset 
of the action of UCL1880. 
UCL1-/95 
Figure 5.3.2.2 shows the outward current from a cell which was exposed 
to two concentrations of UCL1495 in the presence of levcromakalim. An 
outward current came on in response to levcromakalim after 30-40 seconds but, 
unlike the current in Figure 5.3.2.1, the outward current in this cell did not 
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have a peak but instead gradually increased. Application of 2µM UCL1495 did 
not result in any block and in fact the current continues to rise. In this cell the 
application of 10µM UCL1495 scarcely affected the current. The subsequent 
application of I gM glibenclamide inhibited it by - 60%. 
Figure 5.3.2.3 shows the whole-cell current from a different cell in 
which 10µM UCL1495 was tested. The outward current came on in response to 
the application of levcromakalim after a delay of 30-40 seconds and the current 
increased rapidly over a period of 1 minute and then more slowly. The 
application of 10µM UCL1495 decreased the current at first after which the 
outward current began to increase again in the continuing presence of 
UCL 1495. After the UCL 1495 was washed out the outward current rose sharply 
(presumably as the effect of UCL1495 reversed). The subsequent application of 
glibenclamide blocked the current thus confirming that it was IKATP and that 
drug solutions were reaching the cell. The results of all the experiments with 
UCL1495 have been included in Table 5.3.1. 
BARIUM 
Ba 2+ was also tested on this current as shown in Figure 5.3.2.4.300gM 
barium can be seen to cause almost complete block. Also shown are the effect 
of 1µM glibenclamide and 10µM UCL1880. Both blocked the current at all 
potentials. 
The log concentration-response curve for the action of Ba2+ is shown in 
Figure 5.3.2.5 together with the results for the other compounds tested. The Hill 
equation was fitted to the data for Ba 
2+ block giving an estimate for the IC50 of 
165 ± 14µM. 
C1; TIEDIL 
Cetiedil was also tested against this current and it can be seen from 
Figure 5.3.2.5 that cetiedil is about 2 times less potent than UCL1880 with an 
IC; o of --- 10µM. 
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Figure 5.3.2.4: The current-voltage relationship for a rat ventricular myocyte. 
The background current(- -) displays inward rectification. The effect of 5OpM 
levcromakalim is shown (-"-). Also shown are the effects of 1 pM glibenclamide 
(-A-), 10pM UCL1880(-y-) and 100pM barium(-*---). The cell was held at 
approximately -5OmV. Voltage steps were applied in 10mV increments, down by 
-7OmV and up by +90mV, relative to the holding potential. Blockers were applied 
in the presence of levcromakalim. Current-voltage traces were recorded 4 minutes 
after application of blocker. 
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Figure5.3.2.5: Log-concentration response curves showing the effects of 
barium (-. -), glibenclamide (-"-), cetiedil UCL1880 (-v-) and 
UCL 1495 (_" ) on the current induced by 50pM Ievcromakalim in rat ventricular 
myocytes. Cells were held at -50mV. Averages are from at least 3 observations. 
Note that only barium was fitted with a Hill equation giving an IC 50 value of 
165 
±14pM, and a Hill slope of 1.2± 0.1. 
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The effects of all the compounds tested are summarized in Table 5.3.1. 
COMPOUND CONCENTRATION % n 
(µM) INHIBITION 
OF IKATP 
UCL1880 2 26 ±6 9 
10 70±12 4 
UCL1495 2 7±5 7 
10 6 ±4 3 
GLIBENCLAMIDE 1 66 ± 15 7 
CETIEDIL 2 15 ±8 3 
20 66±8 10 
Table 5.3.1. Effects of UCL 1880, UCL 1495, glibenclamide and cetiedil on 
IKATP in rat ventricular myocytes. The values are % inhibitions of the outward 
current activated by 50µM levcromakalim, at a holding potential of - -50mV. 
Values are averages of the n number indicated in the extreme right hand side 
column. 
5.3.3: A SPONTANEOUSLY DEVELOPING OUTWARD CURRENT IN ATRIAL 
MYOCYTES. 
In atrial cells during some long recordings an outward current developed 
which was susceptible to block by glibenclamide. Though recordings from these 
cells were normally discontinued, Figure 5.3.3 shows an outward current 
developing in a cell after a long recording of -' 15 minutes. The current 
increased over a period of 2 minutes and was blocked by 20µM glibenclamide. 
Although such currents appeared after long recordings they were not observed 
in all long recordings. Thus the testing of drugs on this current was in 
accordance with the type of experiment being carried out. The current amplitude 
observed in 13 cells was 159 ± 41pA and the application of 20µM 
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ý_ 
1 minute 
300pA 
Figure 5.3.3: Effect of glibenclamide on a spontaneous outward current in an 
atrial myocyte cell. The horizontal bar above the trace indicates the application 
of 20µM glibenclamide. The cell was held at -50mV The horizontal arrow on 
the left indicates the zero current level. 
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glibenclamide blocked the current by 100% (n=3) though this is a high 
concentration and possibly enough to block other channels. Lower 
concentrations of glibenclamide were not tested, and this remains for a future 
study. This will be discussed further in the Discussion of this chapter (section 
5.4). 
5.4: DISCUSSION: 
5.4.1: THE LEVCROMAKLIM-ACTIVATED CURRENT. 
The results presented in this chapter indicate the presence of KATP 
channels in rat ventricular cells which can be activated by the K+-channel 
opener levcromakalim and blocked by the sulphonylurea glibenclamide. In 
contrast, levcromakalim was not effective in activating an outward current in rat 
atrial cells in studies under identic t conditions. It is possible that there are not 
as many KATP channels in the atrial as compared with the ventricular cells. 
The atrial cells sometimes spontaneously developed an outward 
current which is blocked was glibenclamide, strongly suggest that rat atrial cells 
do contain KATP channels. Thus there may be a tissue-specific action of 
levcromakalim. There are precedents for this. For example, vascular smooth 
muscle is 10-30 times more sensitive to the effects of cromakalim than cardiac 
tissue and also cromakalim is more potent in ferret than in guinea-pig papillary 
muscle (Quast eta!., 1988, Winquist et al., 1989) - thus it may be that KATP 
channels in atrial cells are less sensitive to the effects of cromakalim than the 
channels in ventricular cells. This would merit further study. 
IKATP is weakly rectifying and as seen in Figure 5.3.1.2 at potentials 
positive to the net reversal potential the current-voltage relationship is almost 
linear, showing appreciable rectification only at about +25mV. This has been 
reported previously (Isenberg et al., 1983; Hamada et al., 1990; Wilde et al., 
1990; Benndorf et al., 1992; Findlay et al., 1993). In single channel studies it 
has been reported that KATP currents are more strongly rectifying when external 
[K+] is increased (Krause et al.., 1995). 
5.4.2: Ti-f; BLOCK OF THE LEVCROMAKLIM-ACTIVATED CURRENT. 
THE LEVCROMAI-ALIM-LSD ('CED CtBREIFT 
148 
The results presented in this chapter show that UCL1880 blocks the 
levcromakalim-induced current at -50mV though at concentrations higher 
than those needed to block IKACh (Chapter Three). The block occurred fairly 
soon after addition of UCL1880 and there was no recovery from a 10µM 
application even after 15 minutes. It may be recalled from Chapter Three that 
recovery was also very slow for the block of the G-protein-gated current by 
UCL 1880. To reliably estimate recovery from block by UCL 1880 it is essential 
that the current activated by levcromakalim is maintained at a steady level. 
However the levcromakalim response seems to suffer varying degrees of 
rundown which in some cases frustrated a proper assessment of recovery. 
However channel rundown was not observed in other experiments and also the 
blocks by glibenclamide, barium, and cetiedil were reversible. Therefore it 
seems likely that UCL1880 takes a long time to wash out of the lipid 
membranes or dissociates slowly from the channel protein, especially after high 
concentrations have been applied. 
The structural analogue of cetiedil, UCL1495, caused only a small 
reduction in the KATP current at concentrations of up to 10µM even after a4 
minute incubation period. 
Cetiedil is the lead compound from which UCL1495 was developed and 
was found to be effective in blocking the G-protein-gated current (Jones, 1995) 
and the red blood cell Cat+-activated K+ channels (Benton, 1995,1996) and it 
proved to be effective in blocking the levcromakalim-activated current at 
concentrations between 2 and 20µM. 
An interesting observation in atrial cells was the spontaneous activation 
of an outward current after long recordings (over 10 minutes). This current was 
susceptible to block by glibenclamide and was thus considered to be the KATP 
current. The appearance of this current was an unexpected observation since the 
application of levcromaklim to the atrial cells did not result in the activation of 
an outward current. The activation of an outward current after long recordings 
has been observed in guinea-pig ventricular myocytes (Belles et al., 1987) 
where the current was blocked by tolbutamide with an IC50 of 0.38mM. It was 
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also observed that increasing the concentration of intracellular ATP delayed the 
development of the spontaneous current (Belles et al., 1987). 
The current which develops spontaneously may be a consequence of cell 
deterioration and metabolic inhibition. Intracellular nucleotide diphosphates 
(NDP) build up during metabolic inhibition and are thought to activate the KATP 
channels. In smooth muscle cells the characteristics of these channels are similar 
to the KATP channels and it is thought that the blocking effects of ATP only 
occur after activation of the channel by NDPs (Beech et al., 1993). Subsequent 
studies have revealed two types of ATP-sensitive K' channels in smooth 
muscles of rat portal vein one of which is similar to the 'traditional' KATP 
channesl and the other is thought to be the one regulated by NDPs, KNDP, 
(Zhang and Bolton, 1996). It has been suggested that the main target for KCOs 
in rat mesenteric artery smooth muscle cells is the small conductance KNDP 
channel (Zhang and Bolton, 1995) (see General Introduction). 
This seems to be the situation in smooth muscle cells, but are there also 
two types of KATP channels in cardiac cells? Thus far there has been no evidence 
which indicates the existence of two channel types in cardiac myocytes. The 
effects of sulphonylureas such as tolbutamide and glibenclamide on the channel 
activated by metabolic inhibition in the intact heart are less compared to their 
effects on KATP channels in excised membrane patches. It is thought that during 
myocardial ischemia and hypoxia, cytosolic [ADP] rises to the 100µM range 
and this may account for the limited potency of sulphonylureas under these 
conditions, perhaps by competing for the same binding site (Venkatesh el al., 
1991). 
It has also been observed in ventricular myocytes from rat hearts that 
sulphonylurea drugs lose their ability, with time, to inhibit the ATP-sensitive 
channels activated by metabolic inhibition (Findlay 1993). The ability of 
tolbutamide and glibenclamide to block the current activated by bimakalim was 
unaltered. The increase of ADP during metabolic inhibition was thought to be 
the reason for this change in sensitivity to sulphonylureas (Findlay 1993). 
It has also been proposed that the difference in sensitivity of the 
channels to block by sulphonylureas may be due to the difference in their 
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activation. Firstly the channels activated by metabolic inhibition have twice the 
conductance of the channels activated by rilmakalim and, secondly, the current 
that was activated by rilmakalim was blocked by glibenclamide with an IC50 of 
8nM whereas the block of the current activated by metabolic inhibition occured 
with an IC50 of 48OnM (Krause et al., 1995). This may reflect the activation of 
different KATP channel subtypes or possibly differences in the state of a single 
channel. 
In the present work Ba 2+ blocked the ATP-sensitive K+ channels with an 
IC50 of 164µM and an nH value of 1.15 at -50mV. In pancreatic ß-cells the 
blocking action of Ba 2+ is voltage-dependent, the IC50 being 180µM at -62mV 
and -13 µM at -123 mV but it is not thought that K+ and Ba 2+ compete for the 
same site since increasing [K+]o did not affect the Ba 2+ block observed (Takano 
and Ashcroft 1996). However in frog skeletal muscle, where the block by Ba 2+ 
occurred with an IC50 of 85mM at OmV, single channel studies showed that Ba 2+ 
decreased the mean channel lifetime of KATP channels indicating that there was 
a block of the open channels (Quayle et al., 1988). However, Quayle et al., 
(1988) did not examine the effects of altering external K+ on Ba2+ block. Thus it 
is not clear whether or not Bat' and K+ compete for the same site within KATP 
channels, but it is most likely that there is a block of open channels as is the case 
for the Ba 2+ block of IK1 and IKACh (see Chapter One). 
The results obtained in this chapter reveal that the concentrations of 
glibenclamide needed to block KATP channels are much less than those needed 
to block IKACh. Thus it appears that the application of adenosine to rat 
ventricular cells does not lead to a significant activation of ATP channels. 
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CHAPTER SIX: DISCUSSION OF RESULTS. 
The following section contains a brief discussion of the three different 
currents investigated in the present study and the effects of the drugs on them. 
This is be followed by a final passage discussing the relative potencies of each 
drug on these currents. 
6.1: THE INHIBITION OF THE G PROTEIN-GATED K+ CURRENT. 
The results presented in Chapter 3 have shown that adenosine when bath 
applied at 1 µM activates an outward current that displays some fade. Its 
characteristics have been discussed in discussed in Chapter 3. UCL1880, 
UCL1495, glibenclamide and Bat block this current measured at a standard 
holding potential of -50mV. 
Of the novel compounds tested the clotrimazole analogue UCL 1880 is 
the most potent inhibitor of the G protein-gated K+ channel in neonatal rat atrial 
myocytes, with an IC50 of 0.18±0.02µM. UCL1495 and glibenclamide inhibit 
with IC50 values of 0.46 and 24µM, respectively. It was observed that UCL1880 
altered the `shape' of the current in response to adenosine in that there was an 
increase in fade compared with that seen in the control response, suggesting a 
use-dependent action. Importantly, at low concentrations there was no reduction 
in the peak response but the current decayed to a lower steady state level. This 
has been observed previously for the effect of clotrimazole on the adenosine- 
induced change in conductance in rat atrial myocytes (Jones, 1995). Quantifying 
the ratio of steady state to peak current confirmed that UCL1880 caused a 
significant increase in fade. UCL1495 was also active in this regard. However, 
no change in fade was observed for the adenosine-response in the presence of 
glibenclamide. 
In principle, it is possible that UCL1880 and UCL1495 could block the 
receptor, the receptor-G protein interaction, the activated G protein, the 
activated G protein-channel interaction or the open channel. There is, however, 
little or no block of closed channels by these two compounds, as assessed by the 
unchanged peak current recorded in low concentrations of drug. UCL 1880 also 
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blocked the response to ACh in the atrial myocytes thus increasing the 
likelihood of a block occurring after receptor activation. The use of GTP-y-S in 
some experiments allowed the blocking effect of the compounds on the current 
to be studied independent of receptor activation. Any inhibition of the 
current would therefore not be due to a block at the receptor level. UCLI 880 did 
in fact have a blocking effect on the current supported by GTP-y-S though 
increased concentrations were required and there was also some suggestion that 
a residual component of the current remained unaffected. This residual 
UCL1880-insensitive current could possibly be IKA. rP as this 
has been reported 
to be regulated by G proteins (Ito et al., 1992, Terzic et al., 1994). However, 
since 1 pM glibenclamide was much less effective against this current than it 
was on the KATP channels activated by levcromakalim in ventricular cells, 
(Chapter 5) IKATP is unlikely to have been involved. This has been discussed 
further in Chapter 3. 
It has previously been observed that UCL1495 inhibited the adenosine- 
induced increase in conductance in rat atrial myocytes with an IC50 of - 0.4µM 
and 1 pM UCL 1495 blocked the GTP-y-S current in the same tissue by -40% 
(Jones, 1995). The IC50 value for inhibition of the adenosine response - by 
-50% - was estimated in the present study to be 0.46µM. It would appear that 
the block of the preactivated current by 1 µM UCL 1495 is less than the expected 
level of block. This can be taken as additional evidence to support the 
suggestion that the inclusion of GTP-y-S in the filling solution causes the 
activation of another conductance which is insensitive to both UCL 1880 and 
UCL1495. Jones (1995) observed that application of 20µM cetiedil resulted in 
an almost complete block of the GTP-y-S current, and the block seen in the 
present study by 20µM cetiedil was -60%, - almost maximal. This further 
supports the idea that there is, in addition to activation of the IKACh, activation of 
another component insensitive to UCL1880, UCL 1495 and cetiedil. 
As noted in Chapter 3, control responses to adenosine showed fade. 
Low concentrations of UCL 1880 and UCL 1495 increased the fade. Thus it 
could be speculated that these compounds increase the desensitisation process as 
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their mechanism of block. For example, ß-arrestin has been observed to increase 
the desensitisation observed in the response to ACh in reconstructed muscarinic 
receptor/K+ channel in Chinese hamster ovary cells (Shui et al, 1998). The 
activation of the muscarinic response and the recovery from desensitisation was 
also slower in the presence of ß-arrestin. In the present study the adenosine 
response took a long time to recover after washout of high concentrations of 
UCL1880. This has also been observed for high concentrations of 
clotrimazole (Jones, 1995). Initial responses to adenosine after washout of the 
drug still displayed a characteristic fade. It was concluded by Jones (1995) that, 
since clotrimazole is lipophilic, it dissolves in the membrane lipid and moves 
from lipid membrane to K+ channels when these open in response to subsequent 
applications of adenosine. The outcome is channel block. The same may hold 
for UCL1880. 
Drugs blocking open channels are often found to bind to a site in the 
pore of the channel which is within the electrical field of the membrane. This 
would be expected to lead to an effect of voltage on the action of blocking 
agents that carry an electrical charge. However, the block of the adenosine- 
current by UCLI 880 and UCL1495 displayed little voltage-dependence. It is 
possible that the drugs are blocking the open channel in an un-ionised form that 
is not affected by voltage. Alternatively, the concentration attained at the 
blocking site may not be influenced by the membrane potential. 
Glibenclamide blocked the IKACh current with an IC50 of 24µM. There 
was no evidence of use- or voltage-dependence block. The block of the GTP-y- 
S current, as well as that elicited by adenosine, reduces the likelihood that the 
block occurs at the receptor. An action at the channel and/or the G protein is 
more probable. The lack of a use-dependent or a voltage-dependent effect does 
not completely rule out a block of the channel since glibenclamide may block in 
an un-ionised form, or it may act a site beyond the electrical field. However, as 
discussed later, glibenclamide is known to interact with the sulphonylurea 
receptor to block the K: \TP current. There is no published work showing 
glibenclamide blocks K' channels directly. Thus it may be that the block of the 
IK: 
k(, i, 
by glibenclamide is due to a cardiac SUR associating with the channel 
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protein. Alternatively it is possible that adenosine activates KATP in addition to 
Koch channels and this possibility is discussed later. 
6.2: THE EFFECT OF DRUGS ON IKI 
Rat atrial myocytes displayed an inwardly rectifying background 
current. The current pulse induced by a step to -120mV showed varying degrees 
of inactivation which has been attributed to block by extracellular cations, in 
particular Na+. This has been discussed in Chapter 1 and 4. There was minimal 
block of this current by UCL1880, UCL1495 and glibenclamide at those 
concentrations that were effective in blocking the adenosine-induced current. 
Ba 2+ blocked the current with an IC50 of 17µM at -120mV. It was the initial aim 
to compare any blocking action of the novel compounds with the blocking 
action of Ba2+ to determine if there was any open channel block. 10µM 
UCL 1880 blocked the current by -20% without affecting the kinectics. In 
contrast low concentrations of Ba2+ caused an increase in the decay (see Figure 
4.3.2.1 and section 4.3.3). Therefore the small block which occurred by 
UCL1880 was not the same as the block seen by Bat+. 
6.3: THE EFFECT OF DRUGS ON IKA. LP- 
The current activated by levcromakalim in the ventricular cells was 
blocked by glibenclamide with an IC50 of less than 1 µM. This is less than the 
reported values of 5-20µM for glibenclamide block of these channels in cardiac 
cells (Zunkler et al., 1988a, b, Rippoll et al., 1990). It is generally thought that 
the sulphonylurea receptors SUR2A and SUR2B are both present in cardiac 
tissue. SUR1 is thought to combine with the channel in pancreatic ß-cells and 
to be responsible for the increased potency of glibenclamide in these cells. Since 
the mRNA for SUR1 has been detected in small amounts in the heart (Inagaki et 
al., 1995; Anguilar-Bryan et al., 1995) it may be possible that in neonatal rats 
there is a significant amount of SURI combining with Kir6.2 which results in an 
increased potency of block by glibenclamide. 
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UCL 1880 was also effective in blocking the levcromakalim-induced 
current, exhibiting an IC50 of --5µM. It is thus less potent on the levcromakalim- 
activated current than it is on the adenosine-induced current. Cetiedil blocked 
the current with an IC50 of '10µM whereas the structural analogue UCL1495 
did not cause any block even at 
10µM. Ba 2+ blocked the current with an IC50 of 165µM at -50mV thus being 
much less potent than on the adenosine-induced current and the background 
inwardly rectifying current. 
6.4: SELECTIVE EFFECTS OF THE COMPOUNDS TESTED BETWEEN IKACW 
11K1 AND IKATP 
The compounds tested in this study display some degree of selectivity in 
their blocking effect between the currents that were examined. The order and 
degree of 
selectivity and any similarities in blocking actions are discussed in the following 
sections with reference to each compound. 
UCL1880: 
It has been shown that UCL1880 is not as effective in blocking IKland 
IKATP currents in cardiac myocytes as it is in blocking IKACh. The results are 
summarised in Figure 6.1.2µM UCL1880 caused a block of - 90% of the G- 
protein-gated current but virtually no block of the IK1 current. When tested 
against the current activated by levcromakalim in ventricular myocytes 2µM 
caused a block of 26%. Thus it appears that the UCL1880 has considerable 
selectivity for IKACh . 
The adenosine-induced current is regulated by G proteins and there is 
evidence to suggest that K: \TP channels may also be modulated by G proteins. It 
might be concluded, therefore, that UCL 1880 interacts in some way with G- 
proteins to suppress the current. However the activation of K:, TP channels by 
levcromakalim does not involve G protein activation and yet they are blocked 
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Figure 6.1: The effect of UCL 1880 on the three inward rectifiers; 
the G protein-gated current, the KA current and the background 
inward rectifier, I.. 
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by UCLI 880. Also'K1 is not regulated by G-proteins. An action of UCL1880 
through G-proteins therefore seems unlikely. 
UCL 1495 : 
UCL1495 was highly selective for block of the adenosine-induced 
current with an IC50 of 0.4µM whereas concentrations of 2µM and 10 µM did 
not inhibit either IK1 or IKATP. The results for the effect of UCL1495 are 
summarised in Figure 6.2. bearing in mind its blocking actions on some other 
K' currents, such as the Cat+-activated K+ conductance in erythrocytes (IC50 of 
1.2µM), (Benton et al., 1994) as well as the G-protein-gated current and its use- 
dependent action, the block most probably occurs at the G protein and/or the 
channel level. 
GLIBENCLAMIDE: 
Glibenclamide is known to block IKATP by interaction with SUR which is 
thought to be specific for KATP, and there is no evidence to indicate that it is 
capable of blocking channels directly (though see later). In the present study, 
glibenclamide blocked the G protein-gated current with an IC50 of 24µM with 
no evidence of use- or voltage- dependence. The block of the levcromakalim- 
activated current occurs at concentrations lower than 1 µM. 
The results in this study are summarised in Figure 6.3 and show that 
1 pM glibenclamide blocks the KATP channels by 66%, compared. with an IC50 of 
24µM against the KACh current. Since 2µM -the lowest concentration tested on 
the KACh current - caused a block of only -7% of the adenosine induced current 
it seems unlikely that there is any significant contribution of KATP channels to 
the adenosine response in neonatal rat atrial myocytes. 
6.5: DOES THE SUR ASSOCIATE WITH AND MODIFY INWARDLY 
RECTIFYING K+ CHANNELS OTHER THAN KATP? 
The effects of glibenclamide are thought to occur through its interaction 
with the sulphonylurea receptor. Thus if the SUR was to combine with other 
inward rectifier channel proteins this might produce a mechanism whereby 
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Figure 6.2: The effect of UCL 1495 on the IKACL, IkATP and IK, currents in neonatal 
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glibenclamide could modify their activation. It has been suggested that the SUR 
associates with an endogenous Kir in HEK293 cells as the current was inhibited 
by tolbutamide with an IC50 of 5.3µM (Ämmälä et al., 1996). Also block by 
tolbutamide and glibenclamide of Kirl. Ia and Kir6.1 expressed in these cells, 
was only seen when the cloned subunits were coexpressed with the SUR. Thus 
it appears that the SUR may associate with Kirs in general and not just Kir6.2. 
Any blocking effect of glibenclamide may therefore be indicative of the 
presence of a SUR associating with inward rectifier channels. Contrastingly, it 
has been observed that the endogenous KIR current in coronary vascular smooth 
muscle is blocked by 100µM glibenclamide by only 16% - whereas in the same 
tissue glibenclamide concentrations below 10µM were sufficient to block the 
KATP current (Wellman et al., 1996). This would argue against any general 
association of the SUR with the KIR channel. It seems possible that the SUR in 
atrial cells of the rat can associate with the G-protein gated channel making it 
susceptible to block by glibenclamide. From the results in Chapter Four, and 
applying the above argument, it can be concluded that the SUR does not 
associate with the IK1 channel in rat atrial cells because of the lack of effect of 
50pM glibenclamide on this current. 
There are two possibilities regarding the effect of glibenclamide on the 
G-protein gated channels. The first is that there is association of SUR with the G 
protein-gated channels but not the IK1 channel. This would explain the block of 
the adenosine induced current and the lack of block of the IK1 by glibenclamide . 
The differences in the concentrations needed to blockIKACI, and IKATP may be 
due to the binding to the channels of different SURs which each have their own 
affinity for glibenclamide. 
The interpretation that the block of the adenosine-induced current by 
glibenclamide is due to adenosine activation of KATP is dependent upon the 
supposition that glibenclamide is specific for KATP channels. This may be the 
second possibility : it may be, in fact, that glibenclamide is not as selective as it 
was first thought. It is possible that glibenclamide blocks the G-protein-gated 
channel directly. Phentolamine, an a-adrenoceptor antagonist, has been 
observed to block the wild type Kir6.2/SUR1 and the Kit-6.2 independent of 
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SUR] currents expressed in Xenopus oocytes with similar potencies of -1 µM 
(Proks and Ashcroft, 1997). The Hill coefficients were -1 suggesting a 1: 1 
interaction between drug molecule and binding protein. It was concluded that 
phentolamine binds with the Kir6.2 protein to cause inhibition. A blocking 
action of glibenclamide may, therefore, not be indicative of either KATP or a 
SUR, but may be due, instead, to the sulphonylurea blocking the K+ channel 
directly. 
6.6: THE EFFECT OF BARIUM: 
Ba2+ blocks all three currents and is most potent on the IK1 current with 
an IC50 of 17µM at -120mV. The effects of Ba 
2+ are summarised in Figure 
6.4. The effect of voltage was difficult to determine due to the lack of any 
significant current at the holding potential of -50mV. An increased current 
would have been obtained by using a higher [K' ]o or by holding at OmV and 
investigating the currents at -50 and -lOmV. Ba2+ blocks the adenosine-induced 
current with an IC50 of 35µM at -50mV and 3.8µM at -120mV. This is in 
keeping with other studies which have also demonstrated that the block by Ba2+ 
is dependent on voltage and on the concentration of external K+, indicating that 
Ba 2+ blocks the open channel (Standen et al., 1978, Zang et al., 1995, Carmeliet 
and Mubagwa). The dependence on external K+ may also indicate that both Ba 2+ 
and K+ share a common binding site within the channel pore. Ba 2+ blocked the 
levcromakalim-induced current at -50mV with an IC50 of 165µM which is close 
to reported values such as 180µM at -62mV in pancreatic ß-cells (Takano and 
Ashcroft, 1996). Single channel studies in frog skeletal muscle show that Ba 2+ 
decreases the mean channel open time suggesting a block of the open channels 
(Quayle et al., 1988). 
The blocking action of Ba 2+ is known to be dependent on the presence of 
specific amino acid residues within the channel peptides. For example expressed 
Kir2.3/HRKI channels which are strongly rectifying are blocked by external 
Cs' 
, with an 
IC50 of 50µM, and by Ba 2+ with an IC50 of 60µM. Kirl. l a/ROMK 1 
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channels which are weak rectifiers are blocked by Ba 2+ with an IC50 of 50µM, 
and are almost insensitive to Cs' with an IC50 of - 3mM. Mutation of aspartate 
(164) in the M2 region of Kir2.3 to asparagine reduced the sensitivity to Cs+ 
and Ba 2+ (IC50 of 200 and 300µM respectively). Mutation of asparagine at the 
corresponding site (171) in Kirl. Ia to aspartate increased the sensitivity of the 
channel to Ba 2+ and Cs+ (IC50 of 10µM and 1 mM respectively). Thus negative 
charges at these sites increase Ba 2+ sensitivity and block by external cations 
(Henry et al., 1996). 
The differences in potencies of Ba 2+ and the other compounds in 
blocking the currents and the possible role of the structure of the channels in 
determining the block observed will now be discussed. 
6.7: THE CONTRIBUTION OF CHANNEL STRUCTURE TO THE EFFECTS OF 
THE COMPOUNDS TESTED. 
The selective blocking action of UCL 1495 on the G-protein-gated 
current would be expected to be closely related to the structure of the channel. 
There are sites within the channel which have been shown to be important in the 
binding of Mg2+ and polyamines and so in controlling rectification (see Chapter 
1). Sites in the M2 and C-terminal domain -referred to as binding sites R1 and 
R2 - are both negatively charged in strong rectifiers, for G protein channels 
only one site is negatively charged and in weak rectifiers the amino acids are 
neutral (Lu and MacKinnon, 1994; Lopatin et al., 1994; Ficker et al., 1994; 
Wible et al., 1994; Stanfield et al., 1994; Yamada et al., 1995). It is highly 
likely that there are sites in the channel which determine the block by the novel 
compounds tested in this study. Identifying these sites requires one to know 
whether the drugs block in ionised or unionised forms and whether they block 
from the inside or the outside of the membrane, or from within it. This 
information has still to be obtained. Using our present knowledge of the 
structural determinants of rectification it can be speculated that if the drugs 
block from the inside then the channels with negative residues at both R1 and 
R2, i. e. lKl, will be most potently blocked by the compounds and the channels 
with neutral residues at these sites i. e. KATP should be the least blocked in 
accordance with this theory. 
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UCL 1495 is rather potent against the IKACh and at the concentrations 
tested had no blocking effect on the other two currents. UCL1880 is also the 
most potent of the compounds tested in blocking the G protein gated current and 
is -25 times more active than on the KATP current. There is also a small block of 
the IK, current at higher concentrations. The results from the Bat' experiments 
showed that Ba 2+ was most potent on the IK1, then IKACh and least potent on 
IKATP. These findings with Ba 2+ are in keeping with what is known about the 
residues present in the R1 and R2 positions. UCL1880 blocks with a quite 
different order of potency and so it may be concluded that the residues present 
at RI and R2 are not important for its blocking action. UCL1495 is selective for 
the adenosine-induced current and has no effect on the other two. Thus it is 
possible that these residues are again not important. 
The Hill slopes can give information (albeit indirectly) regarding the 
number of drug molecules binding to the channel. UCL1880 has a Hill slope of 
-1 which at face value indicates a 1: 1 interaction between the drug molecule 
and the blocking site. The same applies to glibenclamide which has a Hill slope 
of 0.8. For UCL1495 the Hill slope is 1.7, significantly greater than 1. This may 
mean either that more than 1 molecule binds to the site of interaction or that 
positive co-operativity occurs. 
The Hill slope for Ba 2+ block of IKACh is 0.6 at -50mv and 0.5 at - 
120mV. For IK1 the slope is only 0.2 at -120mV. For IKATP the slope is 1.2 . 
Thus 
for IK 
ATP and perhaps 
IKACh there may be a 1: 1 interaction of Ba 2+ with its 
binding site but for IK1 the data is inconsistent with so simple a scheme. It is 
unlikely that there is 'negative co-operativity'. The data for Iß; 1 
in Figure 6.4 
which summarises the effect of Ba2+ on the three inward rectifiers may be fitted 
with 2 components though the precision of the data is too low to allow this to be 
done with any certainty. It is unlikely that Bat' has 2 binding sites with different 
affinities as it has been well established that Bat' has a 1: 1 interaction at a site 
within the channel pore (Zang et al., 1995, Carmeliet and Mubagwa, 1996). It 
seems more likely that Ba 
2+ is blocking 2 populations of K+ channels. As 
mentioned previously in Chapter 4 there is activation of If as well as IK, on 
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stepping to hyperpolarising potentials. Whilst it is generally considered that 
these channels are present in the cells of the sino-atrial node where they are 
involved in the pacemaker activity (DiFrancesco, 1993) a hyperpolarisation 
activated current has also been described in atrial tissues (Thuringer et al., 
1992). Another possibility is that some sino-atrial node cells may have been 
present in the culture. Ba 2+ will block the two different channels with different 
affinities. 
The results of this study have revealed that the IC50 values for the block 
of the channels by Ba2+ are in keeping with the amino acids present at the 
important positions in the M2 and C-terminal domain. The Hill slopes for block 
of IKACh and IKATP suggest a 1: 1 interaction of the Ba 2+ ion and its binding site 
within the channel. As described there is a voltage-dependent effect for Bat } 
block of IKACh which suggests that the ion blocks the channel within the voltage 
field, some distance from the external side of the membrane. The low Hill slope 
for the block by Ba2+ of IK1 may be due to the block of another component, 
possibly If, in addition to block of IK1. 
Comparing the blocks by the other compounds with that by Ba 2+ 
suggests, in all likelihood, that the amino acid residues which are important in 
Ba 2+ block in the three channels are not as important for the block caused by 
UCLI880, UCL1495 and glibenclamide. The increased potency of UCLA 880 
and UCL 1495 on the steady state current, and the use-dependent effect data 
suggest a block of the channels. 
6.8: FuTuRE woRK. 
Single channel recordings should prove useful in establishing whether or 
not the compounds UCL 1880 and UCL 1495 block the channel directly, as the 
results suggest. The novel compound UCL1880 has proven to be very potent 
against the G-protein-gated current and exhibits considerable selectivity. 
Investigating its effect on other K-currents - indeed, as many other currents as 
possible- would allow a profile of its selectivity to be built up. It is possible that 
it will prove a useful tool in investigating cardiac K+ currents if it is indeed as 
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selective as appears from my work. Single channel recordings would also aid in 
determining if the activation of the G-protein-gated muscarinic K+ channel 
includes activation of IKATP. It is possible that the block of a current under 
investigation by glibenclamide does not necessarily indicate the presence of 
IKATP. Mutational studies would be useful in identifying the residues within the 
structures of these 3 channels that determine the degree of inhibition observed. 
Finding how UCL1880 interacts with its binding site in the G-protein-gated 
channel - be it a positively or negatively charged residue - could aid the future 
development of compounds of greater potency and selectivity. 
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